Phorbol 12-myristate 13-acetate
Based on 825 publication(s) in Google Scholar
Phorbol 12-myristate 13-acetate (PMA; TPA; Phorbol myristate acetate), a phorbol ester, is a dual SphK and protein kinase C (PKC) activator. Phorbol 12-myristate 13-acetate is a NF-κB activator. Phorbol 12-myristate 13-acetate induces differentiation in THP-1 cells (Validated by MedChemExpress).
For research use only. We do not sell to patients.
- Purity: 99.80%
- CAS No.: 16561-29-8
- Formula: C36H56O8
- Molecular Weight:616.83
-
Storage:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications Citing Use of MedChemExpress (MCE) Phorbol 12-myristate 13-acetate
More- Signal Transduct Target Ther. 2025 Dec 26;10(1):420. [Abstract]
- Signal Transduct Target Ther. 2023 Aug 9;8(1):290. [Abstract]
- Cancer Cell. 2026 Apr 13;44(4):809-830.e11. [Abstract]
- Cancer Cell. 2026 Mar 9;44(3):658-675.e12. [Abstract]
- Science. 2025 Nov 20;390(6775):eadz4712. [Abstract]
- Cell. 2025 Dec 11;188(25):7291-7308.e23. [Abstract]
- Cell. 2025 Aug 21;188(17):4586-4603.e31. [Abstract]
- Cell. 2025 May 29;188(11):3013-3029.e19. [Abstract]
- Cell. 2023 Nov 9;186(23):5114-5134.e27. [Abstract]
- Mol Cancer. 2026 Jan 5;25(1):3. [Abstract]
- Mol Cancer. 2025 Jul 19;24(1):199. [Abstract]
- Cell Metab. 2025 Jan 7;37(1):87-103.e10. [Abstract]
- Cell Metab. 2024 Aug 6;36(8):1806-1822.e11. [Abstract]
- Cell Res. 2023 Aug;33(8):585-603. [Abstract]
- Adv Mater. 2025 Nov 14:e17968. [Abstract]
- Adv Mater. 2025 Jul;37(28):e2501137. [Abstract]
- Mil Med Res. 2022 Aug 23;9(1):46. [Abstract]
- Cancer Commun (Lond). 2025 Dec 26.
- Cancer Commun (Lond). 2025 Jun;45(6):677-701. [Abstract]
- Nat Cancer. 2025 May;6(5):768-785. [Abstract]
- Nat Immunol. 2025 Oct;26(10):1660-1672. [Abstract]
- Cell Mol Immunol. 2026 May;23(5):491-504. [Abstract]
- Cell Mol Immunol. 2026 Apr;23(4):349-366. [Abstract]
- Bioact Mater. 2025 Aug 20:54:248-272. [Abstract]
- Bioact Mater. 2024 Jul 24:41:271-292. [Abstract]
- Cell Host Microbe. 2025 Jun 11;33(6):915-931.e9. [Abstract]
- Nat Cell Biol. 2026 Apr;28(4):812-827. [Abstract]
- Nat Cell Biol. 2024 Jun;26(6):1003-1018. [Abstract]
- Adv Fiber Mater. 2025 Mar 10.
- Cancer Res. 2024 Dec 16;84(24):4199-4213. [Abstract]
- Cancer Res. 2023 Mar 15;83(6):906-921. [Abstract]
- Cancer Res. 2021 Jun 15;81(12):3215-3228. [Abstract]
- J Extracell Vesicles. 2026 Apr;15(4):e70276. [Abstract]
- Sci Bull. 2024 Dec 30;69(24):3908-3924. [Abstract]
- Bone Res. 2025 Jun 11;13(1):60. [Abstract]
- Adv Funct Mater. 2024 Jun 25.
- Adv Funct Mater. 2024 May 1.
- Autophagy. 2026 May 25. [Abstract]
- Protein Cell. 2022 Apr;13(4):281-301. [Abstract]
- Nat Commun. 2026 May 14. [Abstract]
- Nat Commun. 2026 May 27. [Abstract]
- Nat Commun. 2026 Mar 27;17(1):2800. [Abstract]
- Nat Commun. 2025 Nov 11;16(1):9915. [Abstract]
- Nat Commun. 2025 Nov 24;16(1):10384. [Abstract]
- Nat Commun. 2025 Oct 10;16(1):9015. [Abstract]
- Nat Commun. 2025 Jul 18;16(1):6610. [Abstract]
- Nat Commun. 2025 Feb 24;16(1):1909. [Abstract]
- Nat Commun. 2025 Jan 15;16(1):687. [Abstract]
- Nat Commun. 2024 Sep 12;15(1):7996. [Abstract]
- Nat Commun. 2024 Jul 18;15(1):6043. [Abstract]
- Nat Commun. 2022 Aug 15;13(1):4795. [Abstract]
- ACS Nano. 2026 Jun 30;20(25):18111-18131. [Abstract]
- ACS Nano. 2025 Dec 16;19(49):41540-41556. [Abstract]
- ACS Nano. 2025 Mar 11;19(9):9390-9411. [Abstract]
- J Adv Res. 2025 Jul 12:S2090-1232(25)00545-4. [Abstract]
- Trends Biotechnol. 2026 May 7:S0167-7799(26)00144-7. [Abstract]
- Redox Biol. 2025 Feb:79:103449. [Abstract]
- Mol Cell. 2022 Jul 7;82(13):2401-2414.e9. [Abstract]
- Gut Microbes. 2024 Jan-Dec;16(1):2410474. [Abstract]
- J Nanobiotechnology. 2025 Dec 20. [Abstract]
- J Nanobiotechnology. 2025 Jul 26;23(1):540. [Abstract]
- J Nanobiotechnology. 2025 Feb 17;23(1):114. [Abstract]
- J Nanobiotechnology. 2024 Sep 12;22(1):556. [Abstract]
- J Nanobiotechnology. 2022 Mar 9;20(1):120. [Abstract]
- Theranostics. 2025 May 25;15(13):6329-6346. [Abstract]
- Theranostics. 2024 Feb 24;14(5):1909-1938. [Abstract]
- Theranostics. 2022 Apr 4;12(7):3251-3272. [Abstract]
- Acta Pharm Sin B. 2026 Jun 8.
- Genes Dis. 2026 Feb 28.
- Acta Pharm Sin B. 2025 Aug;15(8):4078-4095. [Abstract]
- Acta Pharm Sin B. 2024 Oct;14(10):4360-4377. [Abstract]
- Acta Pharm Sin B. 2022 Apr;12(4):1840-1855. [Abstract]
- Acta Pharm Sin B. 2021 Jan;11(1):71-88. [Abstract]
- J Clin Invest. 2025 Aug 1;135(15):e191119. [Abstract]
- Adv Sci (Weinh). 2026 Jun;13(36):e23605. [Abstract]
- Adv Sci (Weinh). 2026 Jun 15:e76131. [Abstract]
- Adv Sci (Weinh). 2026 Jun;13(32):e17642. [Abstract]
- Adv Sci (Weinh). 2026 Jun;13(31):e74889. [Abstract]
- Adv Sci (Weinh). 2026 Apr;13(20):e15431. [Abstract]
- Adv Sci (Weinh). 2026 Apr;13(23):e15742. [Abstract]
- Adv Sci (Weinh). 2026 Apr 24:e19955. [Abstract]
- Adv Sci (Weinh). 2026 Jan 9:e18180. [Abstract]
- Adv Sci (Weinh). 2025 Dec 5:e15693. [Abstract]
- Adv Sci (Weinh). 2025 Sep;12(33):e14909. [Abstract]
- Adv Sci (Weinh). 2025 Sep 23:e11945. [Abstract]
- Adv Sci (Weinh). 2025 Sep 24:e09073. [Abstract]
- Adv Sci (Weinh). 2025 Aug;12(30):e00225. [Abstract]
- Adv Sci (Weinh). 2025 May;12(17):e2417312. [Abstract]
- Adv Sci (Weinh). 2025 Mar;12(10):e2411274. [Abstract]
- Adv Sci (Weinh). 2025 Feb;12(7):e2412740. [Abstract]
- Adv Sci (Weinh). 2025 Jan;12(2):e2406865. [Abstract]
- Adv Sci (Weinh). 2024 Dec;11(45):e2404756. [Abstract]
- Adv Sci (Weinh). 2024 Dec;11(45):e2404571. [Abstract]
- Adv Sci (Weinh). 2024 Nov;11(44):e2401931. [Abstract]
- Adv Sci (Weinh). 2024 Jul;11(26):e2400297. [Abstract]
- MedComm. 2024 May 13;5(5):e535. [Abstract]
- Adv Sci (Weinh). 2024 May;11(19):e2306378. [Abstract]
- MedComm. 2023 Jun 29;4(4):e303. [Abstract]
- Adv Sci (Weinh). 2022 Jan;9(3):e2102435. [Abstract]
- Cell Rep Med. 2026 Jun 16;7(6):102833. [Abstract]
- Cell Rep Med. 2026 Apr 21;7(4):102691. [Abstract]
- Cell Rep Med. 2025 Dec 18:102529. [Abstract]
- Cell Rep Med. 2025 Apr 15;6(4):102079. [Abstract]
- Sci Adv. 2025 Mar 21;11(12):eads8351. [Abstract]
- Biomaterials. 2026 Jun:329:123922. [Abstract]
- Biomaterials. 2026 Feb:325:123600. [Abstract]
- Cell Death Differ. 2025 Dec 15. [Abstract]
- Biomaterials. 2018 Jul:170:70-81. [Abstract]
- Med. 2026 Jan 9;7(1):100936. [Abstract]
- Neuro Oncol. 2024 Dec 5;26(12):2256-2271. [Abstract]
- Neuro Oncol. 2024 Jan 5;26(1):137-152. [Abstract]
- Research (Wash D C). 2026 Apr 27:9:1207. [Abstract]
- Research (Wash D C). 2026 Feb 25:9:1161. [Abstract]
- Research (Wash D C). 2025 Sep 19:8:0902. [Abstract]
- Research (Wash D C). 2025 Jan 30:8:0598. [Abstract]
- Chem Eng J. 2025 Dec 10;527:171773.
- Chem Eng J. 2025 Jul 1.
- J Control Release. 2026 Jun 10:394:114903. [Abstract]
- J Control Release. 2026 Mar 10:391:114629. [Abstract]
- Cancer Biol Med. 2025 Oct 23:j.issn.2095-3941.2024.0241. [Abstract]
- J Control Release. 2025 Apr 10:380:1109-1126. [Abstract]
- J Control Release. 2020 Apr 10:320:304-313. [Abstract]
- Cell Death Dis. 2026 Jun 23. [Abstract]
- Cell Death Dis. 2026 May 20. [Abstract]
- Cell Death Dis. 2026 Mar 30;17(1):430. [Abstract]
- Cell Death Dis. 2025 Dec 19. [Abstract]
- Cell Death Dis. 2025 Nov 24;16(1):856. [Abstract]
- Cell Death Dis. 2025 May 14;16(1):379. [Abstract]
- Cell Death Dis. 2025 Apr 26;16(1):345. [Abstract]
- Cell Death Dis. 2025 Apr 15;16(1):301. [Abstract]
- Pharmacol Res. 2024 Dec:210:107525. [Abstract]
- Environ Sci Technol. 2024 Feb 13;58(6):2652-2661. [Abstract]
- Cell Mol Biol Lett. 2024 Jan 3;29(1):8. [Abstract]
- Environ Sci Technol. 2023 Jan 10;57(1):428-439. [Abstract]
- Pharmacol Res. 2023 Jan:187:106564. [Abstract]
- Pharmacol Res. 2022 Sep:183:106376. [Abstract]
- Cell Death Dis. 2022 Feb 24;13(2):183. [Abstract]
- Cell Death Dis. 2021 Aug 30;12(9):818. [Abstract]
- Cell Death Dis. 2021 May 25;12(6):533. [Abstract]
- Cell Death Dis. 2020 Jan 30;11(1):78. [Abstract]
- Pharmacol Res. 2019 Apr:142:1-13. [Abstract]
- Cell Death Dis. 2018 Aug 29;9(9):880. [Abstract]
- Cancer Lett. 2026 Sep 28:656:218655. [Abstract]
- Cancer Lett. 2026 May 28:646:218425. [Abstract]
- Cancer Lett. 2026 Apr 10:643:218288. [Abstract]
- Cancer Lett. 2026 Jan 28:638:218156. [Abstract]
- Cancer Lett. 2025 Sep 1:627:217544. [Abstract]
- Cancer Lett. 2024 Apr 10:587:216732. [Abstract]
- Cancer Lett. 2024 Mar 31:585:216660. [Abstract]
- Cancer Lett. 2023 Nov 28:577:216435. [Abstract]
- J Immunother Cancer. 2025 Nov 28;13(11):e011976. [Abstract]
- J Immunother Cancer. 2025 Aug 22;13(8):e011091. [Abstract]
- J Immunother Cancer. 2025 Jul 31;13(7):e012029. [Abstract]
- Int J Biol Sci. 2025 Apr 22;21(7):3061-3080. [Abstract]
- J Immunother Cancer. 2025 Jan 4;13(1):e010183. [Abstract]
- Int J Biol Sci. 2025 Jan 6;21(3):940-954. [Abstract]
- J Immunother Cancer. 2024 Sep 4;12(9):e009318. [Abstract]
- Int J Biol Sci. 2024 Jan 12;20(3):968-986. [Abstract]
- Int J Biol Sci. 2020 Jun 27;16(13):2382-2391. [Abstract]
- Cell Commun Signal. 2026 May 28. [Abstract]
- Cell Commun Signal. 2026 Mar 24;24(1):262. [Abstract]
- Cell Commun Signal. 2025 Jul 21;23(1):348. [Abstract]
- Cell Commun Signal. 2025 Jan 6;23(1):6. [Abstract]
- Cell Commun Signal. 2023 Jul 21;21(1):176. [Abstract]
- Cell Commun Signal. 2023 May 1;21(1):86. [Abstract]
- J Exp Med. 2022 May 2;219(5):e20212414. [Abstract]
- J Neuroinflammation. 2022 Jul 28;19(1):194. [Abstract]
- Phytomedicine. 2026 Aug:158:158386. [Abstract]
- Phytomedicine. 2026 Jun:155:158148. [Abstract]
- Phytomedicine. 2025 Sep:145:157083. [Abstract]
- Phytomedicine. 2025 Jul 25:143:156884. [Abstract]
- Phytomedicine. 2025 Jun:141:156674. [Abstract]
- Phytomedicine. 2025 Apr:139:156513. [Abstract]
- Phytomedicine. 2024 Apr:126:155410. [Abstract]
- Phytomedicine. 2024 Apr:126:155450. [Abstract]
- Phytomedicine. 2022 Nov:106:154416. [Abstract]
- Phytomedicine. 2021 Jun:86:153562. [Abstract]
- J Pharm Anal. 2026 Apr 2.
- EBioMedicine. 2023 Jan:87:104410. [Abstract]
- Mater Today Bio. 2026 Apr 30. [Abstract]
- Adv Healthc Mater. 2026 Mar 10:e04039. [Abstract]
- Mater Today Bio. 2025 Dec 3:35:102629. [Abstract]
- Cancer Genet. 2025 Nov:298-299:285-294. [Abstract]
- Mater Today Bio. 2025 Sep 6;35:102286.
- Adv Healthc Mater. 2025 Mar;14(8):e2401574. [Abstract]
- Nano Today. 2024 Dec.
- J Hazard Mater. 2026 Apr 1:507:141765. [Abstract]
- Mol Psychiatry. 2025 Oct 1. [Abstract]
- Acta Pharmacol Sin. 2025 May 20. [Abstract]
- Cell Death Discov. 2025 Feb 20;11(1):69. [Abstract]
- Cell Death Discov. 2024 Nov 3;10(1):463. [Abstract]
- Cell Death Discov. 2024 Oct 5;10(1):429. [Abstract]
- Cell Death Discov. 2024 May 2;10(1):214. [Abstract]
- Acta Pharmacol Sin. 2023 May;44(5):940-953. [Abstract]
- Cell Death Discov. 2023 Jan 23;9(1):26. [Abstract]
- Acta Pharmacol Sin. 2022 Sep;43(9):2429-2438. [Abstract]
- Cell Death Discov. 2022 Feb 2;8(1):43. [Abstract]
- Acta Biomater. 2019 Apr 1:88:392-405. [Abstract]
- J Transl Med. 2025 Aug 21;23(1):950. [Abstract]
- J Transl Med. 2025 Aug 18;23(1):923. [Abstract]
- J Transl Med. 2025 Jan 22;23(1):103. [Abstract]
- J Transl Med. 2024 Dec 20;22(1):1125. [Abstract]
- J Transl Med. 2024 Jul 30;22(1):706. [Abstract]
- J Transl Med. 2023 May 9;21(1):314. [Abstract]
- Sci China Life Sci. 2025 Aug 21. [Abstract]
- Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):e2114851119. [Abstract]
- Nano Res. 2021 Mar 27.
- Diabetes. 2025 Jan 1;74(1):82-95. [Abstract]
- Dev Cell. 2026 Apr 29:S1534-5807(26)00150-4. [Abstract]
- Dev Cell. 2025 Jun 23;60(12):1751-1767.e9. [Abstract]
- Basic Res Cardiol. 2021 Apr 23;116(1):30. [Abstract]
- Oncogene. 2026 Aug;45(29):2959-2977. [Abstract]
- BME Front. 2025 Nov 25:6:0203. [Abstract]
- Oncogene. 2024 Nov;43(49):3598-3616. [Abstract]
- Apoptosis. 2026 Jan 23;31(2):57. [Abstract]
- Apoptosis. 2025 Oct 16. [Abstract]
- Apoptosis. 2024 Dec;29(11-12):2108-2127. [Abstract]
- Apoptosis. 2024 Oct;29(9-10):1810-1823. [Abstract]
- Alzheimers Res Ther. 2022 Jul 26;14(1):103. [Abstract]
- Food Res Int. 2026 Feb 11.
- Leukemia. 2025 Aug;39(8):1997-2009. [Abstract]
- Leukemia. 2023 Mar;37(3):560-570. [Abstract]
- Int J Biol Macromol. 2026 Feb:347:150757. [Abstract]
- Int J Biol Macromol. 2026 Jan;339(Pt 2):150110. [Abstract]
- Int J Biol Macromol. 2025 Dec 12;338(Pt 1):149672. [Abstract]
- Int J Biol Macromol. 2025 Jul 29;321(Pt 3):146394. [Abstract]
- J Headache Pain. 2025 May 15;26(1):116. [Abstract]
- Int J Biol Macromol. 2025 May;305(Pt 1):141026. [Abstract]
- Int J Nanomedicine. 2025 Apr 5:20:4145-4163. [Abstract]
- BMC Med. 2025 Mar 31;23(1):189. [Abstract]
- Int J Biol Macromol. 2024 Nov;281(Pt 1):136178. [Abstract]
- Int J Biol Macromol. 2024 Nov;280(Pt 2):135743. [Abstract]
- Int J Biol Macromol. 2024 Mar;260(Pt 1):129455. [Abstract]
- Int J Biol Macromol. 2023 Jul 31:244:125373. [Abstract]
- Int J Mol Med. 2026 Jun;57(6):158. [Abstract]
- Int J Mol Med. 2026 Apr;57(4):85. [Abstract]
- Int J Mol Med. 2025 May;55(5):78. [Abstract]
- Microbiol Res. 2024 Dec:289:127927. [Abstract]
- Neural Regen Res. 2024 Nov 1;19(11):2488-2498. [Abstract]
- NPJ Breast Cancer. 2025 Jul 7;11(1):67. [Abstract]
- JACC Basic Transl Sci. 2024 Oct 9;9(12):1388-1405. [Abstract]
- EMBO J. 2023 Dec 1;42(23):e114086. [Abstract]
- J Clin Periodontol. 2025 Aug;52(8):1196-1210. [Abstract]
- J Clin Periodontol. 2025 Apr;52(4):622-636. [Abstract]
- Mol Med. 2024 Dec 19;30(1):245. [Abstract]
- Mol Med. 2024 Jul 30;30(1):110. [Abstract]
- Mater Des. 2026 Jun 3;267:116298.
- Antioxidants (Basel). 2026 Mar 25;15(4):413. [Abstract]
- Cell Mol Gastroenterol Hepatol. 2025;19(10):101558. [Abstract]
- Phytother Res. 2026 Apr;40(4):1935-1950. [Abstract]
- Phytother Res. 2024 Nov;38(11):5088-5106. [Abstract]
- Phytother Res. 2023 Oct;37(10):4690-4705. [Abstract]
- Phytother Res. 2023 Oct;37(10):4607-4620. [Abstract]
- Free Radic Biol Med. 2026 Mar 16:246:80-92. [Abstract]
- Free Radic Biol Med. 2025 Nov:239:540-551. [Abstract]
- Free Radic Biol Med. 2025 Oct 28:S0891-5849(25)01324-3. [Abstract]
- Free Radic Biol Med. 2025 Sep 12:241:14-23. [Abstract]
- Free Radic Biol Med. 2025 Aug 15:240:108-123. [Abstract]
- Free Radic Biol Med. 2024 Nov 20:225:482-493. [Abstract]
- Free Radic Biol Med. 2024 Nov 6:226:13-28. [Abstract]
- Free Radic Biol Med. 2024 Jan:210:352-366. [Abstract]
- Cancer Immunol Res. 2026 May 4;14(5):875-891. [Abstract]
- Clin Transl Med. 2026 May;16(5):e70698. [Abstract]
- Cancer Immunol Res. 2025 Dec 9. [Abstract]
- Cancer Immunol Res. 2025 Jul 2;13(7):1037-1052. [Abstract]
- Clin Transl Med. 2025 Mar;15(3):e70263. [Abstract]
- Clin Transl Med. 2024 Aug;14(8):e1799. [Abstract]
- Stem Cell Res Ther. 2025 Nov 14;16(1):639. [Abstract]
- Am J Chin Med. 2025 Aug 30:1-32. [Abstract]
- Stem Cell Res Ther. 2025 Jun 3;16(1):286. [Abstract]
- ACS Appl Mater Interfaces. 2024 Nov 6;16(44):60045-60055. [Abstract]
- Br J Cancer. 2024 May;130(11):1770-1782. [Abstract]
- Cell Rep. 2026 Jun 11;45(6):117546. [Abstract]
- Cell Rep. 2026 Jun 22:117579. [Abstract]
- Cell Rep. 2026 Mar 12;45(3):117083. [Abstract]
- Cell Rep. 2025 Nov 25;44(11):116505. [Abstract]
- Cell Rep. 2025 Sep 1;44(9):116139. [Abstract]
- World J Gastroenterol. 2025 Aug 21;31(31):109605. [Abstract]
- Cell Rep. 2025 Jun 13;44(6):115851. [Abstract]
- Cell Rep. 2025 May 28;44(6):115771. [Abstract]
- Cell Rep. 2024 Dec 13;43(12):115060. [Abstract]
- Cell Rep. 2024 Aug 7;43(8):114613. [Abstract]
- Cell Rep. 2024 Jul 31;43(8):114573. [Abstract]
- Cell Rep. 2024 Mar 23;43(4):114003. [Abstract]
- Cell Rep. 2023 Jun 19;42(6):112654. [Abstract]
- Cell Rep. 2023 Jun 27;42(7):112700. [Abstract]
- Cell Rep. 2023 Mar 13;42(3):112259. [Abstract]
- Cell Rep. 2021 Jul 20;36(3):109404. [Abstract]
- Br J Pharmacol. 2026 May 27. [Abstract]
- Brain Behav Immun. 2025 Jul:127:126-146. [Abstract]
- Br J Pharmacol. 2021 Dec;178(23):4646-4662. [Abstract]
- Chin Med. 2026 May 20;21(1):136. [Abstract]
- Neurotherapeutics. 2026 Mar 30;23(3):e00895. [Abstract]
- Chin Med. 2025 Dec 10;20(1):215. [Abstract]
- Cell Mol Neurobiol. 2024 Apr 18;44(1):36. [Abstract]
- J Med Chem. 2026 May 13. [Abstract]
- Clin Sci. 2026 Feb 11;140(2):201-219. [Abstract]
- J Med Chem. 2026 Jan 22;69(2):1507-1529. [Abstract]
- J Med Chem. 2025 Aug 14;68(15):16059-16075. [Abstract]
- Environ Health (Wash). 2024 Jul 1;2(11):786-801. [Abstract]
- J Med Chem. 2022 Dec 8;65(23):15710-15724. [Abstract]
- Environ Pollut. 2025 Oct 1:382:126762. [Abstract]
- Atherosclerosis. 2026 Jan 26:414:120648. [Abstract]
- Front Immunol. 2026 Jan 14:16:1684836. [Abstract]
- J Invest Dermatol. 2025 Nov 4:S0022-202X(25)03517-1. [Abstract]
- Cancer Cell Int. 2025 Nov 17;25(1):408. [Abstract]
- J Invest Dermatol. 2025 Apr 19:S0022-202X(25)00413-0. [Abstract]
- Front Immunol. 2025 Mar 24:16:1558139. [Abstract]
- Front Immunol. 2024 May 17:15:1405622. [Abstract]
- Cancer Cell Int. 2023 May 29;23(1):105. [Abstract]
- Emerg Microbes Infect. 2022 Dec;11(1):2556-2569. [Abstract]
- Front Immunol. 2021 Oct 21;12:749369. [Abstract]
- Front Immunol. 2021 May 20;12:653030. [Abstract]
- PLoS Biol. 2025 Nov 24;23(11):e3003490. [Abstract]
- J Ethnopharmacol. 2026 Nov 15:370:121985. [Abstract]
- J Ethnopharmacol. 2026 Jul 15:366:121657. [Abstract]
- J Ethnopharmacol. 2026 Oct 28:369:121903. [Abstract]
- J Ethnopharmacol. 2026 May 10:362:121315. [Abstract]
- JCI Insight. 2026 Jan 22;11(5):e195176. [Abstract]
- J Ethnopharmacol. 2025 Jul 10;353(Pt A):120280. [Abstract]
- J Ethnopharmacol. 2025 May 28:348:119913. [Abstract]
- J Autoimmun. 2025 May:153:103411. [Abstract]
- J Ethnopharmacol. 2024 Apr 6:323:117711. [Abstract]
- Eur J Med Chem. 2026 May 5:309:118765. [Abstract]
- J Agric Food Chem. 2025 Oct 22;73(42):27089-27098. [Abstract]
- Eur J Med Chem. 2022 Jul 5;237:114338. [Abstract]
- Eur J Med Chem. 2021 Jun 5:218:113388. [Abstract]
- CNS Neurosci Ther. 2026 Feb;32(2):e70796. [Abstract]
- Ecotoxicol Environ Saf. 2025 Dec:308:119481. [Abstract]
- CNS Neurosci Ther. 2024 Sep;30(9):e70067. [Abstract]
- Ecotoxicol Environ Saf. 2023 Sep 15:263:115265. [Abstract]
- Ecotoxicol Environ Saf. 2023 Mar 1:252:114637. [Abstract]
- Ecotoxicol Environ Saf. 2023 Jan 1:249:114465. [Abstract]
- Biochem Pharmacol. 2026 Jul:249:117925. [Abstract]
- Biochem Pharmacol. 2026 May 14;250(Pt 2):118056. [Abstract]
- Cell Mol Life Sci. 2025 May 28;82(1):218. [Abstract]
- Biochem Pharmacol. 2024 Jan:219:115957. [Abstract]
- Cell Biosci. 2023 Aug 21;13(1):154. [Abstract]
- Biochem Pharmacol. 2023 Jul:213:115618. [Abstract]
- Mol Ther Nucleic Acids. 2021 Dec 11:27:375-389. [Abstract]
- Life Sci. 2026 Jul 15:397:124392. [Abstract]
- Cell Insight. 2026 Apr 2;5(3):100323. [Abstract]
- Life Sci. 2025 Nov 1:380:123926. [Abstract]
- Life Sci. 2025 Oct 15:379:123858. [Abstract]
- Life Sci. 2025 Jun 1:370:123561. [Abstract]
- Life Sci. 2025 Apr 1:366-367:123498. [Abstract]
- Life Sci. 2024 Mar 1:340:122437. [Abstract]
- Life Sci. 2021 Jan 1:264:118687. [Abstract]
- Life Sci. 2020 Jan 15:241:117103. [Abstract]
- Life Sci. 2018 Aug 15:207:296-303. [Abstract]
- Food Biosci. 2026 Mar 23.
- Oncoimmunology. 2025 Dec 31;14(1):2581910. [Abstract]
- Inflamm Res. 2024 Sep;73(9):1529-1545. [Abstract]
- Inflamm Res. 2024 Jun;73(6):961-978. [Abstract]
- Inflamm Res. 2024 Jun;73(6):945-960. [Abstract]
- Oncoimmunology. 2024 May 10;13(1):2352179. [Abstract]
- Drug Des Devel Ther. 2024 Jul 22:18:3143-3156. [Abstract]
- EMBO Rep. 2025 Nov 17. [Abstract]
- EMBO Rep. 2025 Sep 16. [Abstract]
- J Clin Transl Hepatol. 2025 Jul 28;13(7):555-567. [Abstract]
- Cells. 2025 May 8;14(10):678. [Abstract]
- J Am Heart Assoc. 2022 Feb 15;11(4):e023800. [Abstract]
- Cancer Immunol Immunother. 2026 Jun 16. [Abstract]
- Commun Biol. 2026 Jun 5. [Abstract]
- Cancer Immunol Immunother. 2026 May 30. [Abstract]
- Mol Cancer Res. 2026 Mar 2. [Abstract]
- Cancer Immunol Immunother. 2025 Dec 23;75(1):25. [Abstract]
- Cancer Immunol Immunother. 2025 Nov 3;74(12):356. [Abstract]
- Nutrients. 2025 Nov 12;17(22):3534. [Abstract]
- Cancer Immunol Immunother. 2025 Oct 15;74(11):340. [Abstract]
- Commun Biol. 2025 Mar 12;8(1):417. [Abstract]
- Commun Biol. 2025 Mar 28;8(1):514. [Abstract]
- Cancer Immunol Immunother. 2025 Feb 1;74(3):87. [Abstract]
- Cancer Immunol Immunother. 2025 Jan 3;74(2):64. [Abstract]
- Cancer Immunol Immunother. 2024 Nov 2;74(1):11. [Abstract]
- Cancer Immunol Immunother. 2023 Jun;72(6):1917-1932. [Abstract]
- Nutrients. 2020 Oct 11;12(10):3088. [Abstract]
- Eur J Pharmacol. 2026 Jan 20:1012:178500. [Abstract]
- Eur J Pharmacol. 2026 Feb 10:1014:178540. [Abstract]
- Cancer Biol Ther. 2025 Dec 31;26(1):2589658. [Abstract]
- Respir Res. 2025 Jul 10;26(1):238. [Abstract]
- Eur J Pharmacol. 2025 Jan 15:987:177157. [Abstract]
- Pharmaceuticals (Basel). 2025 Jan 29;18(2):181. [Abstract]
- Eur J Pharmacol. 2023 Jul 5:950:175771. [Abstract]
- Pharmaceuticals (Basel). 2023 Jun 15;16(6):885. [Abstract]
- Acta Physiol. 2023 Apr;237(4):e13926. [Abstract]
- Int Immunopharmacol. 2026 Aug 15:183:116879. [Abstract]
- Int Immunopharmacol. 2026 Aug 1:182:116787. [Abstract]
- Int Immunopharmacol. 2026 Jul 15:181:116770. [Abstract]
- Int Immunopharmacol. 2026 Jun 16:185:117018. [Abstract]
- Cell Oncol (Dordr). 2026 Jun 6. [Abstract]
- Int Immunopharmacol. 2026 May 15:177:116533. [Abstract]
- Int Immunopharmacol. 2026 May 15:177:116542. [Abstract]
- Int Immunopharmacol. 2026 Feb 1:170:116081. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 2):115954. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 1):115803. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 1):115747. [Abstract]
- Int Immunopharmacol. 2026 Feb 15:171:116162. [Abstract]
- Int Immunopharmacol. 2025 Dec 10:167:115663. [Abstract]
- Int J Mol Sci. 2025 Oct 6;26(19):9718. [Abstract]
- Int Immunopharmacol. 2025 Sep 23:166:115596. [Abstract]
- Int Immunopharmacol. 2025 Sep 20:166:115539. [Abstract]
- Int Immunopharmacol. 2025 Sep 13:165:115485. [Abstract]
- Noncoding RNA Res. 2025 Aug 29:15:156-171. [Abstract]
- Int Immunopharmacol. 2025 Aug 28:161:115064. [Abstract]
- Int Immunopharmacol. 2025 Jun 26:159:114939. [Abstract]
- Int Immunopharmacol. 2025 Jun 17:158:114884. [Abstract]
- Int Immunopharmacol. 2025 Jun 26:159:114954. [Abstract]
- Int J Mol Sci. 2025 May 20;26(10):4913. [Abstract]
- Int J Mol Sci. 2025 Apr 2;26(7):3321. [Abstract]
- Biomolecules. 2025 Feb 1;15(2):208. [Abstract]
- Int Immunopharmacol. 2025 Feb 6:147:113944. [Abstract]
- Int Immunopharmacol. 2025 Feb 6:147:113856. [Abstract]
- Int Immunopharmacol. 2024 Nov 7;143(Pt 3):113530. [Abstract]
- Int J Mol Sci. 2024 Nov 14;25(22):12260. [Abstract]
- Int Immunopharmacol. 2024 Oct 16;143(Pt 2):113328. [Abstract]
- Int Immunopharmacol. 2024 Oct 18;143(Pt 2):113387. [Abstract]
- Int Immunopharmacol. 2024 Oct 25:140:112742. [Abstract]
- Int Immunopharmacol. 2024 Oct 14;143(Pt 1):113323. [Abstract]
- Int Immunopharmacol. 2024 Sep 30;143(Pt 1):113270. [Abstract]
- Int Immunopharmacol. 2024 Aug 20:137:112491. [Abstract]
- Int Immunopharmacol. 2024 Jan 5:126:111212. [Abstract]
- Int Immunopharmacol. 2023 Dec;125(Pt B):111196. [Abstract]
- Int Immunopharmacol. 2023 Oct:123:110763. [Abstract]
- Int Immunopharmacol. 2023 Oct:123:110685. [Abstract]
- Int Immunopharmacol. 2023 Oct:123:110456. [Abstract]
- Int J Mol Sci. 2023 Sep 30;24(19):14808. [Abstract]
- Int J Mol Sci. 2023 Sep 30;24(19):14771. [Abstract]
- Int Immunopharmacol. 2023 Jul:120:110378. [Abstract]
- Int J Mol Sci. 2023 Feb 27;24(5):4588. [Abstract]
- Int Immunopharmacol. 2021 Dec;101(Pt B):108372. [Abstract]
- Int Immunopharmacol. 2021 Oct:99:107922. [Abstract]
- Int Immunopharmacol. 2021 May:94:107455. [Abstract]
- Int Immunopharmacol. 2020 Apr:81:106030. [Abstract]
- Int Immunopharmacol. 2018 Dec:65:458-469. [Abstract]
- Mol Neurobiol. 2025 May;62(5):5501-5517. [Abstract]
- Antibiotics (Basel). 2024 May 15;13(5):449. [Abstract]
- Immunology. 2026 Mar 3. [Abstract]
- Inflammation. 2025 Dec 20;49(1):11. [Abstract]
- BMC Biol. 2025 Mar 12;23(1):76. [Abstract]
- Immunology. 2024 Dec;173(4):672-688. [Abstract]
- J Periodontal Res. 2024 Feb;59(1):140-150. [Abstract]
- Inflammation. 2023 Oct;46(5):1849-1858. [Abstract]
- Front Pharmacol. 2021 May 13:12:655726. [Abstract]
- Front Pharmacol. 2020 Jul 31:11:1038. [Abstract]
- Front Pharmacol. 2020 Jan 28:10:1589. [Abstract]
- Probiotics Antimicrob Proteins. 2025 Nov 26. [Abstract]
- Front Cell Dev Biol. 2021 Apr 15:9:665869. [Abstract]
- Chem Biol Interact. 2026 Aug 1:436:112213. [Abstract]
- Int Dent J. 2026 Jun 27;76(5):109698. [Abstract]
- Chem Biol Interact. 2025 Jun 1:414:111495. [Abstract]
- Toxicology. 2024 May 11:153829. [Abstract]
- ACS Omega. 2022 Aug 5;7(32):28334-28341. [Abstract]
- Molecules. 2024 Aug 20;29(16):3919. [Abstract]
- Molecules. 2023 Nov 10;28(22):7527. [Abstract]
- Clin Exp Allergy. 2026 Feb 12. [Abstract]
- Mol Med Rep. 2026 Jan;33(1):44. [Abstract]
- Food Sci Nutr. 2025 Aug 19;13(8):e70794. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2025 Jun 9;1871(7):167947. [Abstract]
- Mol Med Rep. 2025 May;31(5):120. [Abstract]
- Mol Med Rep. 2024 May;29(5):83. [Abstract]
- Sci Rep. 2026 Jul 10. [Abstract]
- Transl Oncol. 2026 Jun:68:102778. [Abstract]
- Sci Rep. 2026 May 9;16(1):21231. [Abstract]
- Sci Rep. 2026 Apr 15;16(1):17490. [Abstract]
- Sci Rep. 2026 Mar 8;16(1):12575. [Abstract]
- Sci Rep. 2026 Mar 31. [Abstract]
- APL Bioeng. 2026 Jan 30;10(1):016107. [Abstract]
- Sci Rep. 2025 Oct 6;15(1):34724. [Abstract]
- PLoS Pathog. 2025 Jul 16;21(7):e1013344. [Abstract]
- Sci Rep. 2025 Jul 10;15(1):24895. [Abstract]
- Sci Rep. 2025 May 16;15(1):17112. [Abstract]
- Transl Oncol. 2025 Apr:54:102343. [Abstract]
- World J Stem Cells. 2025 Apr 26;17(4):103919. [Abstract]
- Transl Oncol. 2025 Feb 21:54:102327. [Abstract]
- Sci Rep. 2025 Mar 22;15(1):8542. [Abstract]
- J Mol Cell Cardiol. 2024 Nov:196:71-83. [Abstract]
- PLoS Pathog. 2024 Sep 9;20(9):e1012543. [Abstract]
- Dig Liver Dis. 2024 Jul;56(7):1237-1247. [Abstract]
- PLoS Pathog. 2024 Jul 29;20(7):e1012330. [Abstract]
- Cancer Sci. 2024 Jul;115(7):2444-2460. [Abstract]
- Sci Rep. 2024 Mar 4;14(1):5237. [Abstract]
- J Mol Cell Cardiol. 2020 Jun;143:1-14. [Abstract]
- Mediators Inflamm. 2020 Feb 29:2020:2720369. [Abstract]
- Eur J Med Res. 2026 Apr 24;31(1):843.
- Eur J Med Res. 2025 Oct 9;30(1):947. [Abstract]
- Eur J Med Res. 2025 Jun 21;30(1):504. [Abstract]
- Eur J Med Res. 2025 May 12;30(1):378. [Abstract]
- Eur J Med Res. 2025 Jan 7;30(1):12. [Abstract]
- Cancers (Basel). 2024 Jan 8;16(2):269. [Abstract]
- Cell Signal. 2026 Oct:146:112676. [Abstract]
- Neuropharmacology. 2026 Aug 1:293:110965. [Abstract]
- Mol Cell Biochem. 2026 Jun 19. [Abstract]
- J Cell Mol Med. 2026 Jan;30(1):e71000. [Abstract]
- J Cell Mol Med. 2025 Nov;29(22):e70953. [Abstract]
- J Cell Mol Med. 2025 Oct;29(20):e70915. [Abstract]
- J Cell Mol Med. 2025 Oct;29(19):e70878. [Abstract]
- Cell Signal. 2025 Mar:127:111550. [Abstract]
- Cell Signal. 2024 Dec:124:111453. [Abstract]
- J Cell Mol Med. 2024 Apr;28(8):e18356. [Abstract]
- J Cell Mol Med. 2024 Jan;28(1):e18037. [Abstract]
- Med Oncol. 2022 Dec 28;40(1):64. [Abstract]
- Cell Signal. 2022 Sep:97:110393. [Abstract]
- Cell Signal. 2022 Apr:92:110242. [Abstract]
- Cell Signal. 2021 Dec:88:110168. [Abstract]
- J Inflamm Res. 2026 May 12:19:568022. [Abstract]
- Oncol Res. 2026 Jan 19;34(2):25. [Abstract]
- J Inflamm Res. 2025 Dec 10:18:17253-17269. [Abstract]
- J Inflamm Res. 2025 Aug 12:18:10939-10952. [Abstract]
- J Inflamm Res. 2025 Apr 25:18:5573-5586. [Abstract]
- J Inflamm Res. 2025 Mar 19:18:4143-4156. [Abstract]
- J Inflamm Res. 2025 Mar 20:18:4213-4231. [Abstract]
- J Inflamm Res. 2024 Sep 11:17:6307-6316. [Abstract]
- J Innate Immun. 2021;13(1):38-48. [Abstract]
- Biomedicines. 2026 May 18;14(5):1145. [Abstract]
- Neurochem Res. 2026 Apr 27;51(3):146. [Abstract]
- Poult Sci. 2026 Jan 12;105(3):106426. [Abstract]
- iScience. 2025 Dec 3.
- iScience. 2025 Sep 5;28(10):113517. [Abstract]
- Clin Exp Med. 2025 Aug 15;25(1):294. [Abstract]
- iScience. 2025 May 13;28(7):112658. [Abstract]
- iScience. 2024 Aug 31;27(10):110751. [Abstract]
- Mol Nutr Food Res. 2023 Oct;67(19):e2300083. [Abstract]
- iScience. 2023 Aug 9;26(9):107601. [Abstract]
- iScience. 2023 Jul 22;26(8):107451. [Abstract]
- Epigenetics Chromatin. 2023 Apr 19;16(1):11. [Abstract]
- Comp Biochem Physiol C Toxicol Pharmacol. 2023 Apr:266:109557. [Abstract]
- Endocr Relat Cancer. 2023 Apr 3;30(5):e230012. [Abstract]
- Front Mol Neurosci. 2023 Mar 10:16:1071327. [Abstract]
- Front Mol Neurosci. 2023 Jan 6:15:1078309. [Abstract]
- BMC Complement Med Ther. 2022 Dec 6;22(1):323. [Abstract]
- Front Mol Biosci. 2022 Apr 27;9:835590. [Abstract]
- Front Mol Neurosci. 2017 Sep 6:10:287. [Abstract]
- Front Mol Neurosci. 2017 Aug 7:10:247. [Abstract]
- Mol Divers. 2026 Aug;30(4):6403-6419. [Abstract]
- Autoimmunity. 2025 Dec;58(1):2538860. [Abstract]
- FASEB J. 2025 Nov 30;39(22):e71239. [Abstract]
- FASEB J. 2025 Nov 15;39(21):e71182. [Abstract]
- FASEB J. 2025 Mar 31;39(6):e70474. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2024 Apr;1871(4):119689. [Abstract]
- FASEB J. 2024 Mar 31;38(6):e23564. [Abstract]
- J Pharmacol Exp Ther. 2022 Jan;380(1):15-25. [Abstract]
- Fish Shellfish Immunol. 2024 Nov:154:109975. [Abstract]
- Fish Shellfish Immunol. 2024 May:148:109515. [Abstract]
- Fish Shellfish Immunol. 2023 Oct:141:109027. [Abstract]
- Fish Shellfish Immunol. 2022 Jan:120:102-110. [Abstract]
- Clin Immunol. 2026 Jun:285:110705. [Abstract]
- J Virol. 2026 Apr 21;100(4):e0179325. [Abstract]
- J Virol. 2026 Mar 24;100(3):e0195225. [Abstract]
- J Biol Chem. 2026 Jan 20:111182. [Abstract]
- J Biol Chem. 2025 Dec 20;302(2):111091. [Abstract]
- Microbiol Spectr. 2025 Dec 29:e0221825. [Abstract]
- Microbiol Spectr. 2025 Aug 5;13(8):e0018825. [Abstract]
- BMC Cancer. 2025 Jul 31;25(1):1250. [Abstract]
- J Antimicrob Chemother. 2024 Dec 2;79(12):3254-3263. [Abstract]
- Funct Integr Genomics. 2026 Jun 10;26(1):130. [Abstract]
- ACS Pharmacol Transl Sci. 2025 Oct 27;8(11):3835-3843. [Abstract]
- J Cell Commun Signal. 2025 Sep 4;19(3):e70044. [Abstract]
- Regen Ther. 2024 May 18:26:33-41. [Abstract]
- Development. 2021 Jul 15;148(14):dev199461. [Abstract]
- J Immunol. 2021 Mar 1;206(5):963-977. [Abstract]
- J Cell Physiol. 2019 Dec;234(12):22857-22873. [Abstract]
- J Funct Foods. 2026 Apr 11;140:107290.
- J Funct Foods. 2024 Dec.
- J Funct Foods. 2023 Dec, 111, 105885.
- BMC Oral Health. 2026 Jun 22. [Abstract]
- Pathogens. 2026 Apr 16;15(4):427. [Abstract]
- Neurotoxicology. 2026 Mar:113:103405. [Abstract]
- J Orthop Surg Res. 2025 Nov 7;20(1):976. [Abstract]
- Metab Brain Dis. 2025 Oct 30;40(8):301. [Abstract]
- J Proteome Res. 2025 Oct 23. [Abstract]
- Carcinogenesis. 2025 Apr 3;46(2):bgaf009. [Abstract]
- BMC Oral Health. 2024 Aug 23;24(1):987. [Abstract]
- Carcinogenesis. 2023 Dec 15;44(10-11):748-759. [Abstract]
- Endocrinology. 2022 Dec 19;164(2):bqac210. [Abstract]
- Mol Immunol. 2026 Jul:195:172-185. [Abstract]
- J Med Virol. 2026 Apr;98(4):e70906. [Abstract]
- Pathol Res Pract. 2026 Mar:279:156368. [Abstract]
- Kidney Dis (Basel). 2025 May 9;11(1):450-468. [Abstract]
- J Med Virol. 2025 Mar;97(3):e70267. [Abstract]
- Pathol Res Pract. 2024 Oct:262:155544. [Abstract]
- Parasit Vectors. 2023 Apr 24;16(1):139. [Abstract]
- Mol Immunol. 2021 Sep:137:155-162. [Abstract]
- J Med Virol. 2020 Dec;92(12):3057-3066. [Abstract]
- Mol Immunol. 2020 May:121:72-80. [Abstract]
- J Diabetes Investig. 2026 Jun 8. [Abstract]
- J Biochem Mol Toxicol. 2026 Apr;40(4):e70808. [Abstract]
- Basic Clin Pharmacol Toxicol. 2025 Dec;137(6):e70135. [Abstract]
- Stem Cells Int. 2025 Dec 17:2025:1891956. [Abstract]
- PLoS Negl Trop Dis. 2025 Dec 11;19(12):e0013815. [Abstract]
- J Biochem Mol Toxicol. 2025 Apr;39(4):e70232. [Abstract]
- Genomics. 2025 Feb 4;117(2):111013. [Abstract]
- Nanotoxicology. 2020 Oct;14(8):1137-1155. [Abstract]
- Toxicol Appl Pharmacol. 2019 Mar 1:366:83-95. [Abstract]
- Appl Biochem Biotechnol. 2026 Jul;198(7):5429-5447. [Abstract]
- J Radiat Res Appl Sci. 2026 Apr 8;19(2):102348.
- J Radiat Res Appl Sci. 2026 Mar 13.
- Arch Biochem Biophys. 2026 Feb:776:110714. [Abstract]
- Appl Biochem Biotechnol. 2026 Feb;198(2):1374-1390. [Abstract]
- Cardiovasc Drugs Ther. 2026 Jan 24. [Abstract]
- Exp Cell Res. 2025 Dec 24;455(2):114869. [Abstract]
- Exp Cell Res. 2025 Nov 25;454(2):114842. [Abstract]
- Arch Biochem Biophys. 2025 Nov:773:110593. [Abstract]
- Immun Inflamm Dis. 2025 Nov;13(11):e70268. [Abstract]
- Cell Biol Int. 2025 Jan;49(1):79-91. [Abstract]
- Arch Biochem Biophys. 2024 Sep:759:110102. [Abstract]
- Mol Carcinog. 2024 Sep;63(9):1827-1841. [Abstract]
- Arch Biochem Biophys. 2024 Aug:758:110051. [Abstract]
- Vaccines. 2023 May 25;11(6):1026. [Abstract]
- Exp Cell Res. 2020 Oct 1;395(1):112194. [Abstract]
- Arch Biochem Biophys. 2020 Jul 15;687:108375. [Abstract]
- Diabetes Metab Syndr Obes. 2019 Nov 4:12:2289-2302. [Abstract]
- Arch Microbiol. 2026 Jun 11;208(9):434. [Abstract]
- J Evid Based Integr Med. 2024 Jan-Dec:29:2515690X241291381. [Abstract]
- J Neurooncol. 2024 Sep;169(3):659-670. [Abstract]
- Front Oncol. 2024 Sep 9:14:1452282. [Abstract]
- J Cancer. 2024 May 5;15(11):3510-3530. [Abstract]
- Reproduction. 2021 Dec 30;163(1):57-68. [Abstract]
- Mol Cell Endocrinol. 2019 Aug 20:494:110490. [Abstract]
- Carbohydr Res. 2005 Feb 28;340(3):355-72. [Abstract]
- Cell Immunol. 2025 Dec:418:105046. [Abstract]
- J Cancer Res Clin Oncol. 2025 May 14;151(5):163. [Abstract]
- Breast Cancer Res Treat. 2019 Jun;175(2):459-472. [Abstract]
- Mol Biol Rep. 2026 Apr 22;53(1):645. [Abstract]
- Animals (Basel). 2026 Mar 17;16(6):942. [Abstract]
- IUBMB Life. 2026 Mar;78(3):e70094. [Abstract]
- Food Chem Toxicol. 2025 Dec:206:115771. [Abstract]
- Mol Biol Rep. 2025 Nov 6;53(1):53. [Abstract]
- Mol Biotechnol. 2025 May;67(5):1852-1866. [Abstract]
- Mol Biol Rep. 2024 Jun 1;51(1):720. [Abstract]
- Mol Biotechnol. 2024 May;66(5):1314-1325. [Abstract]
- Immunol Lett. 2023 Nov:263:25-32. [Abstract]
- Food Chem Toxicol. 2022 Oct:168:113354. [Abstract]
- Immunobiology. 2026 Jun 25;231(4):153211. [Abstract]
- Tissue Cell. 2026 Feb:98:103199. [Abstract]
- Immunobiology. 2025 Dec 31;231(1):153154. [Abstract]
- Tissue Cell. 2025 Apr:93:102645. [Abstract]
- FEBS Lett. 2025 Feb;599(3):367-380. [Abstract]
- BMC Pulm Med. 2025 Feb 28;25(1):97. [Abstract]
- Tissue Cell. 2024 Dec:91:102580. [Abstract]
- Immunobiology. 2024 Nov;229(6):152854. [Abstract]
- Placenta. 2024 Aug 21:156:30-37. [Abstract]
- Placenta. 2024 May 28:153:59-74. [Abstract]
- FEBS Lett. 2024 Feb;598(4):400-414. [Abstract]
- J Proteomics. 2023 May 30:280:104889. [Abstract]
- Platelets. 2022 Jul 4;33(5):755-763. [Abstract]
- Immunopharmacol Immunotoxicol. 2022 Jun;44(3):437-446. [Abstract]
- Tissue Cell. 2022 Feb:74:101683. [Abstract]
- J Neuroimmunol. 2020 Aug 15:345:577286. [Abstract]
- Mult Scler Relat Disord. 2025 Sep 16:104:106759. [Abstract]
- Cell Biochem Biophys. 2025 Mar 28. [Abstract]
- Front Cardiovasc Med. 2021 Nov 8;8:770163. [Abstract]
- Neurogastroenterol Motil. 2020 Oct;32(10):1514-1528. [Abstract]
- J Cell Biochem. 2020 Apr;121(4):2828-2838. [Abstract]
- PeerJ. 2024 Nov 27:12:e18612. [Abstract]
- PeerJ. 2023 Aug 4:11:e15798. [Abstract]
- Chem Biodivers. 2021 Sep;18(9):e2100308. [Abstract]
- Biomed Res Int. 2021 May 14:2021:5565748. [Abstract]
- Biomed Res Int. 2020 Aug 8:2020:5960375. [Abstract]
- PLoS One. 2026 Jun 22;21(6):e0351858. [Abstract]
- Dig Dis Sci. 2026 Apr 25. [Abstract]
- Curr Microbiol. 2025 Dec 27;83(2):100. [Abstract]
- Hum Cell. 2025 Sep 30;38(6):168. [Abstract]
- Hum Cell. 2025 Sep 17;38(6):163. [Abstract]
- Vet Microbiol. 2025 Aug:307:110628. [Abstract]
- Discov Oncol. 2025 Jul 6;16(1):1269. [Abstract]
- Discov Oncol. 2025 Jul 1;16(1):1196. [Abstract]
- PLoS One. 2025 Jul 18;20(7):e0328258. [Abstract]
- Reprod Sci. 2025 Jul;32(7):2233-2243. [Abstract]
- Vet Microbiol. 2025 Jun:305:110529. [Abstract]
- Int J Immunopathol Pharmacol. 2025 Jan-Dec:39:3946320251348715. [Abstract]
- Discov Oncol. 2025 May 12;16(1):730. [Abstract]
- Biomol Biomed. 2025 Mar 7;25(4):857-868. [Abstract]
- Cardiovasc Ther. 2025 Mar 24:2025:2973633. [Abstract]
- Vet Microbiol. 2024 May:292:110066. [Abstract]
- J Pharmacol Sci. 2022 Jan;148(1):116-124. [Abstract]
- FEBS Open Bio. 2026 Feb 6. [Abstract]
- Chem Pap. 2025 Dec 9.
- Gene. 2025 Jul 20:958:149483. [Abstract]
- FEBS Open Bio. 2025 Feb;15(2):311-323. [Abstract]
- Clin Breast Cancer. 2023 Jul;23(5):546-560. [Abstract]
- World J Tradit Chin Med. 2025 Oct 28.
- Burns. 2025 Jun 27;51(7):107589. [Abstract]
- Hereditas. 2025 May 11;162(1):74. [Abstract]
- J Mol Histol. 2025 May 26;56(3):166. [Abstract]
- Prostaglandins Other Lipid Mediat. 2024 Oct:174:106882. [Abstract]
- BMC Med Genomics. 2023 May 12;16(1):100. [Abstract]
- J Nat Med. 2023 Mar;77(2):251-261. [Abstract]
- Biochem Biophys Res Commun. 2026 Jun 23:829:154192. [Abstract]
- Biochem Biophys Res Commun. 2026 Jan 25:797:153099. [Abstract]
- Biochem Biophys Res Commun. 2025 Sep 19:785:152676. [Abstract]
- Biochem Biophys Res Commun. 2025 Sep 1:777:152330. [Abstract]
- Biochem Biophys Res Commun. 2025 Aug 15:775:152110. [Abstract]
- Biochem Biophys Res Commun. 2023 Jul 23:666:115-121. [Abstract]
- Am J Reprod Immunol. 2023 Mar;89(3):e13656. [Abstract]
- Biochem Biophys Res Commun. 2020 Mar 19;523(4):972-978. [Abstract]
- Chem Afr. 2026 Jun 23;9(5):229.
- Comparative Immunology Reports. 2025 Jun.
- Pulm Circ. 2024 Oct 9;14(4):e12454. [Abstract]
- Onco Targets Ther. 2018 Oct 18:11:7229-7243. [Abstract]
- Ann Hematol. 2026 May 29. [Abstract]
- Immunol Invest. 2026 Jan 12:1-26. [Abstract]
- Ann Hematol. 2024 Dec;103(12):5817-5833. [Abstract]
- Int J Gen Med. 2024 Jan 10:17:59-74. [Abstract]
- Immunol Invest. 2022 Aug;51(6):1785-1803. [Abstract]
- Int Arch Allergy Immunol. 2020;181(3):159-169. [Abstract]
- Arch Oral Biol. 2019 Feb:98:92-98. [Abstract]
- Cytotechnology. 2025 Dec;77(6):194. [Abstract]
- Exp Ther Med. 2023 Dec 6;27(2):55. [Abstract]
- Exp Ther Med. 2023 May 22;26(1):337. [Abstract]
- Exp Ther Med. 2023 Feb 15;25(4):147. [Abstract]
- Exp Ther Med. 2021 Dec;22(6):1401. [Abstract]
- Braz J Microbiol. 2026 May 18;57(1):146. [Abstract]
- Oncol Lett. 2026 Mar 30;31(5):203. [Abstract]
- Asia Pac J Clin Oncol. 2025 Feb;21(1):12-30. [Abstract]
- Oncol Lett. 2022 Aug 24;24(4):356. [Abstract]
- J Biophotonics. 2026 Jan 14;19(1):e70220.
- Int J Genomics. 2025 Nov 26:2025:6152675. [Abstract]
- Anticancer Drugs. 2025 Jul 1;36(6):459-467. [Abstract]
- Anticancer Drugs. 2025 Jun 13. [Abstract]
- In Vitro Cell Dev Biol Anim. 2025 Jun;61(6):635-643. [Abstract]
- In Vitro Cell Dev Biol Anim. 2025 Feb;61(2):245-256. [Abstract]
- Int J Rheum Dis. 2021 Apr;24(4):599-607. [Abstract]
- Biochem Genet. 2026 Jan 3. [Abstract]
- Biochem Genet. 2025 Jul 1. [Abstract]
- J Interferon Cytokine Res. 2025 Mar 21. [Abstract]
- Eur J Histochem. 2025 Apr 7;69(2). [Abstract]
- Transl Androl Urol. 2024 Jul 31;13(7):1239-1255. [Abstract]
- Ann Dermatol. 2021 Feb;33(1):37-45. [Abstract]
- Hum Mutat. 2026 Apr 15:2026:3003097. [Abstract]
- Biol Pharm Bull. 2023;46(6):803-810. [Abstract]
- Acta Paediatr. 2021 Jul;110(7):2221-2229. [Abstract]
- Iran J Pharm Res. 2025 Mar 8;24(1):e159395. [Abstract]
- Transpl Immunol. 2026 Feb:94:102346. [Abstract]
- Cent Eur J Immunol 2026; 51.
- Crit Rev Eukaryot Gene Expr. 2025;35(7):51-63. [Abstract]
- Tohoku J Exp Med. 2025 Mar 27;265(3):173-182. [Abstract]
- Tohoku J Exp Med. 2024 Jan 10;262(1):13-22. [Abstract]
- Nat Prod Commun. 2023 Mar 7.
- STAR Protoc. 2026 Apr 24;7(2):104523. [Abstract]
- Mol Cell Toxicol. 2025 Nov 26.
- Eur J Integr Med. 2024 Nov 22.
- Transfus Apher Sci. 2022 Dec;61(6):103494. [Abstract]
- Biomed Pharmacother. 2026 Jul:200:119638. [Abstract]
- SSRN. 2026 Jun 3.
- SSRN. 2026 Jun 21.
- bioRxiv. 2026 Jun 3:2026.06.01.728985. [Abstract]
- Res Sq. 2026 May 29.
- bioRxiv. 2026 May 29:2026.05.26.727520. [Abstract]
- Res Sq. 2026 May 6.
- bioRxiv. 2026 May 27.
- SSRN. 2026 May 15.
- bioRxiv. 2026 Apr 1.
- Res Sq. 2026 Apr 10.
- Res Sq. 2026 Apr 22.
- J Environ Sci (China). 2026 Mar:161:189-200. [Abstract]
- bioRxiv. 2026 Mar 10.
- Res Sq. 2026 Mar 2.
- Res Sq. 2026 Jan 11.
- Res Sq. 2026 Jan 7.
- bioRxiv. 2026 Jan 8.
- SSRN. 2026 Jan 27.
- Res Sq. 2025 Dec 18.
- bioRxiv. 2025 Dec 12:2025.12.12.693952. [Abstract]
- SSRN. 2025 Dec 12.
- Res Sq. 2025 Oct 16.
- SSRN. 2025 Oct 1.
- bioRxiv. 2025 Aug 14:2025.08.14.670414. [Abstract]
- Environ Toxicol. 2025 May 12. [Abstract]
- bioRxiv. 2025 March 28.
- bioRxiv. 2025 March 03.
- Res Sq. 2025 Mar 17.
- bioRxiv. 2025 January 22.
- bioRxiv. 2025 Jan 6:2025.01.06.631444. [Abstract]
- Res Sq. 2024 Oct 31.
- bioRxiv. 2024 September 29.
- Res Sq. 2024 Aug 30.
- Research Square Preprint. 2024 Sep 10.
- Biomed Pharmacother. 2024 Nov:180:117606. [Abstract]
- Sci Total Environ. 2024 Oct 20:948:174979. [Abstract]
- Oncology and Translational Medicine. 2024 Oct.10(5):p 231-244.
- Res Sq. 2024 Jun 13.
- Res Sq. 2024 Jun 11.
- Heliyon. 2024 May 23;10(11):e31818. [Abstract]
- Authorea. 2024 May 2
- Research Square Preprint. 2024 Apr 5.
- bioRxiv. 2024 Apr 12.
- Research Square Preprint. 2024 Mar 18.
- Heliyon. 2024 Mar 28;10(7):e28806. [Abstract]
- Pharmaceutical Science Advances. 2024 Mar, 100039.
- Chemosphere. 2023 Dec:343:140237. [Abstract]
- SSRN. 2023 Nov 14.
- Research Square Preprint. 2023 Nov 17.
- Heliyon. 2023 Nov 17;9(11):e21664. [Abstract]
- Research Square Preprint. 2023 Oct 16.
- Research Square Preprint. 2023 Aug 29.
- bioRxiv. 2023 Sep 19:2023.09.18.558306. [Abstract]
- Research Square Preprint. 2023 Aug 24.
- Research Square Preprint. 2023 Aug 22.
- SSRN. 2023 Jul 6.
- Authorea. 2023 Jul 19.
- Biomed Pharmacother. 2023 May:161:114560. [Abstract]
- Environ Toxicol. 2023 May;38(5):1053-1062. [Abstract]
- Environ Toxicol. 2023 Mar;38(3):500-510. [Abstract]
- Sci Total Environ. 2023 Mar 15:864:161059. [Abstract]
- Preprints. 2023 Mar 6.
- SSRN. 2023 Feb 24.
- Research Square Print. 2023 Feb 3.
- Research Square Print. 2023 Feb 23.
- Research Square Print. December 19th, 2022.
- SSRN. 13 Dec 2022.
- Trop J Pharm Res. 2022; 21(12): 2508.
- Research Square Print. December 3rd, 2022.
- SSRN. 29 Oct 2022.
- Biomed Pharmacother. 2022 Jul;151:113098. [Abstract]
- Oxid Med Cell Longev. 2022 Jun 18:2022:6489923. [Abstract]
- Ann Transl Med. 2022 Apr;10(8):456. [Abstract]
- J Oncol. 2022 Apr 8:2022:3997562. [Abstract]
- Research Square Preprint. 2021 Sep.
- Research Square Preprint. 2021 Aug.
- Elife. 2021 Jul 13;10:e69047. [Abstract]
- Evid Based Complement Alternat Med. 2021 Jul 16;2021:6622848. [Abstract]
- Research Square Preprint. 2021 Jun.
- Aging (Albany NY). 2020 Apr 14;12(8):6928-6946. [Abstract]
- Griffith University. 2017 Jul.
-
Cell Migration/Invasion Assay
-
WB
-
WB
-
WB
-
WB
Biological Activity
|
PKC 11.7 nM (EC50) |
NF-κB |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| K562 | GI50 |
0.00012 μg/mL
Compound: 7
|
Cytotoxicity against human K562 cells
Cytotoxicity against human K562 cells
|
[PMID: 18163590] |
| K562 | GI50 |
0.12 ng/mL
Compound: 7
|
Cytotoxicity against human K562 cells
Cytotoxicity against human K562 cells
|
[PMID: 18163590] |
| MT4 | EC50 |
0.7 nM
Compound: 13
|
Antiviral activity against HIV2 ROD infected in MT4 cells assessed as cell viability after 5 days by MTT assay
Antiviral activity against HIV2 ROD infected in MT4 cells assessed as cell viability after 5 days by MTT assay
|
[PMID: 25970561] |
| MT4 | EC50 |
0.9 nM
Compound: 13
|
Antiviral activity against HIV1 3B infected in MT4 cells assessed as cell viability after 5 days by MTT assay
Antiviral activity against HIV1 3B infected in MT4 cells assessed as cell viability after 5 days by MTT assay
|
[PMID: 25970561] |
| NIH3T3 | GI50 |
0.01 μg/mL
Compound: 7
|
Cytotoxicity against BALB/c mouse 3T3 cells
Cytotoxicity against BALB/c mouse 3T3 cells
|
[PMID: 18163590] |
| SNU-387 | IC50 |
>10 μM
Compound: 10
|
Cytotoxicity against human SNU387 cells after 48 hrs by MTT assay
Cytotoxicity against human SNU387 cells after 48 hrs by MTT assay
|
[PMID: 23701597] |
| U-937 | EC50 |
0.45 nM
Compound: PMA
|
Induction of attachment of U937 cells after 48 hrs
Induction of attachment of U937 cells after 48 hrs
|
[PMID: 17284021] |
| Vero | CC50 |
5.7 μM
Compound: 4, TPA
|
Cytotoxicity against african green monkey Vero cells by MTS assay
Cytotoxicity against african green monkey Vero cells by MTS assay
|
[PMID: 23215460] |
| Vero | EC50 |
>162 μM
Compound: 4, TPA
|
Antiviral activity against Semliki forest virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
Antiviral activity against Semliki forest virus infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
|
[PMID: 23215460] |
| Vero | EC50 |
0.0029 μM
Compound: 4, TPA
|
Antiviral activity against Chikungunya virus 899 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
Antiviral activity against Chikungunya virus 899 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
|
[PMID: 23215460] |
| Vero | EC50 |
2.2 μM
Compound: 4, TPA
|
Antiviral activity against Sindbis virus HRsp infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
Antiviral activity against Sindbis virus HRsp infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect incubated for 6 to 7 days by MTS assay
|
[PMID: 23215460] |
| Vero | EC50 |
2.9 nM
Compound: 13
|
Antiviral activity against chikungunya virus Indian ocean strain 899 infected in Vero cells assessed as virus-induced cytopathic effect after 6 to 7 days
Antiviral activity against chikungunya virus Indian ocean strain 899 infected in Vero cells assessed as virus-induced cytopathic effect after 6 to 7 days
|
[PMID: 25970561] |
| Vero | CC50 |
5.7 μM
Compound: TPA
|
Cytotoxicity against African green monkey Vero cells assessed as morphological changes by microscopic method
Cytotoxicity against African green monkey Vero cells assessed as morphological changes by microscopic method
|
[PMID: 28925702] |
PMA (100, 200 ng/mL; 1-5 days) induce THP-1 cells to differentiate into macrophage-like cells (THP-1 macrophages), characterized by changes in morphology (adherent macrophage-like phenotype), and increases cell surface expression of CD11b[3][5].
PMA (20 ng/mL, 36 h) inhibits endothelial cell migration through activating the PKC-δ/Syk/NF-κB-mediated up-regulation of Thy-1[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.
Phorbol 12-myristate 13-acetate (PMA) can be used to create models of ear edema[8][9].
Administration: Topically applied in one ear • 100 μg/mL in 20 μL (2 μg/ear) vehicle • single dose
Indicator changes: Increased vascular permeability.
Mice: Swiss albino • male • 25-30 g
Administration: Topically applied in one ear • 2.5 μg in 20 μL vehicle • single dose
Indicator changes: Stimulate macrophages to produce superoxide anions.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 16561-29-8
-
Appearance Solid
-
Molecular Weight 616.83
-
Formula C36H56O8
-
Color White to off-white
-
SMILES
CCCCCCCCCCCCCC(O[C@H]([C@H]1C)[C@]2(OC(C)=O)[C@@]([C@@](C=C(CO)C[C@]34O)([H])[C@@]1(O)[C@]4([H])C=C(C)C3=O)([H])C2(C)C)=O
-
Synonyms
PMA; TPA; Phorbol myristate acetate
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (825)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression. [Abstract]2025 Dec 26;10(1):420. PMID: 41449244 -
Signal Transduct Target Ther
NPRC deletion mitigated atherosclerosis by inhibiting oxidative stress, inflammation and apoptosis in ApoE knockout mice. [Abstract]2023 Aug 9;8(1):290. PMID: 37553374 -
Cancer Cell
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer. [Abstract]2026 Apr 13;44(4):809-830.e11. PMID: 41720086 -
Cancer Cell
Chemotherapy triggers immune evasion by fostering LEPR+ Kupffer cell differentiation in liver metastases. [Abstract]2026 Mar 9;44(3):658-675.e12. PMID: 41687606 -
Science
An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis. [Abstract]2025 Nov 20;390(6775):eadz4712. PMID: 41264716 -
Cell
2025 Dec 11;188(25):7291-7308.e23. PMID: 41161316 -
Cell
De novo assembly of nuclear stress bodies rearranges and enhances NFIL3 to restrain acute inflammatory responses. [Abstract]2025 Aug 21;188(17):4586-4603.e31. PMID: 40436014 -
Cell
2025 May 29;188(11):3013-3029.e19. PMID: 40252640 -
Cell
Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria. [Abstract]2023 Nov 9;186(23):5114-5134.e27. PMID: 37875108 -
Mol Cancer
Integrating single cell- and spatial- resolved transcriptomics unravels the inter-tumor heterogeneity and immunosuppressive landscape in HBV- and Clonorchis sinensis-associated hepatocellular carcinoma. [Abstract]2026 Jan 5;25(1):3. PMID: 41491521 -
Mol Cancer
CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA. [Abstract]2025 Jul 19;24(1):199. PMID: 40684174 -
Cell Metab
Stress triggers irritable bowel syndrome with diarrhea through a spermidine-mediated decline in type I interferon. [Abstract]2025 Jan 7;37(1):87-103.e10. PMID: 39366386 -
Cell Metab
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer. [Abstract]2024 Aug 6;36(8):1806-1822.e11. PMID: 38897198 -
Cell Res
An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression. [Abstract]2023 Aug;33(8):585-603. PMID: 37337030 -
Adv Mater
Diatomic Mn/Ca Nanozymes with Jaw Vascular Unit Mimicry for Triple-Enzyme Synergistic Therapy of Osteoradionecrosis. [Abstract]2025 Nov 14:e17968. PMID: 41235623 -
Adv Mater
Zwitterionic Brush-Grafted Interfacial Bio-Lubricant Evades Complement C3-Mediated Macrophage Phagocytosis for Osteoarthritis Therapy. [Abstract]2025 Jul;37(28):e2501137. PMID: 40304130 -
Mil Med Res
Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles. [Abstract]2022 Aug 23;9(1):46. PMID: 35996168 -
-
Cancer Commun (Lond)
Blocking ITGA5 potentiates the efficacy of anti-PD-1 therapy on glioblastoma by remodeling tumor-associated macrophages. [Abstract]2025 Jun;45(6):677-701. PMID: 40084746 -
Nat Cancer
Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity. [Abstract]2025 May;6(5):768-785. PMID: 40108413 -
Nat Immunol
Delaying pyroptosis with an AI-screened gasdermin D pore blocker mitigates inflammatory response. [Abstract]2025 Oct;26(10):1660-1672. PMID: 40954252 -
Cell Mol Immunol
MAIT cell plasticity generates CD4+ MAIT cells that promote HCC progression via metabolic crosstalk with tumor cells. [Abstract]2026 May;23(5):491-504. PMID: 41974917 -
Cell Mol Immunol
Oncolytic virus M1 reinvigorates CD8+ T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen. [Abstract]2026 Apr;23(4):349-366. PMID: 41781696 -
Bioact Mater
Nano MgO loaded thermosensitive HPCH@HA hydrogel accelerates in situ bone repair through osteoimmunomodulation while enhancing angiogenesis and osteogenesis. [Abstract]2025 Aug 20:54:248-272. PMID: 40895238 -
Bioact Mater
An NIR-propelled janus nanomotor with enhanced ROS-scavenging, immunomodulating and biofilm-eradicating capacity for periodontitis treatment. [Abstract]2024 Jul 24:41:271-292. PMID: 39149593 -
Cell Host Microbe
Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy. [Abstract]2025 Jun 11;33(6):915-931.e9. PMID: 40441145 -
Nat Cell Biol
TOLLIP targets GSDME-NT-carrying endocytic vesicles for autophagy to regulate pyroptosis and chemotherapy efficacy. [Abstract]2026 Apr;28(4):812-827. PMID: 41803502 -
Nat Cell Biol
Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma. [Abstract]2024 Jun;26(6):1003-1018. PMID: 38858501 -
-
Cancer Res
Inhibition of JNK Signaling Overcomes Cancer-Associated Fibroblast-Mediated Immunosuppression and Enhances the Efficacy of Immunotherapy in Bladder Cancer. [Abstract]2024 Dec 16;84(24):4199-4213. PMID: 39292817 -
Cancer Res
Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Anti-Tumor Immunity. [Abstract]2023 Mar 15;83(6):906-921. PMID: 36634207 -
Cancer Res
SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS-STING Activation and Chemotherapeutic Sensitivity in Colon Cancer. [Abstract]2021 Jun 15;81(12):3215-3228. PMID: 33820798 -
J Extracell Vesicles
VAMP4/STX8 Mediate the Autophagic Secretion of Mitochondria and Promote TAMs Polarization in HNSCC. [Abstract]2026 Apr;15(4):e70276. PMID: 41979085 -
Sci Bull
Restoring sweat gland function in mice using regenerative sweat gland cells derived from chemically reprogrammed human epidermal keratinocytes. [Abstract]2024 Dec 30;69(24):3908-3924. PMID: 39550273 -
Bone Res
Inflammatory macrophage-derived itaconate inhibits DNA demethylase TET2 to prevent excessive osteoclast activation in rheumatoid arthritis. [Abstract]2025 Jun 11;13(1):60. PMID: 40500265 -
-
-
Autophagy
Exercise hormone irisin alleviates rheumatoid arthritis by removing dysfunctional mitochondria. [Abstract]2026 May 25. PMID: 42186185 -
Protein Cell
Drug target inference by mining transcriptional data using a novel graph convolutional network framework. [Abstract]2022 Apr;13(4):281-301. PMID: 34677780 -
Nat Commun
Maternal obesity induces macrophage to myofibroblast transition in kidneys of male offspring through a pathway driven by 20-hydroxyeicosatetraenoic acid. [Abstract]2026 May 14. PMID: 42135322 -
Nat Commun
Single-nucleus analysis reveals human-specific oligodendrocyte polarization and conserved neuronal responses after severe traumatic brain injury. [Abstract]2026 May 27. PMID: 42203771 -
Nat Commun
Structural dynamics of the midnolin-proteasome during ubiquitin-independent substrate turnover. [Abstract]2026 Mar 27;17(1):2800. PMID: 41896529 -
Nat Commun
A monoclonal antibody that inhibits the shedding of CD16a and CD16b and promotes antibody-dependent cellular cytotoxicity against tumors. [Abstract]2025 Nov 11;16(1):9915. PMID: 41219228 -
Nat Commun
Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma. [Abstract]2025 Nov 24;16(1):10384. PMID: 41285849 -
Nat Commun
Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion. [Abstract]2025 Oct 10;16(1):9015. PMID: 41073405 -
Nat Commun
Targeting CD37 promotes macrophage-dependent phagocytosis of multiple cancer cell types and facilitates tumor clearance in mice. [Abstract]2025 Jul 18;16(1):6610. PMID: 40675974 -
Nat Commun
Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury. [Abstract]2025 Feb 24;16(1):1909. PMID: 39994192 -
Nat Commun
Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer. [Abstract]2025 Jan 15;16(1):687. PMID: 39814714 -
Nat Commun
Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions. [Abstract]2024 Sep 12;15(1):7996. PMID: 39266508 -
Nat Commun
Necroptosis enhances 'don't eat me' signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. [Abstract]2024 Jul 18;15(1):6043. PMID: 39025845 -
Nat Commun
Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands. [Abstract]2022 Aug 15;13(1):4795. PMID: 35970825 -
ACS Nano
Personalized Pathogenic Nanoplastic Coronas Orchestrate Efferocytosis-Driven Immune Evasion in Lung Adenocarcinoma. [Abstract]2026 Jun 30;20(25):18111-18131. PMID: 42307976 -
ACS Nano
Sequential Mitochondrial Transplantation for Myocardial Ischemia-Reperfusion Injury Treatment. [Abstract]2025 Dec 16;19(49):41540-41556. PMID: 41320927 -
ACS Nano
Microneedles Loaded with Nitric-Oxide Driven Nanomotors Improve Force-Induced Efferocytosis Impairment and Sterile Inflammation by Revitalizing Macrophage Energy Metabolism. [Abstract]2025 Mar 11;19(9):9390-9411. PMID: 40025734 -
J Adv Res
SIRT7 facilitates ferroptosis resistance of melanocytes via activating the SMAD3-ATF3-GPX4 signaling pathway in vitiligo. [Abstract]2025 Jul 12:S2090-1232(25)00545-4. PMID: 40659088 -
Trends Biotechnol
2026 May 7:S0167-7799(26)00144-7. PMID: 42103601 -
Redox Biol
Macrophage metabolic reprogramming ameliorates diabetes-induced microvascular dysfunction. [Abstract]2025 Feb:79:103449. PMID: 39647239 -
Mol Cell
Localization of a TORC1-eIF4F translation complex during CD8+ T cell activation drives divergent cell fate. [Abstract]2022 Jul 7;82(13):2401-2414.e9. PMID: 35597236 -
Gut Microbes
Synergistic activity of Enterococcus Faeciu m-induced ferroptosis via expansion of IFN-γ+CD8+ T cell population in advanced hepatocellular carcinoma treated with sorafenib. [Abstract]2024 Jan-Dec;16(1):2410474. PMID: 39353096 -
J Nanobiotechnology
Nitric oxide-releasing nanocarriers integrated with ginsenoside compound K in dissolvable microneedles for androgenetic alopecia. [Abstract]2025 Dec 20. PMID: 41422253 -
J Nanobiotechnology
Extracellular vesicles from ovarian cancer cells induce senescent lipid-laden macrophages to facilitate omental metastasis. [Abstract]2025 Jul 26;23(1):540. PMID: 40713812 -
J Nanobiotechnology
RGD hydrogel-loaded ADSC extracellular vesicles mitigate uranium-induced renal injury via TLR4/NF-κB pathway inhibition. [Abstract]2025 Feb 17;23(1):114. PMID: 39962465 -
J Nanobiotechnology
A novel spherical GelMA-HAMA hydrogel encapsulating APET×2 polypeptide and CFIm25-targeting sgRNA for immune microenvironment modulation and nucleus pulposus regeneration in intervertebral discs. [Abstract]2024 Sep 12;22(1):556. PMID: 39267105 -
J Nanobiotechnology
The ketone body β-hydroxybutyrate alleviates CoCrMo alloy particles induced osteolysis by regulating NLRP3 inflammasome and osteoclast differentiation. [Abstract]2022 Mar 9;20(1):120. PMID: 35264201 -
Theranostics
2025 May 25;15(13):6329-6346. PMID: 40521193 -
Theranostics
Neutrophil extracellular trap-mediated impairment of meningeal lymphatic drainage exacerbates secondary hydrocephalus after intraventricular hemorrhage. [Abstract]2024 Feb 24;14(5):1909-1938. PMID: 38505607 -
Theranostics
Mitochondria-targeted supramolecular coordination container encapsulated with exogenous itaconate for synergistic therapy of joint inflammation. [Abstract]2022 Apr 4;12(7):3251-3272. PMID: 35547753 -
-
-
Acta Pharm Sin B
2025 Aug;15(8):4078-4095. PMID: 40893681 -
Acta Pharm Sin B
Macrophage P2Y6R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses. [Abstract]2024 Oct;14(10):4360-4377. PMID: 39525587 -
Acta Pharm Sin B
2022 Apr;12(4):1840-1855. PMID: 35847488 -
Acta Pharm Sin B
Activated PKB/GSK-3 β synergizes with PKC- δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity: Therapeutic efficacy of dihydrotanshinone-I. [Abstract]2021 Jan;11(1):71-88. PMID: 33532181 -
J Clin Invest
2025 Aug 1;135(15):e191119. PMID: 40759573 -
Adv Sci (Weinh)
NQO1-Mediated Anoikis Resistance and Immune Evasion Define a High-Risk Multi-Omic Subtype for Precision Management of T1 High-Grade Bladder Cancer. [Abstract]2026 Jun;13(36):e23605. PMID: 41945867 -
Adv Sci (Weinh)
HLA-DR+ Schwann Cells Generate the Protumor Cancer-Neuron-Immune Niche in Head and Neck Squamous Cell Carcinoma. [Abstract]2026 Jun 15:e76131. PMID: 42295734 -
Adv Sci (Weinh)
Bifidobacterium Pseudolongum-Derived Acetate Attenuates Acute Pancreatitis Through GPR43-Mediated Suppression of M1 Macrophage Polarization. [Abstract]2026 Jun;13(32):e17642. PMID: 41903115 -
Adv Sci (Weinh)
2026 Jun;13(31):e74889. PMID: 41902517 -
Adv Sci (Weinh)
pH/ROS-Responsive Injectable Hydrogel Co-Loaded with B7-H3 Blocker and NETs Suppressor Boosts OSCC Synergistic Immunotherapy. [Abstract]2026 Apr;13(20):e15431. PMID: 41684277 -
Adv Sci (Weinh)
SR-B1-Mediated Transplacental Transfer of Hydrophobic Toxicants Disrupts Fetal Development During Barriergenesis. [Abstract]2026 Apr;13(23):e15742. PMID: 41736660 -
Adv Sci (Weinh)
O-GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer. [Abstract]2026 Apr 24:e19955. PMID: 42028629 -
Adv Sci (Weinh)
Hepatocyte BPGM Induces RET Lactylation and Macrophage Reprogramming to Promote Tumorigenesis in Hepatocellular Carcinoma. [Abstract]2026 Jan 9:e18180. PMID: 41514495 -
Adv Sci (Weinh)
Elevator-Like Hollow Channels in Porous Scaffolds Accelerate Vascularized Bone Regeneration via NETs-Fibrin-Mediated Macrophage Recruitment. [Abstract]2025 Dec 5:e15693. PMID: 41347607 -
Adv Sci (Weinh)
H3K36me3-Guided m6A Modification of Oncogenic L1CAM-AS1 Drives Macrophage Polarization and Immunotherapy Resistance in Hepatocellular Carcinoma. [Abstract]2025 Sep;12(33):e14909. PMID: 40536332 -
Adv Sci (Weinh)
Synovium-On-A-Chip: Simulating the Microenvironment of the Rheumatoid Arthritis Synovium via Multicell Interactions to Target Fibroblast-Like Synoviocytes. [Abstract]2025 Sep 23:e11945. PMID: 40985312 -
Adv Sci (Weinh)
Secondary Bile Acids Modified by Odoribacter Splanchnicus Alleviate Colitis by Suppressing Neutrophil Extracellular Trap Formation. [Abstract]2025 Sep 24:e09073. PMID: 40990446 -
Adv Sci (Weinh)
Nanoparticle-Mediated CXCL12-CXCR4 Inhibition Reprograms Macrophages and Suppresses Gastric Carcinoma. [Abstract]2025 Aug;12(30):e00225. PMID: 40536774 -
Adv Sci (Weinh)
Plac1+ Tumor Cell-Treg Interplay Supports Tumorigenesis and Progression of Head and Neck Cancer. [Abstract]2025 May;12(17):e2417312. PMID: 40056047 -
Adv Sci (Weinh)
Nanocapsuled Neutrophil Extracellular Trap Scavenger Combating Chronic Infectious Bone Destruction Diseases. [Abstract]2025 Mar;12(10):e2411274. PMID: 39823437 -
Adv Sci (Weinh)
Single-Cell and Spatial Transcriptomics Delineate the Microstructure and Immune Landscape of Intrahepatic Cholangiocarcinoma in the Leading-Edge Area. [Abstract]2025 Feb;12(7):e2412740. PMID: 39716897 -
Adv Sci (Weinh)
Integrin β8 Facilitates Macrophage Infiltration and Polarization by Regulating CCL5 to Promote LUAD Progression. [Abstract]2025 Jan;12(2):e2406865. PMID: 39535362 -
Adv Sci (Weinh)
ASH1L in Hepatoma Cells and Hepatic Stellate Cells Promotes Fibrosis-Associated Hepatocellular Carcinoma by Modulating Tumor-Associated Macrophages. [Abstract]2024 Dec;11(45):e2404756. PMID: 39377228 -
Adv Sci (Weinh)
A Novel Engineering Cell Therapy Platform Mimicking the Immune Thrombocytopenia-Derived Platelets to Inhibit Cytokine Storm in Hemophagocytic Lymphohistiocytosis. [Abstract]2024 Dec;11(45):e2404571. PMID: 39258712 -
Adv Sci (Weinh)
The Thyroid Hormone Analog GC-1 Mitigates Acute Lung Injury by Inhibiting M1 Macrophage Polarization. [Abstract]2024 Nov;11(44):e2401931. PMID: 39373388 -
Adv Sci (Weinh)
Mitochondria-Targeted Nanoadjuvants Induced Multi-Functional Immune-Microenvironment Remodeling to Sensitize Tumor Radio-Immunotherapy. [Abstract]2024 Jul;11(26):e2400297. PMID: 38704675 -
MedComm
Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2. [Abstract]2024 May 13;5(5):e535. PMID: 38741887 -
Adv Sci (Weinh)
2024 May;11(19):e2306378. PMID: 38482749 -
MedComm
M1 macrophage-derived exosomes promote autoimmune liver injury by transferring long noncoding RNA H19 to hepatocytes. [Abstract]2023 Jun 29;4(4):e303. PMID: 37398637 -
Adv Sci (Weinh)
Discovery of Novel GR Ligands toward Druggable GR Antagonist Conformations Identified by MD Simulations and Markov State Model Analysis. [Abstract]2022 Jan;9(3):e2102435. PMID: 34825505 -
Cell Rep Med
Fungal metabolite-based immunotherapy overcomes tumor-associated macrophage immunosuppression. [Abstract]2026 Jun 16;7(6):102833. PMID: 42173096 -
Cell Rep Med
HE4 drives PD-L1 expression in myeloid cells via IFN-γR-JAK-STAT3 signaling to promote tumor immune evasion. [Abstract]2026 Apr 21;7(4):102691. PMID: 41861828 -
Cell Rep Med
Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer. [Abstract]2025 Dec 18:102529. PMID: 41418775 -
Cell Rep Med
Microneedle delivery of CAR-M-like engineered macrophages alleviates intervertebral disc degeneration through enhanced efferocytosis capacity. [Abstract]2025 Apr 15;6(4):102079. PMID: 40199328 -
Sci Adv
Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia. [Abstract]2025 Mar 21;11(12):eads8351. PMID: 40106574 -
Biomaterials
Ultrasound-responsive renal-targeted nanoparticles deliver TAK-242 to inhibit NF-κB/NLRP3 signaling and attenuate sepsis-associated acute kidney injury. [Abstract]2026 Jun:329:123922. PMID: 41481962 -
Biomaterials
Self-adaptive covalent coating for vascular stents: Coordinated coagulation-inflammation regulation to support re-endothelialization for atherosclerosis control. [Abstract]2026 Feb:325:123600. PMID: 40753783 -
Cell Death Differ
Targeting MMA-induced USP36 methylmalonylation to suppress macrophage polarization and tumor progression in clear-cell renal cell carcinoma. [Abstract]2025 Dec 15. PMID: 41398045 -
Biomaterials
pH protective Y1 receptor ligand functionalized antiphagocytosis BPLP-WPU micelles for enhanced tumor imaging and therapy with prolonged survival time. [Abstract]2018 Jul:170:70-81. PMID: 29653288 -
Med
MHC-II-restricted neoantigen vaccine reverses immune microenvironment and overcomes resistance to immune-checkpoint inhibitors in cold tumors. [Abstract]2026 Jan 9;7(1):100936. PMID: 41308654 -
Neuro Oncol
Low level of tumor necrosis factor α in tumor microenvironment maintains self-renewal of glioma stem cells by Vasorin-mediated glycolysis. [Abstract]2024 Dec 5;26(12):2256-2271. PMID: 39093693 -
Neuro Oncol
A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma. [Abstract]2024 Jan 5;26(1):137-152. PMID: 37555799
Phorbol 12-myristate 13-acetate purchased from MedChemExpress. Usage Cited in: Neuro Oncol. 2024 Jan 5;26(1):137-152. [Abstract]
Western Blot (WB) analysis ofADAM22 expression in indicated cells after PMA (150 nM) or forskolin (50 μM) administration for 0 hour, 24 hours, 48 hours, and 72 hours.
-
Research (Wash D C)
NIR-Activated ICG-Loaded M2 Macrophage Exosomes Ameliorate Periodontitis via Targeting Infection Inflammation and Oxidative Stress. [Abstract]2026 Apr 27:9:1207. PMID: 42051363 -
Research (Wash D C)
Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma. [Abstract]2026 Feb 25:9:1161. PMID: 41756725 -
Research (Wash D C)
2025 Sep 19:8:0902. PMID: 40979559 -
Research (Wash D C)
Astrocyte-Derived Interleukin 11 Modulates Astrocyte-Microglia Crosstalk via Nuclear Factor-κB Signaling Pathway in Sepsis-Associated Encephalopathy. [Abstract]2025 Jan 30:8:0598. PMID: 39886603 -
-
-
J Control Release
2026 Jun 10:394:114903. PMID: 41942056 -
J Control Release
Fibrin gel-based co-delivery of self-adjuvant tumor vaccine and PD-1 blockade for post-surgical gastric cancer immunotherapy. [Abstract]2026 Mar 10:391:114629. PMID: 41544668 -
Cancer Biol Med
Chidamide suppresses macrophage-mediated immune evasion and tumor progression in small cell lung cancer by targeting the STAT4/CCL2 signaling pathway. [Abstract]2025 Oct 23:j.issn.2095-3941.2024.0241. PMID: 41131865 -
J Control Release
Archaea-inspired deoxyribonuclease I liposomes prevent multiple organ dysfunction in sepsis. [Abstract]2025 Apr 10:380:1109-1126. PMID: 39986474 -
J Control Release
TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy. [Abstract]2020 Apr 10:320:304-313. PMID: 32004586 -
Cell Death Dis
EFHD2 drives lactate-mediated DNA damage repair and immunosuppression via HMGB1 and HIF-1α to confer radioresistance in colorectal cancer. [Abstract]2026 Jun 23. PMID: 42336814 -
Cell Death Dis
MTFR2 promotes VDAC1 oligomerization to reprogram BCAA metabolism in tumor cells to polarize TAMs in LUAD. [Abstract]2026 May 20. PMID: 42161922 -
Cell Death Dis
2026 Mar 30;17(1):430. PMID: 41912489 -
Cell Death Dis
Hypoxic tumor exosomes suppress macrophage inflammation and ferroptosis via NDUFV2 to enhance bystander tumor radioresistance. [Abstract]2025 Dec 19. PMID: 41419454 -
Cell Death Dis
2025 Nov 24;16(1):856. PMID: 41285805 -
Cell Death Dis
Chemotherapy-induced macrophage CXCL7 expression drives tumor chemoresistance via the STAT1/PHGDH-serine metabolism axis and SAM paracrine feedback to M2 polarization. [Abstract]2025 May 14;16(1):379. PMID: 40368902 -
Cell Death Dis
Fusion of glioma-associated mesenchymal stem/stromal cells with glioma cells promotes macrophage recruitment and M2 polarization via m6A modification of CSF1. [Abstract]2025 Apr 26;16(1):345. PMID: 40287444 -
Cell Death Dis
FTO controls CD8+ T cell survival and effector response by modulating m6A methylation of Fas. [Abstract]2025 Apr 15;16(1):301. PMID: 40234389 -
Pharmacol Res
Antagonising Yin Yang 1 ameliorates the symptoms of lupus nephritis via modulating T lymphocyte signaling. [Abstract]2024 Dec:210:107525. PMID: 39613121 -
Environ Sci Technol
Intracellular Protein Adsorption Behavior and Biological Effects of Polystyrene Nanoplastics in THP-1 Cells. [Abstract]2024 Feb 13;58(6):2652-2661. PMID: 38294362 -
Cell Mol Biol Lett
2024 Jan 3;29(1):8. PMID: 38172700 -
Environ Sci Technol
Triclosan Reprograms Immunometabolism and Activates the Inflammasome in Human Macrophages. [Abstract]2023 Jan 10;57(1):428-439. PMID: 36546883 -
Pharmacol Res
SHH/GLI2-TGF-β1 feedback loop between cancer cells and tumor-associated macrophages maintains epithelial-mesenchymal transition and endoplasmic reticulum homeostasis in cholangiocarcinoma. [Abstract]2023 Jan:187:106564. PMID: 36423790 -
Pharmacol Res
Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis. [Abstract]2022 Sep:183:106376. PMID: 35914680 -
Cell Death Dis
M1 macrophage-derived exosomes and their key molecule lncRNA HOTTIP suppress head and neck squamous cell carcinoma progression by upregulating the TLR5/NF-κB pathway. [Abstract]2022 Feb 24;13(2):183. PMID: 35210436 -
Cell Death Dis
Exosomal transfer of tumor-associated macrophage-derived hsa_circ_0001610 reduces radiosensitivity in endometrial cancer. [Abstract]2021 Aug 30;12(9):818. PMID: 34462422 -
Cell Death Dis
MFG-E8 regulated by miR-99b-5p protects against osteoarthritis by targeting chondrocyte senescence and macrophage reprogramming via the NF-κB pathway. [Abstract]2021 May 25;12(6):533. PMID: 34031369 -
Cell Death Dis
Lipoxin A4 suppresses angiotensin II type 1 receptor autoantibody in preeclampsia via modulating caspase-1. [Abstract]2020 Jan 30;11(1):78. PMID: 32001671 -
Pharmacol Res
Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway. [Abstract]2019 Apr:142:1-13. PMID: 30735802
Phorbol 12-myristate 13-acetate purchased from MedChemExpress. Usage Cited in: Pharmacol Res. 2019 Apr:142:1-13. [Abstract]
Total lysates from cells are analyzed for the expression of MMP-2 and MMP-9 by Western blot analysis in the treatment of different concentrations of PMA and PDD.
Phorbol 12-myristate 13-acetate purchased from MedChemExpress. Usage Cited in: Pharmacol Res. 2019 Apr:142:1-13. [Abstract]
MDA-MB-231 cells are pretreated with PPD for 24 h followed by exposure to 50 ng/mL of PMA for 30 min. The whole cell lysates are analyzed by Western blot for the activation of MAPK.
-
Cell Death Dis
CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling. [Abstract]2018 Aug 29;9(9):880. PMID: 30158589 -
Cancer Lett
Targeting C/EBPβ/SCD1/C16:1 loop-driven macrophage M2 polarization by Bruceine D improves anti-PD-1 immunotherapy in colorectal cancer. [Abstract]2026 Sep 28:656:218655. PMID: 42250753 -
Cancer Lett
Multi-omics driven immune classification of colorectal cancer: Implications for immunotherapy efficacy prediction and enhancement with WNT signaling inhibition. [Abstract]2026 May 28:646:218425. PMID: 41819525 -
Cancer Lett
Neutrophil extracellular traps enhance platinum resistance in ovarian cancer via SHP-1 activation. [Abstract]2026 Apr 10:643:218288. PMID: 41620200 -
Cancer Lett
2026 Jan 28:638:218156. PMID: 41265630 -
Cancer Lett
Traditional medicine Bazi Bushen potentiates immunosurveillance of senescent liver cancer cells via cGAS-STING signaling activation in macrophages. [Abstract]2025 Sep 1:627:217544. PMID: 39929434 -
Cancer Lett
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization. [Abstract]2024 Apr 10:587:216732. PMID: 38360142 -
Cancer Lett
Delivery of CD47-SIRPα checkpoint blocker by BCMA-directed UCAR-T cells enhances antitumor efficacy in multiple myeloma. [Abstract]2024 Mar 31:585:216660. PMID: 38266806 -
Cancer Lett
2023 Nov 28:577:216435. PMID: 37806516 -
J Immunother Cancer
HSP47 inhibition-induced CD155 expression through TRAF2 deubiquitination promotes tumor immune evasion. [Abstract]2025 Nov 28;13(11):e011976. PMID: 41314980 -
J Immunother Cancer
Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma. [Abstract]2025 Aug 22;13(8):e011091. PMID: 40846326 -
J Immunother Cancer
Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data. [Abstract]2025 Jul 31;13(7):e012029. PMID: 40744664 -
Int J Biol Sci
Macrophage-derived S100A9 promotes diabetic cardiomyopathy by disturbing mitochondrial quality control via STAT3 activation. [Abstract]2025 Apr 22;21(7):3061-3080. PMID: 40384874 -
J Immunother Cancer
Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. [Abstract]2025 Jan 4;13(1):e010183. PMID: 39755578 -
Int J Biol Sci
Senescent renal tubular cells derived extracellular vesicles transported miR-20a and miR-21 induced macrophage-to-myofibroblast transition in renal fibrosis after ischemia reperfusion injury. [Abstract]2025 Jan 6;21(3):940-954. PMID: 39897045 -
J Immunother Cancer
Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway. [Abstract]2024 Sep 4;12(9):e009318. PMID: 39237260 -
Int J Biol Sci
SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac-mediated macrophage reprogramming and disturbing immune homeostasis. [Abstract]2024 Jan 12;20(3):968-986. PMID: 38250161 -
Int J Biol Sci
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels. [Abstract]2020 Jun 27;16(13):2382-2391. PMID: 32760206 -
Cell Commun Signal
Intestinal epithelial PIEZO1 regulates macrophage-to-myofibroblast transition via epithelial-derived TGF-α signaling in Crohn's disease. [Abstract]2026 May 28. PMID: 42210253 -
Cell Commun Signal
NSP1 of Alongshan virus antagonizes type I interferon responses by promoting STUB1-mediated degradation of RIG-I. [Abstract]2026 Mar 24;24(1):262. PMID: 41877189 -
Cell Commun Signal
NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment. [Abstract]2025 Jul 21;23(1):348. PMID: 40691620 -
Cell Commun Signal
Helicobacter pylori infection promotes M1 macrophage polarization and gastric inflammation by activation of NLRP3 inflammasome via TNF/TNFR1 axis. [Abstract]2025 Jan 6;23(1):6. PMID: 39762835 -
Cell Commun Signal
2023 Jul 21;21(1):176. PMID: 37480055 -
Cell Commun Signal
Neutrophil extracellular traps induced by the hypoxic microenvironment in gastric cancer augment tumour growth. [Abstract]2023 May 1;21(1):86. PMID: 37127629 -
J Exp Med
EP3 enhances adhesion and cytotoxicity of NK cells toward hepatic stellate cells in a murine liver fibrosis model. [Abstract]2022 May 2;219(5):e20212414. PMID: 35420633 -
J Neuroinflammation
Transforming growth factor-β1 protects against LPC-induced cognitive deficit by attenuating pyroptosis of microglia via NF-κB/ERK1/2 pathways. [Abstract]2022 Jul 28;19(1):194. PMID: 35902863 -
Phytomedicine
Shegan Mahuang Decoction ameliorates pulmonary fibrosis progression by inhibiting CCL3-mediated NETosis. [Abstract]2026 Aug:158:158386. PMID: 42275874 -
Phytomedicine
Oxymatrine attenuates melanoma progression and metastasis through SORBS2-mediated suppression of M2 macrophage polarization. [Abstract]2026 Jun:155:158148. PMID: 41956023 -
Phytomedicine
Wuse-oil Compound 03 mitigates radiation-induced oral mucositis by modulating oral microbiota to mediate TLR4/NF-κB pathway and inhibit M1 macrophage polarization. [Abstract]2025 Sep:145:157083. PMID: 40714424 -
Phytomedicine
Calycosin inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by downregulating early growth response 1. [Abstract]2025 Jul 25:143:156884. PMID: 40446581 -
Phytomedicine
Tetrahydrocurcumin alleviates colorectal tumorigenesis by modulating the SPP1/CD44 axis and preventing M2 tumor-associated macrophage polarization. [Abstract]2025 Jun:141:156674. PMID: 40220425 -
Phytomedicine
Panax notoginseng saponins ameliorate LPS-induced acute lung injury by promoting STAT6-mediated M2-like macrophage polarization. [Abstract]2025 Apr:139:156513. PMID: 40010033 -
Phytomedicine
Protopine ameliorates OVA-induced asthma through modulatingTLR4/MyD88/NF-κB pathway and NLRP3 inflammasome-mediated pyroptosis. [Abstract]2024 Apr:126:155410. PMID: 38367422 -
Phytomedicine
Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARα-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys. [Abstract]2024 Apr:126:155450. PMID: 38368794 -
Phytomedicine
Anemoside B4 protects against chronic relapsing colitis in mice by modulating inflammatory response, colonic transcriptome and the gut microbiota. [Abstract]2022 Nov:106:154416. PMID: 36037770 -
Phytomedicine
Vitexin exerts protective effects against calcium oxalate crystal-induced kidney pyroptosis in vivo and in vitro. [Abstract]2021 Jun:86:153562. PMID: 33857849 -
-
EBioMedicine
Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes. [Abstract]2023 Jan:87:104410. PMID: 36525723 -
Mater Today Bio
Non-destructive debridement and tuneable ion release via magnesium abrasion and electro-dissolution promote bone regeneration and osseointegration of infected implants. [Abstract]2026 Apr 30. PMID: 42182868 -
Adv Healthc Mater
Biomimetic Copper-Doped Nano-Aluminum Adjuvant Potentiates Therapy in Chemoresistant Acute Myeloid Leukemia. [Abstract]2026 Mar 10:e04039. PMID: 41804653 -
Mater Today Bio
Mitochondrial biogenesis modulation by silicon-stimulated mesenchymal stem cells-derived extracellular vesicles drives angio- and lymphangiogenesis in chronic wound healing. [Abstract]2025 Dec 3:35:102629. PMID: 41450334 -
Cancer Genet
2025 Nov:298-299:285-294. PMID: 41265012 -
-
Adv Healthc Mater
MOF-818 Nanozyme Suppresses Calcium Oxalate Kidney Stones by Alleviating Oxidative Stress and Inflammatory Injury. [Abstract]2025 Mar;14(8):e2401574. PMID: 39171497 -
-
J Hazard Mater
Silicon carbide nanoparticles induce pulmonary fibrosis by promoting macrophage apoptosis through parkin-mediated mitophagy disruption and the intervention effect of emodin. [Abstract]2026 Apr 1:507:141765. PMID: 41864028 -
Mol Psychiatry
2025 Oct 1. PMID: 41034505 -
Acta Pharmacol Sin
Norcantharidin promotes M1 macrophage polarization and suppresses colorectal cancer growth. [Abstract]2025 May 20. PMID: 40394236 -
Cell Death Discov
NINJ1-mediated plasma membrane rupture of pyroptotic endothelial cells exacerbates blood-brain barrier destruction caused by neutrophil extracellular traps in traumatic brain injury. [Abstract]2025 Feb 20;11(1):69. PMID: 39979243 -
Cell Death Discov
Overexpressed nicotinamide N‑methyltransferase in endometrial stromal cells induced by macrophages and estradiol contributes to cell proliferation in endometriosis. [Abstract]2024 Nov 3;10(1):463. PMID: 39489776 -
Cell Death Discov
Nuclear PCGF3 inhibits the antiviral immune response by suppressing the interferon-stimulated gene. [Abstract]2024 Oct 5;10(1):429. PMID: 39368978 -
Cell Death Discov
Neutrophil extracellular traps promote invasion and metastasis via NLRP3-mediated oral squamous cell carcinoma pyroptosis inhibition. [Abstract]2024 May 2;10(1):214. PMID: 38697992 -
Acta Pharmacol Sin
Inhibiting von Hippel‒Lindau protein-mediated Dishevelled ubiquitination protects against experimental parkinsonism. [Abstract]2023 May;44(5):940-953. PMID: 36357669 -
Cell Death Discov
Hepatic TNFRSF12A promotes bile acid-induced hepatocyte pyroptosis through NFκB/Caspase-1/GSDMD signaling in cholestasis. [Abstract]2023 Jan 23;9(1):26. PMID: 36690641 -
Acta Pharmacol Sin
Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays. [Abstract]2022 Sep;43(9):2429-2438. PMID: 35110698 -
Cell Death Discov
Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury. [Abstract]2022 Feb 2;8(1):43. PMID: 35110526 -
Acta Biomater
Porous Se@SiO2 nanosphere-coated catheter accelerates prostatic urethra wound healing by modulating macrophage polarization through reactive oxygen species-NF-κB pathway inhibition. [Abstract]2019 Apr 1:88:392-405. PMID: 30753941 -
J Transl Med
Osteopontin derived from hypoxia-induced M2 macrophages promotes osteosarcoma progression through modulation of EGR3/ISG15 signaling and RIG-I expression. [Abstract]2025 Aug 21;23(1):950. PMID: 40841904
Phorbol 12-myristate 13-acetate purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Aug 21;23(1):950. [Abstract]
The migratory and invasive capabilities of HOS and MG-63 cells were assessed using Transwell assays in response to normoxic or hypoxic M0, M1, and M2 macrophages. THP-1 cells underwent differentiation into M0 macrophages following 24 h exposure to 100 ng/mL phorbol 12-myristate 13-acetate (PMA, HY-18739). Following a 24 h recovery in a fresh complete medium, cells were treated with 100 ng/mL lipopolysaccharide and 20 ng/mL IFN-gamma Protein, Human (IFN-γ, HY-P7025A) for 48 h to drive M1 polarization.
-
J Transl Med
Metabolic interplay between endometrial cancer and tumor-associated macrophages: lactate-induced M2 polarization enhances tumor progression. [Abstract]2025 Aug 18;23(1):923. PMID: 40826409 -
J Transl Med
Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma. [Abstract]2025 Jan 22;23(1):103. PMID: 39844299 -
J Transl Med
Napabucasin-loaded PLGA nanoparticles trigger anti-HCC immune responses by metabolic reprogramming of tumor-associated macrophages. [Abstract]2024 Dec 20;22(1):1125. PMID: 39707412 -
J Transl Med
tRNA-derived fragment 3'tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer. [Abstract]2024 Jul 30;22(1):706. PMID: 39080676 -
J Transl Med
P21 facilitates macrophage chemotaxis by promoting CCL7 in the lung epithelial cell lines treated with radiation and bleomycin. [Abstract]2023 May 9;21(1):314. PMID: 37161570 -
Sci China Life Sci
N6-methyladenosine attenuates tumor-associated macrophages M2 polarization via suppressing the translation of Snail. [Abstract]2025 Aug 21. PMID: 40856928 -
Proc Natl Acad Sci U S A
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. [Abstract]2022 Feb 22;119(8):e2114851119. PMID: 35181605 -
-
Diabetes
N 6-Methyladenosine demethylase FTO controls macrophage homeostasis in diabetic vasculopathy. [Abstract]2025 Jan 1;74(1):82-95. PMID: 39446524 -
Dev Cell
2026 Apr 29:S1534-5807(26)00150-4. PMID: 42061405 -
Dev Cell
STAT3-controlled CHI3L1/SPP1 positive feedback loop demonstrates the spatial heterogeneity and immune characteristics of glioblastoma. [Abstract]2025 Jun 23;60(12):1751-1767.e9. PMID: 39933531 -
Basic Res Cardiol
HIMF deletion ameliorates acute myocardial ischemic injury by promoting macrophage transformation to reparative subtype. [Abstract]2021 Apr 23;116(1):30. PMID: 33893593 -
Oncogene
Enhancing glioma immunotherapy by disrupting RBP-J-mediated NNMT signaling in tumor microenvironment. [Abstract]2026 Aug;45(29):2959-2977. PMID: 42310095 -
BME Front
2025 Nov 25:6:0203. PMID: 41306397 -
Oncogene
IL-17RA/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth. [Abstract]2024 Nov;43(49):3598-3616. PMID: 39424989 -
Apoptosis
BMP7 attenuates myocardial injury and preserves cardiac function after myocardial infarction by inhibiting cardiomyocyte pyroptosis. [Abstract]2026 Jan 23;31(2):57. PMID: 41575474 -
Apoptosis
Deciphering macrophage heterogeneity and factors driving M2 polarization in lung adenocarcinoma through single-cell RNA sequencing. [Abstract]2025 Oct 16. PMID: 41099999 -
Apoptosis
Pulsed electromagnetic fields inhibit IL-37 to alleviate CD8+ T cell dysfunction and suppress cervical cancer progression. [Abstract]2024 Dec;29(11-12):2108-2127. PMID: 39404933 -
Apoptosis
Emodin induces ferroptosis in colorectal cancer through NCOA4-mediated ferritinophagy and NF-κb pathway inactivation. [Abstract]2024 Oct;29(9-10):1810-1823. PMID: 38704789 -
Alzheimers Res Ther
Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer's disease via BACE1-mediated APP processing. [Abstract]2022 Jul 26;14(1):103. PMID: 35883144 -
-
Leukemia
Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome. [Abstract]2025 Aug;39(8):1997-2009. PMID: 40588566 -
Leukemia
Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling. [Abstract]2023 Mar;37(3):560-570. PMID: 36550214 -
Int J Biol Macromol
Omentin-1 promotes diabetic wound healing by regulating macrophage efferocytosis and M2 polarization. [Abstract]2026 Feb:347:150757. PMID: 41654047 -
Int J Biol Macromol
A high-throughput reporter assay for screening potential gasdermin D inhibitors from natural products. [Abstract]2026 Jan;339(Pt 2):150110. PMID: 41500275 -
Int J Biol Macromol
Downregulation of the biological macromolecule Spondin-2 disrupts maternal-fetal immune tolerance and trophoblast invasion, driving unexplained recurrent pregnancy loss. [Abstract]2025 Dec 12;338(Pt 1):149672. PMID: 41391791 -
Int J Biol Macromol
Exploiting an evolutionary constraint: Targeting TatD nuclease with chrysosplenol D disrupts Mycoplasma gallisepticum infection. [Abstract]2025 Jul 29;321(Pt 3):146394. PMID: 40744178 -
J Headache Pain
Astrocytic spermidine insufficiency contributes to enhanced pain sensitivity associated with ApoE4. [Abstract]2025 May 15;26(1):116. PMID: 40375206 -
Int J Biol Macromol
Bletilla striata polysaccharides alleviate ARDS by inhibiting NETs-induced pyroptosis in pulmonary alveolar macrophage through the PAD4 pathway. [Abstract]2025 May;305(Pt 1):141026. PMID: 39954881 -
Int J Nanomedicine
Electromechanical Regulation Underlying Protein Nanoparticle-Induced Osmotic Pressure in Neurotoxic Edema. [Abstract]2025 Apr 5:20:4145-4163. PMID: 40207308 -
BMC Med
Enhancing anti-CD3 mAb-mediated diabetes remission in autoimmune diabetes through regulation of dynamin-related protein 1(Drp1)-mediated mitochondrial dynamics in exhausted CD8+T-cell subpopulations. [Abstract]2025 Mar 31;23(1):189. PMID: 40165248 -
Int J Biol Macromol
S100A9 promotes renal calcium oxalate stone formation via activating the TLR4-p38/MAPK-LCN2 signaling pathway. [Abstract]2024 Nov;281(Pt 1):136178. PMID: 39357728 -
Int J Biol Macromol
Ultra-small platinum nano-enzymatic spray with ROS scavenging and anti-inflammatory properties for photoaging treatment. [Abstract]2024 Nov;280(Pt 2):135743. PMID: 39304038 -
Int J Biol Macromol
Purification and structural characterization of two polysaccharides with anti-inflammatory activities from Plumbago zeylanica L. [Abstract]2024 Mar;260(Pt 1):129455. PMID: 38232876 -
Int J Biol Macromol
Polysaccharide from Strongylocentrotus nudus eggs regulates intestinal epithelial autophagy through CD36/PI3K-Akt pathway to ameliorate inflammatory bowel disease. [Abstract]2023 Jul 31:244:125373. PMID: 37327932 -
Int J Mol Med
Triptolide exerts antiviral effects and alleviates influenza A‑induced pneumonia by inhibiting the overactivation of absent in melanoma 2 signaling in immune cells. [Abstract]2026 Jun;57(6):158. PMID: 41992969 -
Int J Mol Med
Hypothermic machine perfusion protects DCD graft liver from ischemia‑reperfusion injury by enhancing macrophage efferocytosis via KLF2‑NLRP3 signaling. [Abstract]2026 Apr;57(4):85. PMID: 41645764 -
Int J Mol Med
Platelet activation stimulates macrophages to enhance ulcerative colitis through PF4/CXCR3 signaling. [Abstract]2025 May;55(5):78. PMID: 40084691 -
Microbiol Res
Christensenellaceae minuta modulates epithelial healing via PI3K-AKT pathway and macrophage differentiation in the colitis. [Abstract]2024 Dec:289:127927. PMID: 39393129 -
Neural Regen Res
Atherosis-associated lnc_000048 activates PKR to enhance STAT1-mediated polarization of THP-1 macrophages to M1 phenotype. [Abstract]2024 Nov 1;19(11):2488-2498. PMID: 38526285 -
NPJ Breast Cancer
NR4A3 potentials M1-like macrophage polarization to facilitate anti-tumor immune responses in breast cancer. [Abstract]2025 Jul 7;11(1):67. PMID: 40624019 -
JACC Basic Transl Sci
ABCA1-Super Enhancer RNA Promotes Cholesterol Efflux, Reduces Macrophage-Mediated Inflammation and Atherosclerosis. [Abstract]2024 Oct 9;9(12):1388-1405. PMID: 39822602 -
EMBO J
Macrophage-derived insulin antagonist ImpL2 induces lipoprotein mobilization upon bacterial infection. [Abstract]2023 Dec 1;42(23):e114086. PMID: 37807855 -
J Clin Periodontol
Exosomes Derived From Human Gingival Mesenchymal Stem Cells Induce Metabolic Reprogramming of Inflammatory Macrophages. [Abstract]2025 Aug;52(8):1196-1210. PMID: 40388972 -
J Clin Periodontol
Dynamin-Related Protein 1 Orchestrates Inflammatory Responses in Periodontal Macrophages via Interaction With Hexokinase 1. [Abstract]2025 Apr;52(4):622-636. PMID: 39762202 -
Mol Med
Extinguishing the flames of inflammation: retardant effect of chlorquinaldol on NLRP3-driven diseases. [Abstract]2024 Dec 19;30(1):245. PMID: 39701924 -
Mol Med
Th1 cells reduce the osteoblast-like phenotype in valvular interstitial cells by inhibiting NLRP3 inflammasome activation in macrophages. [Abstract]2024 Jul 30;30(1):110. PMID: 39080527 -
-
Antioxidants (Basel)
Alpha-Lipoic Acid Inhibits IFN-γ-Induced PD-L1 Expression in Prostate Cancer Cells and Enhances T-Cell-Mediated Anti-Tumor Cytotoxicity. [Abstract]2026 Mar 25;15(4):413. PMID: 42072056 -
Cell Mol Gastroenterol Hepatol
Exercise-induced Metabolite N-lactoyl-phenylalanine Ameliorates Colitis by Inhibiting M1 Macrophage Polarization Via the Suppression of the NF-κB Signaling Pathway. [Abstract]2025;19(10):101558. PMID: 40562095 -
Phytother Res
20(R)-Ginsenoside Rg3 Suppresses P-Glycoprotein-Mediated Multidrug Resistance in A549/Taxol Cells by Targeting MDM2-IκB-α Signaling Axis. [Abstract]2026 Apr;40(4):1935-1950. PMID: 41630373 -
Phytother Res
Ginsenoside Re inhibits non-small cell lung cancer progression by suppressing macrophage M2 polarization induced by AMPKα1/STING positive feedback loop. [Abstract]2024 Nov;38(11):5088-5106. PMID: 39119862 -
Phytother Res
20(S)- Protopanaxadiol saponins isolated from Panax notoginseng target the binding of HMGB1 to TLR4 against inflammation in experimental ulcerative colitis. [Abstract]2023 Oct;37(10):4690-4705. PMID: 37424151 -
Phytother Res
Atractylenolide-III alleviates osteoarthritis and chondrocyte senescence by targeting NF-κB signaling. [Abstract]2023 Oct;37(10):4607-4620. PMID: 37380363 -
Free Radic Biol Med
Fyn deficiency drives pro-inflammatory macrophage activation to exacerbate septic acute lung injury. [Abstract]2026 Mar 16:246:80-92. PMID: 41490764 -
Free Radic Biol Med
PN-CeO2 as a potential therapeutic agent for atopic dermatitis: Antioxidant and anti-inflammatory effects. [Abstract]2025 Nov:239:540-551. PMID: 40782974 -
Free Radic Biol Med
Sophoridine alleviates sepsis-associated encephalopathy by inhibiting MARK4 and NLRP3 signaling. [Abstract]2025 Oct 28:S0891-5849(25)01324-3. PMID: 41167535 -
Free Radic Biol Med
Fat mass and obesity-associated protein inhibits macrophage-mediated inflammation via the m6A demethylation of c-Jun in COPD. [Abstract]2025 Sep 12:241:14-23. PMID: 40945342 -
Free Radic Biol Med
FUNDC1-dependent mitochondrial-ER membranes mediate mitochondrial dysfunction and melanocyte damage under oxidative stress. [Abstract]2025 Aug 15:240:108-123. PMID: 40819663 -
Free Radic Biol Med
2024 Nov 20:225:482-493. PMID: 39426754 -
Free Radic Biol Med
2024 Nov 6:226:13-28. PMID: 39510452 -
Free Radic Biol Med
2024 Jan:210:352-366. PMID: 38056575 -
Cancer Immunol Res
CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer. [Abstract]2026 May 4;14(5):875-891. PMID: 41686262 -
Clin Transl Med
Tumour-derived SAA1 reprogrammes macrophages to promote CXCL1-mediated metastasis in Ovarian Cancer. [Abstract]2026 May;16(5):e70698. PMID: 42145073 -
Cancer Immunol Res
2025 Dec 9. PMID: 41364085 -
Cancer Immunol Res
METTL3 Inhibition Restores PD-L1 Expression and CD8+ T-cell Cytotoxic Function in Immunotherapy-Treated Gastric Cancer. [Abstract]2025 Jul 2;13(7):1037-1052. PMID: 40299705 -
Clin Transl Med
2025 Mar;15(3):e70263. PMID: 40045452 -
Clin Transl Med
Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms. [Abstract]2024 Aug;14(8):e1799. PMID: 39118300 -
Stem Cell Res Ther
AMSC-EVs attenuate acute kidney injury through TXNIP-IKKα/NFκB signaling-mediated renal CX3CR1+ macrophage polarization. [Abstract]2025 Nov 14;16(1):639. PMID: 41239483 -
Am J Chin Med
Identification of Flavonoid Compounds in Treating Alzheimer's Disease Based on Network Medicine Framework Strategy. [Abstract]2025 Aug 30:1-32. PMID: 40884807 -
Stem Cell Res Ther
Enhanced engraftment and immunomodulatory effects of integrin alpha-2-overexpressing mesenchymal stromal cells in lipopolysaccharide-induced acute lung injury. [Abstract]2025 Jun 3;16(1):286. PMID: 40462215 -
ACS Appl Mater Interfaces
Monitoring the Cascade of Monocyte-Derived Macrophages to Influenza Virus Infection in Human Alveolus Chips. [Abstract]2024 Nov 6;16(44):60045-60055. PMID: 39450775 -
Br J Cancer
SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration. [Abstract]2024 May;130(11):1770-1782. PMID: 38600327 -
Cell Rep
2026 Jun 11;45(6):117546. PMID: 42284147 -
Cell Rep
Mrgpra2+ neutrophils integrate infection-derived signals to trigger NET-mediated antimicrobial defense in bone marrow. [Abstract]2026 Jun 22:117579. PMID: 42330955 -
Cell Rep
IRE1α regulates macrophage phagocytosis in immune thrombocytopenia through NR1D1 mRNA decay and lysosomal biogenesis. [Abstract]2026 Mar 12;45(3):117083. PMID: 41824452 -
Cell Rep
Tunneling nanotube-mediated stem cell immunomodulation dysfunction promotes adipose inflammation and insulin resistance in GDM. [Abstract]2025 Nov 25;44(11):116505. PMID: 41187060 -
Cell Rep
SLC6A8-mediated creatine uptake suppresses ERK2-FSP1 signaling and induces ferroptosis in colorectal cancer. [Abstract]2025 Sep 1;44(9):116139. PMID: 40892544 -
World J Gastroenterol
TSC22D1 promotes liver sinusoidal endothelial cell dysfunction and induces macrophage M1 polarization in non-alcoholic fatty liver disease. [Abstract]2025 Aug 21;31(31):109605. PMID: 40901684 -
Cell Rep
ENPP1 governs the metabolic regulation of effector T cells in autoimmunity by detecting cytosolic mitochondrial DNA. [Abstract]2025 Jun 13;44(6):115851. PMID: 40516055 -
Cell Rep
Macrophage extracellular traps as key mediators of scleral remodeling in myopia induced by hypoxia and activated platelets. [Abstract]2025 May 28;44(6):115771. PMID: 40440172 -
Cell Rep
Desuccinylation of TBK1 by SIRT5 regulates inflammatory response of macrophages in sepsis. [Abstract]2024 Dec 13;43(12):115060. PMID: 39673708 -
Cell Rep
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC. [Abstract]2024 Aug 7;43(8):114613. PMID: 39116206 -
Cell Rep
Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy. [Abstract]2024 Jul 31;43(8):114573. PMID: 39093701 -
Cell Rep
Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity. [Abstract]2024 Mar 23;43(4):114003. PMID: 38527062 -
Cell Rep
ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression. [Abstract]2023 Jun 19;42(6):112654. PMID: 37342906 -
Cell Rep
Bacterial effector restricts liquid-liquid phase separation of ZPR1 to antagonize host UPRER. [Abstract]2023 Jun 27;42(7):112700. PMID: 37379216 -
Cell Rep
METTL3-mediated m6A mRNA methylation regulates neutrophil activation through targeting TLR4 signaling. [Abstract]2023 Mar 13;42(3):112259. PMID: 36920907 -
Cell Rep
TRESK channel contributes to depolarization-induced shunting inhibition and modulates epileptic seizures. [Abstract]2021 Jul 20;36(3):109404. PMID: 34289346 -
Br J Pharmacol
Neutrophil extracellular traps drive tubulointerstitial fibrosis via the coiled-coil domain-containing protein 25 (CCDC25)-Yes-associated protein 1 (YAP1) axis-mediated autophagy regulation. [Abstract]2026 May 27. PMID: 42204873 -
Brain Behav Immun
Regulation of macrophage efferocytosis by the CLCF1/NF-κB pathway improves neurological and cognitive impairment following CO poisoning. [Abstract]2025 Jul:127:126-146. PMID: 40081779 -
Br J Pharmacol
Transient Receptor Potential channels, TRPV1 and TRPA1 in melanocytes synergize UV-dependent and UV-independent melanogenesis. [Abstract]2021 Dec;178(23):4646-4662. PMID: 34363226 -
Chin Med
Narcissoside attenuates atherosclerosis by suppressing CD36-mediated foam cell formation via upregulation of NR4A1. [Abstract]2026 May 20;21(1):136. PMID: 42163363 -
Neurotherapeutics
The EGR1/ZFP36 axis governs glycosphingolipid metabolic reprogramming in monocyte-derived macrophages in guillain-barré syndrome. [Abstract]2026 Mar 30;23(3):e00895. PMID: 41916145 -
Chin Med
Fat-targeted small molecule alleviates abnormal adipose tissue remodeling in obesity via SIRT3-driven mitophagy and inflammasome inhibition. [Abstract]2025 Dec 10;20(1):215. PMID: 41372934 -
Cell Mol Neurobiol
Neutrophil Extracellular Traps Regulate Surgical Brain Injury by Activating the cGAS-STING Pathway. [Abstract]2024 Apr 18;44(1):36. PMID: 38637346 -
J Med Chem
Targeted Degradation of Prolyl Hydroxylase Domain Enzyme 1 (PHD1) as a Novel Therapeutic Strategy for Acetaminophen-Induced Acute Liver Injury. [Abstract]2026 May 13. PMID: 42126822 -
Clin Sci
Evaluation of inflammation-mediated cancer progression during FLASH and conventional irradiation-induced lung injury. [Abstract]2026 Feb 11;140(2):201-219. PMID: 41552931 -
J Med Chem
Discovery of Novel Nonsteroidal SGRMs of Sulfonamide-2-Oxo-Tetrahydroquinoline Derivatives by Carbonyl Migration. [Abstract]2026 Jan 22;69(2):1507-1529. PMID: 41490153 -
J Med Chem
Identification of 5,7-Dihydro-6 H-pyrrolo[2,3- d]pyrimidin-6-one Derivatives as ENPP1 Inhibitors for STING Pathway-Mediated Immunotherapy. [Abstract]2025 Aug 14;68(15):16059-16075. PMID: 40711563 -
Environ Health (Wash)
Lung Single-Cell Transcriptomics Offers Insights into the Pulmonary Interstitial Toxicity Caused by Silica Nanoparticles. [Abstract]2024 Jul 1;2(11):786-801. PMID: 39568699 -
J Med Chem
Discovery and Optimization of N-Acyl-6-sulfonamide-tetrahydroquinoline Derivatives as Novel Non-Steroidal Selective Glucocorticoid Receptor Modulators. [Abstract]2022 Dec 8;65(23):15710-15724. PMID: 36399795 -
Environ Pollut
Silica-induced innate immune activation drives macrophage pyroptosis and lung inflammation through glycolytic reprogramming. [Abstract]2025 Oct 1:382:126762. PMID: 40614958 -
Atherosclerosis
Isolinderalactone alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation and inflammatory response in macrophages. [Abstract]2026 Jan 26:414:120648. PMID: 41759391 -
Front Immunol
Macrophage TRIM21 lactylation exacerbates infection-induced orchitis through enhancing STAT1-mediated CXCL9 and CXCL10 production. [Abstract]2026 Jan 14:16:1684836. PMID: 41613144 -
J Invest Dermatol
MRGPRX2-Mediated Mast Cell Activation Promotes Malignant Progression of Cutaneous Squamous Cell Carcinoma through IL-17A Release. [Abstract]2025 Nov 4:S0022-202X(25)03517-1. PMID: 41197765 -
Cancer Cell Int
DPEP2 suppresses metastasis via NF-κB-mediated epithelial-mesenchymal transition and M2 polarization in p53-loss non-small cell lung cancer. [Abstract]2025 Nov 17;25(1):408. PMID: 41250029 -
J Invest Dermatol
2025 Apr 19:S0022-202X(25)00413-0. PMID: 40258471 -
Front Immunol
Comprehensive multiomics analysis identifies PYCARD as a key pyroptosis-related gene in osteoarthritis synovial macrophages. [Abstract]2025 Mar 24:16:1558139. PMID: 40196125 -
Front Immunol
S1PR2 participates in intestinal injury in severe acute pancreatitis by regulating macrophage pyroptosis. [Abstract]2024 May 17:15:1405622. PMID: 38827741 -
Cancer Cell Int
Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration. [Abstract]2023 May 29;23(1):105. PMID: 37246211 -
Emerg Microbes Infect
Interactions between host epithelial cells and Acinetobacter baumannii promote the emergence of highly antibiotic resistant and highly mucoid strains. [Abstract]2022 Dec;11(1):2556-2569. PMID: 36227610 -
Front Immunol
Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer. [Abstract]2021 Oct 21;12:749369. PMID: 34745121 -
Front Immunol
2021 May 20;12:653030. PMID: 34093541 -
PLoS Biol
The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1. [Abstract]2025 Nov 24;23(11):e3003490. PMID: 41284701 -
J Ethnopharmacol
Rexiao Kuining decoction ameliorates ulcerative colitis by restoring immune homeostasis via the protein kinase C alpha-FMS-like tyrosine kinase 3 ligand axis: multi-omics evidence. [Abstract]2026 Nov 15:370:121985. PMID: 42264446 -
J Ethnopharmacol
Sanghuangporus vaninii extract exerts dual anti-tumor effects in colitis-associated colorectal cancer by direct cytotoxicity and macrophage reprogramming via the PPARγ/NF-κB axis. [Abstract]2026 Jul 15:366:121657. PMID: 41974235 -
J Ethnopharmacol
Melampodium divaricatum (Rich.) DC. extracts exert anti-inflammatory effects via inhibition of the NLRP3 inflammasome. [Abstract]2026 Oct 28:369:121903. PMID: 42202918 -
J Ethnopharmacol
Buyang Huanwu Decoction attenuates vascular aging by suppressing the pathway of neutrophil extracellular trap formation via modulation of the HMGB1/TLR4/p38 signaling pathway. [Abstract]2026 May 10:362:121315. PMID: 41655726 -
JCI Insight
LYVE1 ectodomain shedding blunts lymphatic transmigration and clearance of macrophages during kidney injury. [Abstract]2026 Jan 22;11(5):e195176. PMID: 41587141 -
J Ethnopharmacol
Modulation of the CEACAM1/TIM3 pathway by traditional Chinese medicine Xuebijing alleviates sepsis-induced acute lung injury through inhibition of NETs formation. [Abstract]2025 Jul 10;353(Pt A):120280. PMID: 40651727 -
J Ethnopharmacol
Ginseng and Platycodon grandiflorum ameliorated pulmonary fibrosis and inflammation targeting TLR4-P2X7r/NLRP3 signaling pathway. [Abstract]2025 May 28:348:119913. PMID: 40318772 -
J Autoimmun
Neutrophil extracellular traps induce trophoblasts pyroptosis via enhancing NLRP3 lactylation in SLE pregnancies. [Abstract]2025 May:153:103411. PMID: 40179478 -
J Ethnopharmacol
Guarea microcarpa C. DC. extract inhibits NLRP3 inflammasome by suppressing its ATPase activity. [Abstract]2024 Apr 6:323:117711. PMID: 38176663 -
Eur J Med Chem
Synthesis and pharmacological evaluation of brominated derivatives of natural product celastrol for treatment of hepatic fibrosis. [Abstract]2026 May 5:309:118765. PMID: 41844113 -
J Agric Food Chem
Lipidomics Revealed the Suppression of 5-PAHSA from Human Milk on Macrophage Foam Cell Formation. [Abstract]2025 Oct 22;73(42):27089-27098. PMID: 41061708 -
Eur J Med Chem
Synthesis and pharmacological validation of fluorescent diarylsulfonylurea analogues as NLRP3 inhibitors and imaging probes. [Abstract]2022 Jul 5;237:114338. PMID: 35436667 -
Eur J Med Chem
Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms. [Abstract]2021 Jun 5:218:113388. PMID: 33784603 -
CNS Neurosci Ther
Angiotensin II Receptor-Associated Protein (AGTRAP) Enhances Glioma Cell Survival Through the IL-6/JAK2/STAT3 Pathway and Correlates With an Immunosuppressive Microenvironment. [Abstract]2026 Feb;32(2):e70796. PMID: 41689202 -
Ecotoxicol Environ Saf
Cadmium exposure upregulates TXNIP and aggravates calcium oxalate kidney stone formation by promoting cell-crystal adhesion, apoptosis and macrophage M1 polarization. [Abstract]2025 Dec:308:119481. PMID: 41319465 -
CNS Neurosci Ther
Vitamin D3 Attenuates Neuropathic Pain via Suppression of Mitochondria-Associated Ferroptosis by Inhibiting PKCα/NOX4 Signaling Pathway. [Abstract]2024 Sep;30(9):e70067. PMID: 39328008 -
Ecotoxicol Environ Saf
2023 Sep 15:263:115265. PMID: 37478567 -
Ecotoxicol Environ Saf
The protective role of HMGB1 in affecting the balance between autophagy and pyroptosis to maintain neutrophils homeostasis during β-glucan-induced mice lung inflammation. [Abstract]2023 Mar 1:252:114637. PMID: 36774802 -
Ecotoxicol Environ Saf
Nuclear factor-kappaB mediates the survival of rat kidney cells after cadmium exposure via promoting autophagy and inhibiting apoptosis. [Abstract]2023 Jan 1:249:114465. PMID: 38321684 -
Biochem Pharmacol
Recruitment of tumor-associated macrophages via the CCL4-CCR5 axis promotes immune escape through PD-1 signaling in lung adenocarcinoma. [Abstract]2026 Jul:249:117925. PMID: 41876018 -
Biochem Pharmacol
Hypoxia-driven TCF21/CCL11 axis in GCMSCs orchestrates macrophage polarization and lymphatic remodeling to promote gastric cancer lymph node metastasis. [Abstract]2026 May 14;250(Pt 2):118056. PMID: 42134670 -
Cell Mol Life Sci
Dual phosphorylation of glycogen synthase kinase 3β differentially integrates metabolic programs to determine T cell immunity across vertebrates. [Abstract]2025 May 28;82(1):218. PMID: 40434714 -
Biochem Pharmacol
2024 Jan:219:115957. PMID: 38049007 -
Cell Biosci
Differential effects of PGAM5 knockout on high fat high fructose diet and methionine choline-deficient diet induced non-alcoholic steatohepatitis (NASH) in mice. [Abstract]2023 Aug 21;13(1):154. PMID: 37605246 -
Biochem Pharmacol
2023 Jul:213:115618. PMID: 37211172 -
Mol Ther Nucleic Acids
DRAM1 increases the secretion of PKM2-enriched EVs from hepatocytes to promote macrophage activation and disease progression in ALD. [Abstract]2021 Dec 11:27:375-389. PMID: 35036051 -
Life Sci
G0S2 drives lipid metabolism disorders and oxidative stress to promote M1 macrophage polarization and inflammation in polycystic ovary syndrome. [Abstract]2026 Jul 15:397:124392. PMID: 41985712 -
Cell Insight
2026 Apr 2;5(3):100323. PMID: 42011339 -
Life Sci
Exploring the hepatoprotective effects of perillyl alcohol in the experimental models of acute liver injury. [Abstract]2025 Nov 1:380:123926. PMID: 40850494 -
Life Sci
Homoyessotoxin alleviates inflammatory responses by regulating the TLR4/MyD88/NFκB and Nrf2/HO-1 pathways. [Abstract]2025 Oct 15:379:123858. PMID: 40669807 -
Life Sci
M2 macrophage derived exosomal miR-20a-5p ameliorates trophoblast pyroptosis and placental injuries in obstetric antiphospholipid syndrome via the TXNIP/NLRP3 axis. [Abstract]2025 Jun 1:370:123561. PMID: 40127859 -
Life Sci
Targeting the HDAC6/Hint2/MICU1 axis to ameliorate acute liver failure via inhibiting NETosis. [Abstract]2025 Apr 1:366-367:123498. PMID: 39983829 -
Life Sci
TPX2 influences the regulation of macrophage polarization via the NF-κB pathway in lung adenocarcinoma. [Abstract]2024 Mar 1:340:122437. PMID: 38266813 -
Life Sci
PGRN-/- TAMs-derived exosomes inhibit breast cancer cell invasion and migration and its mechanism exploration. [Abstract]2021 Jan 1:264:118687. PMID: 33181174 -
Life Sci
2020 Jan 15:241:117103. PMID: 31783053 -
Life Sci
FcγRI (CD64) contributes to the severity of immune inflammation through regulating NF-κB/NLRP3 inflammasome pathway. [Abstract]2018 Aug 15:207:296-303. PMID: 29920250 -
-
Oncoimmunology
Inhibiting SLAMF8 modulates tumor-associated macrophages and restores CD8+ T cell-mediated antitumor immunity in colorectal cancer. [Abstract]2025 Dec 31;14(1):2581910. PMID: 41211891 -
Inflamm Res
Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma. [Abstract]2024 Sep;73(9):1529-1545. PMID: 39028490 -
Inflamm Res
Transcriptomic analysis reveals molecular characterization and immune landscape of PANoptosis-related genes in atherosclerosis. [Abstract]2024 Jun;73(6):961-978. PMID: 38587531 -
Inflamm Res
Quercetin and Kaempferol inhibit HMC-1 activation via SOCE/NFATc2 signaling and suppress hippocampal mast cell activation in lipopolysaccharide-induced depressive mice. [Abstract]2024 Jun;73(6):945-960. PMID: 38587532 -
Oncoimmunology
CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage. [Abstract]2024 May 10;13(1):2352179. PMID: 38746869 -
Drug Des Devel Ther
Morin Regulates M1/M2 Microglial Polarization via NF-κB p65 to Alleviate Vincristine-Induced Neuropathic Pain. [Abstract]2024 Jul 22:18:3143-3156. PMID: 39071815 -
EMBO Rep
2025 Nov 17. PMID: 41249580 -
EMBO Rep
2025 Sep 16. PMID: 40958049 -
J Clin Transl Hepatol
CCNE1 Promotes the Progression of Hepatic Precancerous Lesion and the Malignant Phenotype of Hepatocellular Carcinoma. [Abstract]2025 Jul 28;13(7):555-567. PMID: 40937080 -
Cells
Naringenin Targets PI3K p85alpha to Suppress PI3K/AKT Signaling Pathway and Ameliorate Disordered MMP-9 Secretion in Cigarette Smoke Extract-Induced Alveolar Macrophages In Vitro. [Abstract]2025 May 8;14(10):678. PMID: 40422181 -
J Am Heart Assoc
HMGB1-Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice. [Abstract]2022 Feb 15;11(4):e023800. PMID: 35156391 -
Cancer Immunol Immunother
CXCL9/SPP1-polarized tumor-associated macrophages exert dual roles in regulating anti-tumor immunity in lung adenocarcinoma. [Abstract]2026 Jun 16. PMID: 42301510 -
Commun Biol
Pseudorabies virus infection induces IRF1-dependent PANoptosis to provoke the excessive release of HMGB1 and IL-1β. [Abstract]2026 Jun 5. PMID: 42249111 -
Cancer Immunol Immunother
A novel oncolytic herpes simplex virus type 2 induces polarization of tumor-associated macrophages and remodels the immune microenvironment in glioblastoma. [Abstract]2026 May 30. PMID: 42217049 -
Mol Cancer Res
ID4 suppresses proliferation and macrophage polarization in esophageal carcinoma through interaction with TCF4. [Abstract]2026 Mar 2. PMID: 41770101 -
Cancer Immunol Immunother
SLC16A3 in lung adenocarcinoma regulates glycolysis and lactate release to facilitate M2 polarization of tumor-associated macrophages : Short Title: SLC16A3 reinforces macrophage M2 polarization through glycolysis. [Abstract]2025 Dec 23;75(1):25. PMID: 41432987 -
Cancer Immunol Immunother
MS4A1 regulates M1-polarized tumor-associated macrophage infiltration, angiogenesis, and cancer progression through the HIPPO pathway in lung adenocarcinoma. [Abstract]2025 Nov 3;74(12):356. PMID: 41182411 -
Nutrients
2025 Nov 12;17(22):3534. PMID: 41305585 -
Cancer Immunol Immunother
Integrating necroptosis and immune landscapes: a multi-omics-derived NecropImmScore stratifies prognosis and therapy in ovarian cancer. [Abstract]2025 Oct 15;74(11):340. PMID: 41094064 -
Commun Biol
Piezo1 promotes the progression of necrotizing enterocolitis by activating the Ca2(+)/CaMKII-dependent pathway. [Abstract]2025 Mar 12;8(1):417. PMID: 40074811 -
Commun Biol
Defining gastric cancer ecology: the crucial roles of TREM2+ macrophages and fibroblasts in tumor microenvironments. [Abstract]2025 Mar 28;8(1):514. PMID: 40155473 -
Cancer Immunol Immunother
SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells. [Abstract]2025 Feb 1;74(3):87. PMID: 39891717 -
Cancer Immunol Immunother
STC1 encapsulated in small extracellular vesicles from laryngeal squamous cell carcinoma cells induces CD8+ T cell dysfunction by reprogramming tumor-associated macrophages into M2-like macrophages. [Abstract]2025 Jan 3;74(2):64. PMID: 39751648 -
Cancer Immunol Immunother
Nicotine promotes M2 macrophage polarization through α5-nAChR/SOX2/CSF-1 axis in lung adenocarcinoma. [Abstract]2024 Nov 2;74(1):11. PMID: 39487876 -
Cancer Immunol Immunother
2023 Jun;72(6):1917-1932. PMID: 36729212 -
Nutrients
Endoplasmic Reticulum Stress Affects Cholesterol Homeostasis by Inhibiting LXRα Expression in Hepatocytes and Macrophages. [Abstract]2020 Oct 11;12(10):3088. PMID: 33050595 -
Eur J Pharmacol
Therapeutic potential of oral edaravone in diabetic endothelial dysfunction through NF-κB and p38 pathway inhibition. [Abstract]2026 Jan 20:1012:178500. PMID: 41421410 -
Eur J Pharmacol
Remimazolam alleviates acute lung injury via translocator protein mediated inhibition of the NF-κB pathway. [Abstract]2026 Feb 10:1014:178540. PMID: 41519458 -
Cancer Biol Ther
CD44v5 enhances the IL-4/IL-4Rα/STAT6/SAM68 aix inducing M2 polarization and promoting triple-negative breast cancer progression. [Abstract]2025 Dec 31;26(1):2589658. PMID: 41319154 -
Respir Res
MTMR14 depletion aggravates intrapulmonary inflammation and emphysema in experimental COPD through activating macrophage M1 polarization. [Abstract]2025 Jul 10;26(1):238. PMID: 40640787 -
Eur J Pharmacol
Cinobufagin modulates vasculogenic mimicry and tumor-associated macrophages to inhibit ovarian cancer progression. [Abstract]2025 Jan 15:987:177157. PMID: 39617163 -
Pharmaceuticals (Basel)
In Vitro and In Vivo Assessment of Pharmacokinetic Profile of Peramivir in the Context of Inhalation Therapy. [Abstract]2025 Jan 29;18(2):181. PMID: 40005995 -
Eur J Pharmacol
Cylindrin from Imperata cylindrica inhibits M2 macrophage formation and attenuates renal fibrosis by downregulating the LXR-α/PI3K/AKT pathway. [Abstract]2023 Jul 5:950:175771. PMID: 37146709 -
Pharmaceuticals (Basel)
Hydrogen Attenuates Inflammation by Inducing Early M2 Macrophage Polarization in Skin Wound Healing. [Abstract]2023 Jun 15;16(6):885. PMID: 37375833 -
Acta Physiol
2023 Apr;237(4):e13926. PMID: 36606511 -
Int Immunopharmacol
Electroacupuncture protects intestinal barrier integrity in MAFLD mice and is associated with a macrophage α7nAChR/exosomal miR-217-5p/epithelial HO-1 signaling axis. [Abstract]2026 Aug 15:183:116879. PMID: 42161050 -
Int Immunopharmacol
Paeonol mitigates age-related osteoporosis via mitophagy-mediated NLRP3 inflammasome inhibition. [Abstract]2026 Aug 1:182:116787. PMID: 42096961 -
Int Immunopharmacol
Clostridium butyricum alleviates DSS-induced colitis by suppressing neutrophil extracellular trap formation via the IL-17 pathway. [Abstract]2026 Jul 15:181:116770. PMID: 42070310 -
Int Immunopharmacol
CTSK+ macrophages drive fibrotic stenosis in benign airway stenosis via the PROS1-AXL pathway. [Abstract]2026 Jun 16:185:117018. PMID: 42302376 -
Cell Oncol (Dordr)
P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer. [Abstract]2026 Jun 6. PMID: 42250059 -
Int Immunopharmacol
Celastrol protects against renal tubular injury in early diabetic kidney disease through modulation of NOX2 and ferroptosis. [Abstract]2026 May 15:177:116533. PMID: 41861539 -
Int Immunopharmacol
Sakuranetin ameliorates joint inflammation and bone erosion in rheumatoid arthritis by suppressing NLRP3 inflammasome-mediated inflammatory signaling. [Abstract]2026 May 15:177:116542. PMID: 41864012 -
Int Immunopharmacol
UBE2C-PI3K/AKT-mediated upregulation of MTHFD2 promotes tumor progression in hepatocellular carcinoma. [Abstract]2026 Feb 1:170:116081. PMID: 41456492 -
Int Immunopharmacol
Nimbolide inhibits NLRP3 inflammasome activation via blocking NEK7-NLRP3 interaction and alleviates sepsis-induced lung injury. [Abstract]2026 Jan 1;168(Pt 2):115954. PMID: 41319565 -
Int Immunopharmacol
2026 Jan 1;168(Pt 1):115803. PMID: 41218583 -
Int Immunopharmacol
Microbial metabolite tigloside alleviates osteoarthritis by repolarizing macrophages from M1 to M2 phenotype through Trafd1 destabilization and Trafd1-mediated NF-κB/STAT6 signaling pathways. [Abstract]2026 Jan 1;168(Pt 1):115747. PMID: 41192114 -
Int Immunopharmacol
Oleanolic acid alleviates intestinal injury after hepatic ischemia-reperfusion under steatosis via PPARG-dependent M2 macrophage polarization. [Abstract]2026 Feb 15:171:116162. PMID: 41494252 -
Int Immunopharmacol
GPRC5A+ myCAFs promote ESCC progression via TGF-β-induced fibroblast activation and ANXA1-mediated M2 macrophage polarization. [Abstract]2025 Dec 10:167:115663. PMID: 41082840 -
Int J Mol Sci
Synovial CXCL3+FOSL2+ Macrophages Mediate Inflammation via FOSL2/AP-1 in Rheumatoid Arthritis: A Single-Cell Transcriptome Analysis. [Abstract]2025 Oct 6;26(19):9718. PMID: 41096984 -
Int Immunopharmacol
Bruceine D promotes TNBC regression by inhibiting M2-like tumor-associated macrophage polarization induced Wnt3a/β-catenin pathway. [Abstract]2025 Sep 23:166:115596. PMID: 40991998 -
Int Immunopharmacol
Timosaponin AIII from Anemarrhena asphodeloides binds and inhibits S100A8-mediated neutrophil infiltration and NET formation ameliorates MASH. [Abstract]2025 Sep 20:166:115539. PMID: 40976053 -
Int Immunopharmacol
Cucurbitacin B suppresses malignant progression of oral leukoplakia via ferroptosis-induced macrophage polarization. [Abstract]2025 Sep 13:165:115485. PMID: 40946669 -
Noncoding RNA Res
Aerobic exercise alleviates allergic airway inflammation by suppressing circMETTL9-mediated formation of macrophage extracellular traps. [Abstract]2025 Aug 29:15:156-171. PMID: 41169933 -
Int Immunopharmacol
High ELK3 expression is associated with the wild type IDH1 in glioma and enhances infiltration of M2 macrophages. [Abstract]2025 Aug 28:161:115064. PMID: 40513332 -
Int Immunopharmacol
The natural compound PEITC ameliorates imiquimod-induced psoriasis in mice by suppressing neutrophil extracellular traps formation. [Abstract]2025 Jun 26:159:114939. PMID: 40414074 -
Int Immunopharmacol
IDH1/MDH1 deacetylation activates the cGAS-STING pathway by promoting NETosis in acute liver failure. [Abstract]2025 Jun 17:158:114884. PMID: 40388861 -
Int Immunopharmacol
Narirutin attenuates LPS-induced neuroinflammatory responses in both microglial cells and wild-type mice. [Abstract]2025 Jun 26:159:114954. PMID: 40424653 -
Int J Mol Sci
CD71-Mediated Effects of Soluble Vasorin on Tumor Progression, Angiogenesis and Immunosuppression. [Abstract]2025 May 20;26(10):4913. PMID: 40430053 -
Int J Mol Sci
Mechanical Force Triggers Macrophage Pyroptosis and Sterile Inflammation by Disrupting Cellular Energy Metabolism. [Abstract]2025 Apr 2;26(7):3321. PMID: 40244158 -
Biomolecules
PAR2 Participates in the Development of Cough Hypersensitivity in Guinea Pigs by Regulating TRPA1 Through PKC. [Abstract]2025 Feb 1;15(2):208. PMID: 40001511 -
Int Immunopharmacol
SPP1-mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal carcinoma. [Abstract]2025 Feb 6:147:113944. PMID: 39742726 -
Int Immunopharmacol
HSPA5-mediated glioma hypoxia tolerance promotes M2 macrophage polarization under hypoxic microenvironment. [Abstract]2025 Feb 6:147:113856. PMID: 39740502 -
Int Immunopharmacol
OSU-T315 overcomes immunosuppression in triple-negative breast cancer by targeting the ILK/NF-κB signaling pathway to enhance immunotherapeutic efficacy. [Abstract]2024 Nov 7;143(Pt 3):113530. PMID: 39515039 -
Int J Mol Sci
2024 Nov 14;25(22):12260. PMID: 39596325 -
Int Immunopharmacol
The VDR/FFAR2 axis mitigates sepsis-induced lung injury by suppressing macrophage lipid peroxidation. [Abstract]2024 Oct 16;143(Pt 2):113328. PMID: 39418731 -
Int Immunopharmacol
Tumor-associated macrophages induce epithelial-mesenchymal transition and promote lung metastasis in breast cancer by activating the IL-6/STAT3/TGM2 axis. [Abstract]2024 Oct 18;143(Pt 2):113387. PMID: 39426226 -
Int Immunopharmacol
M2 Macrophage exosomal HOXC13-AS in laryngeal cancer immunity via targeting miR-485-5p/IGF2BP2/PD-L1. [Abstract]2024 Oct 25:140:112742. PMID: 39126735 -
Int Immunopharmacol
Isosilybin A exhibits anti-inflammatory properties in rosacea by inhibiting MAPK pathway and M1 macrophage polarization. [Abstract]2024 Oct 14;143(Pt 1):113323. PMID: 39405940 -
Int Immunopharmacol
2024 Sep 30;143(Pt 1):113270. PMID: 39353390 -
Int Immunopharmacol
Chinese medicine compound prescription HeQi San ameliorates chronic inflammatory states and modulates gut flora in dehydroepiandrosterone-induced polycystic ovary syndrome mouse model. [Abstract]2024 Aug 20:137:112491. PMID: 38909499 -
Int Immunopharmacol
Fecal microbiota transplantation regulates the microbiota-gut-spinal cord axis to promote recovery after spinal cord injury. [Abstract]2024 Jan 5:126:111212. PMID: 37979452 -
Int Immunopharmacol
Tryptophan metabolism regulates inflammatory macrophage polarization as a predictive factor for breast cancer immunotherapy. [Abstract]2023 Dec;125(Pt B):111196. PMID: 37972471 -
Int Immunopharmacol
Hsa_circRNA_103124 upregulation in Crohn's disease promoted macrophage M1 polarization to maintain an inflammatory microenvironment via activation of the AKT2 and TLR4/NF-κB pathways. [Abstract]2023 Oct:123:110763. PMID: 37567009 -
Int Immunopharmacol
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma. [Abstract]2023 Oct:123:110685. PMID: 37494837 -
Int Immunopharmacol
Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism. [Abstract]2023 Oct:123:110456. PMID: 37494836 -
Int J Mol Sci
Intermittent Hypoxia Promotes TAM-Induced Glycolysis in Laryngeal Cancer Cells via Regulation of HK1 Expression through Activation of ZBTB10. [Abstract]2023 Sep 30;24(19):14808. PMID: 37834257 -
Int J Mol Sci
Ursolic Acid Alleviates Neuroinflammation after Intracerebral Hemorrhage by Mediating Microglial Pyroptosis via the NF-κB/NLRP3/GSDMD Pathway. [Abstract]2023 Sep 30;24(19):14771. PMID: 37834220 -
Int Immunopharmacol
Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway. [Abstract]2023 Jul:120:110378. PMID: 37244119 -
Int J Mol Sci
R-Propranolol Has Broad-Spectrum Anti-Coronavirus Activity and Suppresses Factors Involved in Pathogenic Angiogenesis. [Abstract]2023 Feb 27;24(5):4588. PMID: 36902020 -
Int Immunopharmacol
Extracellular citrate serves as a DAMP to activate macrophages and promote LPS-induced lung injury in mice. [Abstract]2021 Dec;101(Pt B):108372. PMID: 34810128 -
Int Immunopharmacol
Senkyunolide I protect against lung injury via inhibiting formation of neutrophil extracellular trap in a murine model of cecal ligation and puncture. [Abstract]2021 Oct:99:107922. PMID: 34224996 -
Int Immunopharmacol
Effect of gingival mesenchymal stem cell-derived exosomes on inflammatory macrophages in a high-lipid microenvironment. [Abstract]2021 May:94:107455. PMID: 33582592 -
Int Immunopharmacol
Role of gingival mesenchymal stem cell exosomes in macrophage polarization under inflammatory conditions. [Abstract]2020 Apr:81:106030. PMID: 31796385 -
Int Immunopharmacol
Protective effects of dioscin against systemic inflammatory response syndromevia adjusting TLR2/MyD88/NF‑κb signal pathway. [Abstract]2018 Dec:65:458-469. PMID: 30390593 -
Mol Neurobiol
GIV/Girdin Modulation of Microglial Activation in Ischemic Stroke: Impact of FTO-Mediated m6A Modification. [Abstract]2025 May;62(5):5501-5517. PMID: 39560901 -
Antibiotics (Basel)
The Tick Saliva Peptide HIDfsin2 TLR4-Dependently Inhibits the Tick-Borne Severe Fever with Thrombocytopenia Syndrome Virus in Mouse Macrophages. [Abstract]2024 May 15;13(5):449. PMID: 38786177 -
Immunology
STING Drives Psoriatic Inflammation by Promoting Neutrophil Recruitment and Facilitating NETosis. [Abstract]2026 Mar 3. PMID: 41775627 -
Inflammation
Palmatine Attenuates Lipopolysaccharide-Induced Acute Lung Injury Via Suppression of NLRP3 Inflammasome Activation, Pyroptosis, and Metabolic Remodeling. [Abstract]2025 Dec 20;49(1):11. PMID: 41420798 -
BMC Biol
Bradykinin's carbamylation as a mechanistic link to impaired wound healing in patients with kidney dysfunction. [Abstract]2025 Mar 12;23(1):76. PMID: 40075424 -
Immunology
Hypoxic tumour-derived exosomal miR-1290 exacerbates the suppression of CD8+ T cells by promoting M2 macrophage polarization. [Abstract]2024 Dec;173(4):672-688. PMID: 39183579 -
J Periodontal Res
2024 Feb;59(1):140-150. PMID: 37885312 -
Inflammation
Small Extracellular Vesicles from Periodontal Ligament Stem Cells Primed by Lipopolysaccharide Regulate Macrophage M1 Polarization via miR-433-3p Targeting TLR2/TLR4/NF-κB. [Abstract]2023 Oct;46(5):1849-1858. PMID: 37351818 -
Front Pharmacol
Propofol Inhibits Ischemia/Reperfusion-Induced Cardiotoxicity Through the Protein Kinase C/Nuclear Factor Erythroid 2-Related Factor Pathway. [Abstract]2021 May 13:12:655726. PMID: 34054535 -
Front Pharmacol
Eye Drops of Metformin Prevents Fibrosis After Glaucoma Filtration Surgery in Rats via Activating AMPK/Nrf2 Signaling Pathway. [Abstract]2020 Jul 31:11:1038. PMID: 32903813 -
Front Pharmacol
Five Constituents in Psoralea corylifolia L. Attenuate Palmitic Acid-Induced Hepatocyte Injury via Inhibiting the Protein Kinase C-α/Nicotinamide-Adenine Dinucleotide Phosphate Oxidase Pathway. [Abstract]2020 Jan 28:10:1589. PMID: 32116659 -
Probiotics Antimicrob Proteins
Potential Benefits of Metformin Via Roseburia Intestinalis in High-fat Diet-fed Mice With Colorectal Adenomas. [Abstract]2025 Nov 26. PMID: 41296177 -
Front Cell Dev Biol
Enhancing Fatty Acid Catabolism of Macrophages Within Aberrant Breast Cancer Tumor Microenvironment Can Re-establish Antitumor Function. [Abstract]2021 Apr 15:9:665869. PMID: 33937269 -
Chem Biol Interact
Phenylalanine metabolism as a key pathway in polystyrene microplastics-induced abnormal macrophage polarization: Implications for fetal growth and development. [Abstract]2026 Aug 1:436:112213. PMID: 42303205 -
Int Dent J
2026 Jun 27;76(5):109698. PMID: 42364415 -
Chem Biol Interact
Fusobacterium nucleatum-derived 3-indolepropionic acid promotes colorectal cancer progression via aryl hydrocarbon receptor activation in macrophages. [Abstract]2025 Jun 1:414:111495. PMID: 40174685 -
Toxicology
A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction. [Abstract]2024 May 11:153829. PMID: 38740170 -
ACS Omega
Deep Learning Promotes the Screening of Natural Products with Potential Microtubule Inhibition Activity. [Abstract]2022 Aug 5;7(32):28334-28341. PMID: 35990425 -
Molecules
β,β-Dimethylacrylalkannin, a Natural Naphthoquinone, Inhibits the Growth of Hepatocellular Carcinoma Cells by Modulating Tumor-Associated Macrophages. [Abstract]2024 Aug 20;29(16):3919. PMID: 39202998 -
Molecules
Tiliroside Attenuates NLRP3 Inflammasome Activation in Macrophages and Protects against Acute Lung Injury in Mice. [Abstract]2023 Nov 10;28(22):7527. PMID: 38005247 -
Clin Exp Allergy
Prognostic Significance of Eosinophil Extracellular Traps in Chronic Rhinosinusitis and Innovative Nanosheets-Based Clearance Therapy. [Abstract]2026 Feb 12. PMID: 41679737 -
Mol Med Rep
CDK1‑induced regulation of p53 phosphorylation at Ser315 mediates cell cycle arrest and apoptosis of macrophages infected with clinical isolates of Mycobacterium tuberculosis. [Abstract]2026 Jan;33(1):44. PMID: 41268607 -
Food Sci Nutr
Spatial Domain-Based Approach to Analyze the Mechanism of Sparganii Rhizoma-Curcumae Rhizoma Pair in the Treatment of Colorectal Cancer. [Abstract]2025 Aug 19;13(8):e70794. PMID: 40842663 -
Biochim Biophys Acta Mol Basis Dis
Small extracellular vesicles from HO-1 modified BMMSCs alleviate steatotic liver grafts ischemia-reperfusion injury by delivering PDIA4 to promote reparative macrophage polarization. [Abstract]2025 Jun 9;1871(7):167947. PMID: 40494182 -
Mol Med Rep
N‑methyladenosine reader YTHDF2‑mediated AC026691.1 degradation promotes gastric cancer cell proliferation, migration and M2 macrophage polarization. [Abstract]2025 May;31(5):120. PMID: 40052573 -
Mol Med Rep
Targeted degradation of hexokinase 2 for anti‑inflammatory treatment in acute lung injury. [Abstract]2024 May;29(5):83. PMID: 38516767 -
Sci Rep
Multi-target regulation mechanisms of systemic lupus erythematosus, a network pharmacology and molecular docking study on active compounds from Artemisia argyi. [Abstract]2026 Jul 10. PMID: 42432303 -
Transl Oncol
Deciphering IFN signaling in gastric cancer: A single-cell and bulk transcriptomic integration reveals CXCR4 as a key immunomodulator and prognostic determinant. [Abstract]2026 Jun:68:102778. PMID: 42019279 -
Sci Rep
2026 May 9;16(1):21231. PMID: 42103804 -
Sci Rep
FNDC1 is closely related to poor prognosis and immune cell infiltration in gastric cancer. [Abstract]2026 Apr 15;16(1):17490. PMID: 41986425 -
Sci Rep
DUSP6 promotes motility, invasion, and tumorigenicity of thyroid cancer cells via IL8-induced neutrophil extracellular traps. [Abstract]2026 Mar 8;16(1):12575. PMID: 41796219 -
Sci Rep
Pomolic acid alleviates CCl4‑induced liver fibrosis in mice by suppressing β-arrestin 2-mediated pro-fibrotic macrophage polarization. [Abstract]2026 Mar 31. PMID: 41917130 -
APL Bioeng
Multi-omics mapping identifies CYBA-mediated mitochondrial dysfunction driving macrophage polarization and ferroptosis via Nrf2 pathway in atherosclerosis. [Abstract]2026 Jan 30;10(1):016107. PMID: 41624806 -
Sci Rep
Transcriptome analysis combined with single-cell analysis identified that APOC1 influences cholesterol transport by macrophages in ccRCC. [Abstract]2025 Oct 6;15(1):34724. PMID: 41053280 -
PLoS Pathog
2025 Jul 16;21(7):e1013344. PMID: 40668819 -
Sci Rep
Constitutive interaction between neutrophils and von Willebrand factor in peripheral blood. [Abstract]2025 Jul 10;15(1):24895. PMID: 40640566 -
Sci Rep
Identification of natural killer cell-characteristic genes in atherosclerosis based on bioinformatics analysis. [Abstract]2025 May 16;15(1):17112. PMID: 40379756 -
Transl Oncol
Tumor-stroma proportion is associated with increased M2 macrophage abundance and predicts the resistance to immune checkpoint blockade in breast cancer. [Abstract]2025 Apr:54:102343. PMID: 40068383 -
World J Stem Cells
Human umbilical cord mesenchymal stem cell-derived exosomal miR-199a-3p inhibits the MAPK4/NF-κB signaling pathway to relieve osteoarthritis. [Abstract]2025 Apr 26;17(4):103919. PMID: 40308884 -
Transl Oncol
Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogramming. [Abstract]2025 Feb 21:54:102327. PMID: 39986191 -
Sci Rep
2025 Mar 22;15(1):8542. PMID: 40121226 -
J Mol Cell Cardiol
SGK1 contributes to ferroptosis in coronary heart disease through the NEDD4L/NF-κB pathway. [Abstract]2024 Nov:196:71-83. PMID: 39245317 -
PLoS Pathog
Trem2/Syk/PI3K axis contributes to the host protection against Toxoplasma gondii-induced adverse pregnancy outcomes via modulating decidual macrophages. [Abstract]2024 Sep 9;20(9):e1012543. PMID: 39250507 -
Dig Liver Dis
TREM1 facilitates the development of gastric cancer through regulating neutrophil extracellular traps-mediated macrophage polarization. [Abstract]2024 Jul;56(7):1237-1247. PMID: 38151453 -
PLoS Pathog
2024 Jul 29;20(7):e1012330. PMID: 39074162 -
Cancer Sci
Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T-cell lymphoma via TLR4 signaling pathway. [Abstract]2024 Jul;115(7):2444-2460. PMID: 38613253 -
Sci Rep
Aiouea padiformis extract exhibits anti-inflammatory effects by inhibiting the ATPase activity of NLRP3. [Abstract]2024 Mar 4;14(1):5237. PMID: 38433281 -
J Mol Cell Cardiol
MiR-144-5p limits experimental abdominal aortic aneurysm formation by mitigating M1 macrophage-associated inflammation: Suppression of TLR2 and OLR1. [Abstract]2020 Jun;143:1-14. PMID: 32278833 -
Mediators Inflamm
Three Ingredients of Safflower Alleviate Acute Lung Injury and Inhibit NET Release Induced by Lipopolysaccharide. [Abstract]2020 Feb 29:2020:2720369. PMID: 32189992 -
-
Eur J Med Res
The miR-3164/PAD4 axis regulates NETosis to prevent airway inflammation and remodeling through the TLR2/NF-κB signaling pathway. [Abstract]2025 Oct 9;30(1):947. PMID: 41068990 -
Eur J Med Res
GDF-15 upregulates the SLC7A11/GPX4 signaling axis and promotes mitoxantrone resistance in AML cells. [Abstract]2025 Jun 21;30(1):504. PMID: 40544302 -
Eur J Med Res
Invisible appliance promotes bone reconstruction via modulating the periodontal immune microenvironment. [Abstract]2025 May 12;30(1):378. PMID: 40350478 -
Eur J Med Res
GATA1-mediated macrophage polarization via TrkB/cGMP-PKG signaling pathway to promote the development of preeclampsia. [Abstract]2025 Jan 7;30(1):12. PMID: 39773303 -
Cancers (Basel)
MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC). [Abstract]2024 Jan 8;16(2):269. PMID: 38254761 -
Cell Signal
FOLR2+ tumor-associated macrophages drive metastatic microenvironment remodeling and lymphatic dissemination in colorectal cancer. [Abstract]2026 Oct:146:112676. PMID: 42297063 -
Neuropharmacology
CXCL10 activates STAT3 signaling to promote ferroptosis in the spinal dorsal horn during neuropathic pain. [Abstract]2026 Aug 1:293:110965. PMID: 41951153 -
Mol Cell Biochem
CCL3 promotes oxaliplatin resistance in gastric cancer via CCR5-mediated tumor cell survival and macrophage M2 polarization. [Abstract]2026 Jun 19. PMID: 42319715 -
J Cell Mol Med
Betulinic Acid Suppresses UBE2T Expression via MAPK/ERK Inhibition to Block FANCI and FANCD2 Monoubiquitination in Glioblastoma. [Abstract]2026 Jan;30(1):e71000. PMID: 41486508 -
J Cell Mol Med
ZBP1, an M1 Macrophage-Associated Biomarker Identified by Machine Learning, Suppresses Tumorigenesis and Predicts Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. [Abstract]2025 Nov;29(22):e70953. PMID: 41299204 -
J Cell Mol Med
RTP4 Suppresses Colorectal Cancer Progression via MHC-I-Mediated CD8+ T Cell Infiltration and Enhances Immunotherapy Response. [Abstract]2025 Oct;29(20):e70915. PMID: 41126439 -
J Cell Mol Med
The Flavonoid Kaempferol Mitigates Periprosthetic Osteolysis by Regulating the NLRP3 Inflammasome and Balancing Bone Metabolism. [Abstract]2025 Oct;29(19):e70878. PMID: 41053962 -
Cell Signal
Proguanil inhibits proliferation and migration in glioblastoma development through targeting CSF1R receptor. [Abstract]2025 Mar:127:111550. PMID: 39662608 -
Cell Signal
Single-cell analysis reveals that TCF7L2 facilitates the progression of ccRCC via tumor-associated macrophages. [Abstract]2024 Dec:124:111453. PMID: 39366533 -
J Cell Mol Med
Anti-inflammatory effect of Trichospira verticillata via suppression of the NLRP3 inflammasome in neutrophilic asthma. [Abstract]2024 Apr;28(8):e18356. PMID: 38668995 -
J Cell Mol Med
2024 Jan;28(1):e18037. PMID: 37974543 -
Med Oncol
FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells. [Abstract]2022 Dec 28;40(1):64. PMID: 36576661 -
Cell Signal
2022 Sep:97:110393. PMID: 35752352 -
Cell Signal
KLF14 alleviated breast cancer invasion and M2 macrophages polarization through modulating SOCS3/RhoA/Rock/STAT3 signaling. [Abstract]2022 Apr:92:110242. PMID: 34998931 -
Cell Signal
Mechanism of neutrophil extracellular traps generation and their role in trophoblasts apoptosis in gestational diabetes mellitus. [Abstract]2021 Dec:88:110168. PMID: 34634453 -
J Inflamm Res
Yi-qi-hua-yu-jie-du Decoction Inhibits Gastric Cancer Progression by Inducing Tumor-Associated Macrophage Polarization via Modulating PP2A Enzyme Activity to Mediate the PI3K/AKT/NF-κB Axis. [Abstract]2026 May 12:19:568022. PMID: 42152943 -
Oncol Res
SDHA Deficiency in Hepatocellular Carcinoma Promotes Tumor Progression through Succinate-Induced M2 Macrophage Polarization. [Abstract]2026 Jan 19;34(2):25. PMID: 41613800 -
J Inflamm Res
Interleukin-27 and Interleukin-2 Cooperatively Regulate CD4⁺ T Cell Subsets and Immune Imbalance in Coronary Artery Disease. [Abstract]2025 Dec 10:18:17253-17269. PMID: 41399529 -
J Inflamm Res
Downregulated RSAD2 Attenuates the Apoptosis of LPS-Stimulated RAW264.7 via NF-κB Signaling Pathway. [Abstract]2025 Aug 12:18:10939-10952. PMID: 40823355 -
J Inflamm Res
Calycosin-7-Glucoside Alleviates Atherosclerosis by Inhibiting Ox-LDL-Induced Foam Cell Formation and Inflammatory Response in THP-1-Derived Macrophages via ATF-1 Activation Through the p38/MAPK Pathway. [Abstract]2025 Apr 25:18:5573-5586. PMID: 40303003 -
J Inflamm Res
Cordyceps Sinensis Reduces Inflammation and Protects BEAS-2B Cells From LPS-Induced THP-1 Cell Injury. [Abstract]2025 Mar 19:18:4143-4156. PMID: 40125085 -
J Inflamm Res
2025 Mar 20:18:4213-4231. PMID: 40129872 -
J Inflamm Res
Benidipine Hydrochloride Inhibits NLRP3 Inflammasome Activation by Inhibiting LPS-Induced NF-κB Signaling in THP-1 Macrophages. [Abstract]2024 Sep 11:17:6307-6316. PMID: 39281771 -
J Innate Immun
Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma. [Abstract]2021;13(1):38-48. PMID: 33271553 -
Biomedicines
HIF-1α Promotes Macrophage Extracellular Trap Formation and Exacerbates Acute Lung Injury in Neonatal Sepsis. [Abstract]2026 May 18;14(5):1145. PMID: 42193470 -
Neurochem Res
Electroacupuncture Stimulation of the Head Motor Area Alleviates Brain Cell Pyroptosis and Neurobehaviors in Stroke Rats Through the NF-κB/NLRP3 Signaling Axis. [Abstract]2026 Apr 27;51(3):146. PMID: 42043662 -
Poult Sci
Targeting TatD nuclease and the MAPK Pathway: Luteolin multifaceted approach against Mycoplasma gallisepticum infection. [Abstract]2026 Jan 12;105(3):106426. PMID: 41548475 -
-
iScience
M1-like macrophages regulate T cell infiltration in colorectal cancer through P2X4 receptor. [Abstract]2025 Sep 5;28(10):113517. PMID: 41031375 -
Clin Exp Med
HCQ reverses the immune imbalance related to severe infections following chemotherapy of acute myeloid leukemia and exhibits inhibitory effects on inflammatory cytokine storms. [Abstract]2025 Aug 15;25(1):294. PMID: 40815351 -
iScience
AF6 regulates intestinal IgA via crosstalk between intestinal epithelial cells and immune cells in inflammatory bowel disease. [Abstract]2025 May 13;28(7):112658. PMID: 40687779 -
iScience
Atractylodin modulates ASAH3L to improve galactose metabolism and inflammation to alleviate acute lung injury. [Abstract]2024 Aug 31;27(10):110751. PMID: 39351199 -
Mol Nutr Food Res
Pretreatment with Kahweol Attenuates Sepsis-Induced Acute Lung Injury via Improving Mitochondrial Homeostasis in a CaMKKII/AMPK-Dependent Pathway. [Abstract]2023 Oct;67(19):e2300083. PMID: 37483173 -
iScience
Elabela inhibits TRAF1/NF-κB induced oxidative DNA damage to promote diabetic foot ulcer wound healing. [Abstract]2023 Aug 9;26(9):107601. PMID: 37664606 -
iScience
2023 Jul 22;26(8):107451. PMID: 37575189 -
Epigenetics Chromatin
Ovulatory signal-triggered chromatin remodeling in ovarian granulosa cells by HDAC2 phosphorylation activation-mediated histone deacetylation. [Abstract]2023 Apr 19;16(1):11. PMID: 37076890 -
Comp Biochem Physiol C Toxicol Pharmacol
The role of intercellular junction proteins in the penetration resistance of Drosophila larvae to avermectin. [Abstract]2023 Apr:266:109557. PMID: 36717043 -
Endocr Relat Cancer
2023 Apr 3;30(5):e230012. PMID: 36877531 -
Front Mol Neurosci
Chronic salmon calcitonin exerts an antidepressant effect via modulating the p38 MAPK signaling pathway. [Abstract]2023 Mar 10:16:1071327. PMID: 36969556 -
Front Mol Neurosci
The chronification mechanism of orofacial inflammatory pain: Facilitation by GPER1 and microglia in the rostral ventral medulla. [Abstract]2023 Jan 6:15:1078309. PMID: 36683848 -
BMC Complement Med Ther
Pharmacokinetics and pharmacodynamics of bioactive compounds in Penyanqing preparation in THP-1 inflammatory cells induced by Lipopolysaccharide. [Abstract]2022 Dec 6;22(1):323. PMID: 36474249 -
Front Mol Biosci
Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19. [Abstract]2022 Apr 27;9:835590. PMID: 35573725 -
Front Mol Neurosci
Hyperactivity of Hypothalamic-Pituitary-Adrenal Axis Due to Dysfunction of the Hypothalamic Glucocorticoid Receptor in Sigma-1 Receptor Knockout Mice. [Abstract]2017 Sep 6:10:287. PMID: 28932185 -
Front Mol Neurosci
MPTP-Induced Dopamine Depletion in Basolateral Amygdala via Decrease of D2R Activation Suppresses GABAA Receptors Expression and LTD Induction Leading to Anxiety-Like Behaviors. [Abstract]2017 Aug 7:10:247. PMID: 28824377
Phorbol 12-myristate 13-acetate purchased from MedChemExpress. Usage Cited in: Front Mol Neurosci. 2017 Aug 7:10:247. [Abstract]
Bar graphs show levels of GABAAR-α2 mRNA and GABAAR-α2 protein in BLA of control mice treated with BLA-injection of H89 or GF109203X (GFX); in MPTP-mice treated with BLA-injection of PMA, or the co-administration of quinpirole and H89 (quin/+H89) or GF109203X (quin/+GFX).
-
Mol Divers
Unraveling RELA as a potential dioctyl terephthalate-related target regulates M2-like macrophages to induce an immunosuppressive microenvironment in colorectal cancer: a multi-omics data study by experimental validation. [Abstract]2026 Aug;30(4):6403-6419. PMID: 41966666 -
Autoimmunity
CPN2 alleviates cryptorchidism by inhibiting the NF-κB pathway and regulating immune responses. [Abstract]2025 Dec;58(1):2538860. PMID: 40720213 -
FASEB J
SAA1 Induces TGF-β1 Secretion by Ovarian Cancer Cells, Leading to M2 Macrophage Polarization and Inhibition of NK Cell Activity. [Abstract]2025 Nov 30;39(22):e71239. PMID: 41269670 -
FASEB J
Macrophage WTAP Deficiency Protects Atherosclerosis by Improving Macrophage Apoptosis in an m6A-Independent Manner. [Abstract]2025 Nov 15;39(21):e71182. PMID: 41148185 -
FASEB J
Colorectal cancer cell-derived extracellular vesicles trigger macrophage production of IL6 through activating STING signaling to drive metastasis. [Abstract]2025 Mar 31;39(6):e70474. PMID: 40100063 -
Biochim Biophys Acta Mol Cell Res
FOSL1 regulates hyperproliferation and NLRP3-mediated inflammation of psoriatic keratinocytes through the NF-kB signaling via transcriptionally activating TRAF3. [Abstract]2024 Apr;1871(4):119689. PMID: 38367916 -
FASEB J
DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/P66shc signaling pathway in diabetic kidney disease. [Abstract]2024 Mar 31;38(6):e23564. PMID: 38522019 -
J Pharmacol Exp Ther
Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway. [Abstract]2022 Jan;380(1):15-25. PMID: 34740946 -
Fish Shellfish Immunol
Transcription factor networks drive perforin activity in the anti-bacterial immune response of tilapia. [Abstract]2024 Nov:154:109975. PMID: 39427837 -
Fish Shellfish Immunol
Inducible IL-2 production and IL-2+ cell expansion are landmark events for T-cell activation of teleost. [Abstract]2024 May:148:109515. PMID: 38499218 -
Fish Shellfish Immunol
Nitric oxide synthase regulates coelomocytes apoptosis through the NF-κB signaling pathway in the sea cucumber Apostichopus japonicus. [Abstract]2023 Oct:141:109027. PMID: 37633344 -
Fish Shellfish Immunol
The flagellin of Vibrio parahaemolyticus induces the inflammatory response of Tetraodon nigroviridis through TLR5M. [Abstract]2022 Jan:120:102-110. PMID: 34737057 -
Clin Immunol
PLK2 facilitates Mycobacterium tuberculosis clearance via p38 MAPK-mediated ROS production. [Abstract]2026 Jun:285:110705. PMID: 41962814 -
J Virol
2026 Apr 21;100(4):e0179325. PMID: 41805193 -
J Virol
The ASFV CD2v protein inhibits apoptosis by inducing proteasomal degradation of BimEL via activation of the TPL2-MEK-ERK signaling pathway. [Abstract]2026 Mar 24;100(3):e0195225. PMID: 41631827 -
J Biol Chem
Andrographolide targets syndecan4 to impair its interaction with syntenin and inhibits the biogenesis of small extracellular vesicles. [Abstract]2026 Jan 20:111182. PMID: 41570990 -
J Biol Chem
UBE2I promotes immune infiltration and tumor progression in thyroid cancer and modulates hnRNPA2B1 SUMOylation. [Abstract]2025 Dec 20;302(2):111091. PMID: 41429355 -
Microbiol Spectr
A novel anti- Toxoplasma peptide suppresses parasite invasion and rescues host autophagic defenses. [Abstract]2025 Dec 29:e0221825. PMID: 41459975 -
Microbiol Spectr
2025 Aug 5;13(8):e0018825. PMID: 40662581 -
BMC Cancer
Azelaic acid attenuates CCL2/CCR2 axis-mediated skin trafficking of acute myeloid leukemia cells through NF-κB/MAPK signaling modulation in keratinocytes. [Abstract]2025 Jul 31;25(1):1250. PMID: 40745589 -
J Antimicrob Chemother
The two-component sensor factor envZ influences antibiotic resistance and virulence in the evolutionary dynamics of multidrug-resistant Salmonella enteritidis causing multisite invasive infections. [Abstract]2024 Dec 2;79(12):3254-3263. PMID: 39365636 -
Funct Integr Genomics
Peripheral and central immune features in insomnia: Integrative bulk and single-cell transcriptomic analyses reveal core hub genes and candidate compounds. [Abstract]2026 Jun 10;26(1):130. PMID: 42265520 -
ACS Pharmacol Transl Sci
Proviral Integration Site for Moloney Murine Leukemia Virus 2 Suppresses Fibronectin 1 to Drive Adhesion Loss and Epithelial-Mesenchymal Transition in Multiple Myeloma. [Abstract]2025 Oct 27;8(11):3835-3843. PMID: 41262587 -
J Cell Commun Signal
Trans-Coumaryl acetate mediates GRK5/NF-κB/Nrf2 signaling axis to ameliorate septic acute kidney injury. [Abstract]2025 Sep 4;19(3):e70044. PMID: 40917114 -
Regen Ther
PPARA ameliorates sepsis-induced myocardial injury via promoting macrophage M2 polarization by interacting with DUSP1. [Abstract]2024 May 18:26:33-41. PMID: 38798745 -
Development
Clathrin-mediated endocytosis is essential for the selective degradation of maternal membrane proteins and preimplantation development. [Abstract]2021 Jul 15;148(14):dev199461. PMID: 34269385 -
J Immunol
The Anti-Inflammatory Immune Response in Early Trichinella spiralis Intestinal Infection Depends on Serine Protease Inhibitor-Mediated Alternative Activation of Macrophages. [Abstract]2021 Mar 1;206(5):963-977. PMID: 33495238 -
J Cell Physiol
Knockdown of periostin attenuates 5/6 nephrectomy-induced intrarenal renin-angiotensin system activation, fibrosis, and inflammation in rats. [Abstract]2019 Dec;234(12):22857-22873. PMID: 31127625 -
-
-
-
BMC Oral Health
The correlation between Omentin-1 levels and Th17/Treg imbalance in patients with periodontitis (Stage Ⅱ/Ⅲ, Grade B/C) and its diagnostic value. [Abstract]2026 Jun 22. PMID: 42332681 -
Pathogens
The Interaction Between Echinococcus multilocularis Calreticulin S-Domain and Human Complement C1q Inhibits C1q-Dependent Immune Functions. [Abstract]2026 Apr 16;15(4):427. PMID: 42075754 -
Neurotoxicology
2026 Mar:113:103405. PMID: 41690424 -
J Orthop Surg Res
RRM2 contributes to pathogenic phenotype of fibroblast-like synoviocytes by activating NF-κB signaling and inhibiting ferroptosis in rheumatoid arthritis. [Abstract]2025 Nov 7;20(1):976. PMID: 41204303 -
Metab Brain Dis
β-Caryophyllene modulates the JAK2/STAT3 signaling pathway to downregulate neutrophil extracellular traps and alleviate cerebral ischemia-reperfusion injury. [Abstract]2025 Oct 30;40(8):301. PMID: 41165931 -
J Proteome Res
Chemoproteomics Reveals FAM114A2 as a Functional Target of Wikstroelide E for Reversal of HIV-1 Latency. [Abstract]2025 Oct 23. PMID: 41131870 -
Carcinogenesis
LncRNA MEG3 Suppresses Prostate Cancer Progression by Mediating Macrophage Polarization via the miR-148a-3p/ARRDC3 Signaling Axis. [Abstract]2025 Apr 3;46(2):bgaf009. PMID: 40036590 -
BMC Oral Health
Investigation of the mechanism of baicalein in the treatment of periodontitis based on network pharmacology, molecular docking and experimental validation. [Abstract]2024 Aug 23;24(1):987. PMID: 39180042 -
Carcinogenesis
Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer. [Abstract]2023 Dec 15;44(10-11):748-759. PMID: 37747823 -
Endocrinology
Decreased expression of EZH2 in granulosa cells contributes to endometriosis-associated infertility by targeting IL-1R2. [Abstract]2022 Dec 19;164(2):bqac210. PMID: 36524678 -
Mol Immunol
2026 Jul:195:172-185. PMID: 42167049 -
J Med Virol
Quercetin Interrupts the SIRT3/ROS/NF-κB/SPI1 Feedback Loop to Ameliorate Microglia-Mediated HIV-1 Tat Neurotoxicity. [Abstract]2026 Apr;98(4):e70906. PMID: 41964421 -
Pathol Res Pract
DDB2 promotes epithelial-mesenchymal transition through activating NF-κB pathway in glioma. [Abstract]2026 Mar:279:156368. PMID: 41570727 -
Kidney Dis (Basel)
Clinical and Experimental Insights into the Role of NETosis in IgA Nephropathy Pathogenesis. [Abstract]2025 May 9;11(1):450-468. PMID: 40606676 -
J Med Virol
Antiviral Activity of the MEK1/2 Inhibitor Trametinib Against Lymphocytic Choriomeningitis Virus. [Abstract]2025 Mar;97(3):e70267. PMID: 40008425 -
Pathol Res Pract
SPI1-mediated transcriptional activation of CEP55 promotes the malignant growth of triple-negative breast cancer and M2 macrophage polarization. [Abstract]2024 Oct:262:155544. PMID: 39197215 -
Parasit Vectors
Clonorchis sinensis granulin promotes malignant transformation of human intrahepatic biliary epithelial cells through interaction with M2 macrophages via regulation of STAT3 phosphorylation and the MEK/ERK pathway. [Abstract]2023 Apr 24;16(1):139. PMID: 37095578 -
Mol Immunol
Naringenin inhibits pro‑inflammatory cytokine production in macrophages through inducing MT1G to suppress the activation of NF‑κB. [Abstract]2021 Sep:137:155-162. PMID: 34252709 -
J Med Virol
2020 Dec;92(12):3057-3066. PMID: 32776519 -
Mol Immunol
2020 May:121:72-80. PMID: 32172027 -
J Diabetes Investig
Hypoxia-preconditioned adipose-derived mesenchymal stem cells-derived exosomes transferring H19 obstruct neutrophil extracellular traps formation via HOXA5-mediated inactivation of TLR4/NF-κB/NLRP3 inflammatory signaling. [Abstract]2026 Jun 8. PMID: 42257551 -
J Biochem Mol Toxicol
UCP2 in Glioblastoma Cells Regulates Mitochondrial Metabolic Reprogramming to Mediate Immunophenotypic Repolarization of Tumor-Associated Macrophages and Immunotherapy. [Abstract]2026 Apr;40(4):e70808. PMID: 41918143 -
Basic Clin Pharmacol Toxicol
Bergaptol Alleviates Oxidative Stress and Inflammation in Intracerebral Haemorrhage Mice via JAK2/STAT3 and NF-κB Pathways, Improving Neurological Function. [Abstract]2025 Dec;137(6):e70135. PMID: 41139697 -
Stem Cells Int
Ferulic Acid Alleviates Inflammation and Promotes Osteogenic Differentiation in Periodontitis by Inhibiting NF- κ B Pathway. [Abstract]2025 Dec 17:2025:1891956. PMID: 41497811 -
PLoS Negl Trop Dis
The phytochemical arbutin exerts potent anti-Toxoplasma effects through activation of cell-autonomous defense mechanisms while attenuating inflammation. [Abstract]2025 Dec 11;19(12):e0013815. PMID: 41379884 -
J Biochem Mol Toxicol
FTO-mediated m6A Methylation of KCNAB2 Inhibits Tumor Property of Non-Small Cell Lung Cancer Cells and M2 Macrophage Polarization by Inactivating the PI3K/AKT Pathway. [Abstract]2025 Apr;39(4):e70232. PMID: 40114527 -
Genomics
Integrative analysis of genes provides insights into the molecular and immune characteristics of mitochondria-related genes in atherosclerosis. [Abstract]2025 Feb 4;117(2):111013. PMID: 39914597 -
Nanotoxicology
The nanomaterial-induced bystander effects reprogrammed macrophage immune function and metabolic profile. [Abstract]2020 Oct;14(8):1137-1155. PMID: 32916084 -
Toxicol Appl Pharmacol
M1 macrophage mediated increased reactive oxygen species (ROS) influence wound healing via the MAPK signaling in vitro and in vivo. [Abstract]2019 Mar 1:366:83-95. PMID: 30690042 -
Appl Biochem Biotechnol
The Transcription Factor SOX6 Regulates Autophagy Levels Through LAMP5 to Inhibit the Development of Pituitary Adenomas. [Abstract]2026 Jul;198(7):5429-5447. PMID: 42012747 -
-
-
Arch Biochem Biophys
Exosomal miR-4687-5p alleviates silica-induced fibrosis by inhibiting EMT via β-catenin targeting. [Abstract]2026 Feb:776:110714. PMID: 41443291 -
Appl Biochem Biotechnol
LAMA1 Promotes Tumor-Associated Macrophages Polarization Towards the M2 Phenotype and Induces Colorectal Cancer. [Abstract]2026 Feb;198(2):1374-1390. PMID: 41484729 -
Cardiovasc Drugs Ther
High Mobility Group Protein B1 Mediates the Role of the Neutrophil Extracellular Traps in the Progression of Acute Myocardial Infarction. [Abstract]2026 Jan 24. PMID: 41579229 -
Exp Cell Res
Neutrophil extracellular traps promote epithelial-mesenchymal transition in COPD via the RAGE/PI3K/AKT pathway. [Abstract]2025 Dec 24;455(2):114869. PMID: 41453711 -
Exp Cell Res
Pseudane V alleviates ox-LDL-induced macrophage M1 polarization by inhibiting m6A modification of PPARGC1A. [Abstract]2025 Nov 25;454(2):114842. PMID: 41297622 -
Arch Biochem Biophys
NNMT enhances invasive and migratory capacity of keloid fibroblasts and M2 macrophage polarization. [Abstract]2025 Nov:773:110593. PMID: 40818625 -
Immun Inflamm Dis
Neutrophil Extracellular Traps Activate Meningeal Fibroblast to Aggravate Subarachnoid Fibrosis in Kaolin-Induced Hydrocephalus in Rats. [Abstract]2025 Nov;13(11):e70268. PMID: 41236114 -
Cell Biol Int
2025 Jan;49(1):79-91. PMID: 39364689 -
Arch Biochem Biophys
GSDMB involvement in the pathogenesis of abdominal aortic aneurysm through regulation of macrophage non-canonical pyroptosis. [Abstract]2024 Sep:759:110102. PMID: 39029644 -
Mol Carcinog
LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2-macrophage infiltration through activating AKT-IKKβ-p65 axis. [Abstract]2024 Sep;63(9):1827-1841. PMID: 39016636 -
Arch Biochem Biophys
Antitumor activity of dictamnine against colorectal cancer through induction of ferroptosis and inhibition of M2 macrophage polarization via the MAPK signaling. [Abstract]2024 Aug:758:110051. PMID: 38851368 -
Vaccines
2023 May 25;11(6):1026. PMID: 37376415 -
Exp Cell Res
CTRP9 induces macrophages polarization into M1 phenotype through activating JNK pathway and enhances VSMCs apoptosis in macrophages and VSMCs co-culture system. [Abstract]2020 Oct 1;395(1):112194. PMID: 32712018 -
Arch Biochem Biophys
Identification and characterization of human PEIG-1/GPRC5A as a 12-O-tetradecanoyl phorbol-13-acetate (TPA) and PKC-induced gene. [Abstract]2020 Jul 15;687:108375. PMID: 32339486 -
Diabetes Metab Syndr Obes
Essential Role Of High Glucose-Induced Overexpression Of PKCβ And PKCδ In GLP-1 Resistance In Rodent Cardiomyocytes. [Abstract]2019 Nov 4:12:2289-2302. PMID: 31807042 -
Arch Microbiol
YY1-activated LINC00926 promotes the survival of mycobacteria and regulates inflammatory response in Mycobacterium tuberculosis-infected macrophages. [Abstract]2026 Jun 11;208(9):434. PMID: 42274770 -
J Evid Based Integr Med
"Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and MAPK/ERK1/2 Signaling Pathways. [Abstract]2024 Jan-Dec:29:2515690X241291381. PMID: 39410848 -
J Neurooncol
FOSL2-mediated transcription of ISG20 induces M2 polarization of macrophages and enhances tumorigenic ability of glioblastoma cells. [Abstract]2024 Sep;169(3):659-670. PMID: 39073688 -
Front Oncol
Overexpression of serum HMGB1 and IDO in esophageal squamous cell carcinoma patients: potential clinical auxiliary diagnostic markers and immunotherapeutic targets. [Abstract]2024 Sep 9:14:1452282. PMID: 39314628 -
J Cancer
Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis. [Abstract]2024 May 5;15(11):3510-3530. PMID: 38817865 -
Reproduction
Follistatin-like I promotes endometriosis by increasing proinflammatory factors and promoting angiogenesis. [Abstract]2021 Dec 30;163(1):57-68. PMID: 34866594 -
Mol Cell Endocrinol
2019 Aug 20:494:110490. PMID: 31207271 -
Carbohydr Res
Development of specific inhibitors for heparin-binding proteins based on the cobra cardiotoxin structure: an effective synthetic strategy for rationally modified heparin-like disaccharides and a trisaccharide. [Abstract]2005 Feb 28;340(3):355-72. PMID: 15680590 -
Cell Immunol
Mesenchymal stromal cells relieved systemic lupus erythematosus via CCL2 dependent macrophage polarization. [Abstract]2025 Dec:418:105046. PMID: 41187528 -
J Cancer Res Clin Oncol
Single-cell RNA sequencing reveals SLC31A1-mediated M2 polarization of macrophages promotes malignant progression in triple-negative breast cancer. [Abstract]2025 May 14;151(5):163. PMID: 40360897 -
Breast Cancer Res Treat
2019 Jun;175(2):459-472. PMID: 30778902 -
Mol Biol Rep
Overexpression of miR-7641 activates ox-LDL-induced autophagy in macrophages by regulating USP7. [Abstract]2026 Apr 22;53(1):645. PMID: 42018035 -
Animals (Basel)
Neutrophil Extracellular Traps Promote Urolithiasis Formation in Dogs: A Preliminary Study. [Abstract]2026 Mar 17;16(6):942. PMID: 41897919 -
IUBMB Life
OTUD1 Relieves Coxsackievirus-Induced Ferroptosis and Inflammation in Myocardial Cells by Stabilizing NRF2 and Inhibiting NF-κB Signaling. [Abstract]2026 Mar;78(3):e70094. PMID: 41853919 -
Food Chem Toxicol
2025 Dec:206:115771. PMID: 41038372 -
Mol Biol Rep
Inhibition of ACSL6 ameliorates atherosclerosis by suppressing macrophage ferroptosis via the Nrf2 pathway. [Abstract]2025 Nov 6;53(1):53. PMID: 41196445 -
Mol Biotechnol
Unraveling the Molecular Landscape of Neutrophil Extracellular Traps in Severe Asthma: Identification of Biomarkers and Molecular Clusters. [Abstract]2025 May;67(5):1852-1866. PMID: 38801616 -
Mol Biol Rep
Study on the mechanism of heterogeneous tumor-associated macrophages in three subtypes of breast cancer through the integration of single-cell RNA sequencing and in vitro experiments. [Abstract]2024 Jun 1;51(1):720. PMID: 38824268 -
Mol Biotechnol
Tumor Cell-Derived Exosomal miR-191-5p Activates M2-Subtype Macrophages Through SOCS3 to Facilitate Breast Cancer. [Abstract]2024 May;66(5):1314-1325. PMID: 38270757 -
Immunol Lett
Autophagy and LC3-associated phagocytosis contribute negatively to the killing capability of THP-1-derived macrophages against Candida albicans at the mid-stage. [Abstract]2023 Nov:263:25-32. PMID: 37717912 -
Food Chem Toxicol
Effect of propiconazole on neutrophil extracellular traps formation: Assessing the role of autophagy. [Abstract]2022 Oct:168:113354. PMID: 35952824 -
Immunobiology
Chronic stress promotes colorectal cancer progression by inducing M2 macrophage polarization and activating the CCL2-CCR2 axis. [Abstract]2026 Jun 25;231(4):153211. PMID: 42372631 -
Tissue Cell
Silencing of SOX4 prevents endothelial injury from ox-LDL stimulation by inhibiting NF-κB pathway and ferroptosis. [Abstract]2026 Feb:98:103199. PMID: 41166996 -
Immunobiology
ZBP1 aggravates acute lung injury in mice by promoting the macrophage inflammatory phenotype. [Abstract]2025 Dec 31;231(1):153154. PMID: 41496195 -
Tissue Cell
Exosomes secreted from M2-polarized macrophages inhibit osteoclast differentiation via CYLD. [Abstract]2025 Apr:93:102645. PMID: 39671756 -
FEBS Lett
Identification of novel anti-leishmanials targeting glutathione synthetase of the parasite: a drug repurposing approach. [Abstract]2025 Feb;599(3):367-380. PMID: 39266470 -
BMC Pulm Med
β-elemene inhibits tumor-promoting in small cell lung cancer by affecting M2 macrophages and TGF-β. [Abstract]2025 Feb 28;25(1):97. PMID: 40022030 -
Tissue Cell
Bromodomain containing 4 inhibition combats gastric precancerous lesions via modulating macrophage polarization. [Abstract]2024 Dec:91:102580. PMID: 39396437 -
Immunobiology
The role of CD24hiCD27+ regulatory B cells in human chronic rhinosinusitis with/without nasal polyps. [Abstract]2024 Nov;229(6):152854. PMID: 39340956 -
Placenta
High expression of CX3CL1/CX3CR1 at the mother-fetus interface of preeclampsia inhibits trophoblast invasion and migration. [Abstract]2024 Aug 21:156:30-37. PMID: 39236525 -
Placenta
The protective mechanism of human umbilical cord mesenchymal stem cell-derived exosomes against neutrophil extracellular trap-induced placental damage. [Abstract]2024 May 28:153:59-74. PMID: 38823320 -
FEBS Lett
Mdm2-mediated ubiquitination of PKCβII is responsible for insulin-induced heterologous desensitization of dopamine D3 receptor. [Abstract]2024 Feb;598(4):400-414. PMID: 38302840 -
J Proteomics
Global proteomic analysis reveals lysine succinylation contributes to the pathogenesis of aortic aneurysm and dissection. [Abstract]2023 May 30:280:104889. PMID: 36966968 -
Platelets
EloA promotes HEL polyploidization upon PMA stimulation through enhanced ERK1/2 activity. [Abstract]2022 Jul 4;33(5):755-763. PMID: 34697988 -
Immunopharmacol Immunotoxicol
Picroside II alleviates DSS-induced ulcerative colitis by suppressing the production of NLRP3 inflammasomes through NF-κB signaling pathway. [Abstract]2022 Jun;44(3):437-446. PMID: 35293848 -
Tissue Cell
2022 Feb:74:101683. PMID: 34800878 -
J Neuroimmunol
Matairesinol ameliorates experimental autoimmune uveitis by suppression of IRBP-specific Th17 cells. [Abstract]2020 Aug 15:345:577286. PMID: 32559555 -
Mult Scler Relat Disord
2025 Sep 16:104:106759. PMID: 40976200 -
Cell Biochem Biophys
Down-regulation of ATP8B2 in Foam Cells Inhibits Autophagic Flux and ox-LDL Degradation in Atherosclerosis. [Abstract]2025 Mar 28. PMID: 40148707 -
Front Cardiovasc Med
The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway. [Abstract]2021 Nov 8;8:770163. PMID: 34820432 -
Neurogastroenterol Motil
Acute stress induces visceral hypersensitivity via glucocorticoid receptor-mediated membrane insertion of TRPM8: Involvement of a non-receptor tyrosine kinase Pyk2. [Abstract]2020 Oct;32(10):1514-1528. PMID: 32391653 -
J Cell Biochem
M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma. [Abstract]2020 Apr;121(4):2828-2838. PMID: 31692069 -
PeerJ
The effects of plasma from patients with active thyroid-associated orbitopathy on the survival and inflammation of melanoma-associated fibroblasts. [Abstract]2024 Nov 27:12:e18612. PMID: 39619202 -
PeerJ
Vitamin D receptor-deficient keratinocytes-derived exosomal miR-4505 promotes the macrophage polarization towards the M1 phenotype. [Abstract]2023 Aug 4:11:e15798. PMID: 37554338 -
Chem Biodivers
Total Flavonoids of Engelhardia roxburghiana Wall. Leaves Alleviated Foam Cells Formation through AKT/mTOR-Mediated Autophagy in the Progression of Atherosclerosis. [Abstract]2021 Sep;18(9):e2100308. PMID: 34259387 -
Biomed Res Int
Gentiopicroside Produces Endothelium-Independent Vasodilation by Deactivating the PI3K/Akt/Rho-Kinase Pathway in Isolated Rat Thoracic Aorta. [Abstract]2021 May 14:2021:5565748. PMID: 34095301 -
Biomed Res Int
Rapamycin Inhibited Pyroptosis and Reduced the Release of IL-1 β and IL-18 in the Septic Response. [Abstract]2020 Aug 8:2020:5960375. PMID: 32851082 -
PLoS One
Tumor-associated M2 macrophages promote prostate cancer invasion through the M-CSF-PCLAF pathway. [Abstract]2026 Jun 22;21(6):e0351858. PMID: 42329914 -
Dig Dis Sci
Single-Cell Transcriptomics Dissects the Molecular Mechanism by Which Macrophage Polarization Drives Hepatocellular Carcinoma Metastasis Through Crosstalk with Emt-Tumor Microenvironment. [Abstract]2026 Apr 25. PMID: 42032376 -
Curr Microbiol
2025 Dec 27;83(2):100. PMID: 41460255 -
Hum Cell
METTL14 knockdown augmented the polarization of M2-like macrophages to promote acute myeloid leukemia progression. [Abstract]2025 Sep 30;38(6):168. PMID: 41026373 -
Hum Cell
ODC1 loss upon KLF6 upregulation promotes macrophage pyroptosis and acute kidney injury in sepsis. [Abstract]2025 Sep 17;38(6):163. PMID: 40962975 -
Vet Microbiol
FCV activates NLRP3 inflammasome through ion-dependent pathway to promote IL-1β secretion. [Abstract]2025 Aug:307:110628. PMID: 40602240 -
Discov Oncol
Glioma promotes macrophage immunosuppressive phenotype through ANXA1 in a methionine metabolism-dependent manner. [Abstract]2025 Jul 6;16(1):1269. PMID: 40618309 -
Discov Oncol
Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer. [Abstract]2025 Jul 1;16(1):1196. PMID: 40591172 -
PLoS One
Effect of the TIM-3/Gal-9 signaling pathway on macrophage polarization in peri-implantitis. [Abstract]2025 Jul 18;20(7):e0328258. PMID: 40679998 -
Reprod Sci
Targeting Decidual Macrophage Polarization through JNK Signaling Pathway Inhibition Alleviates Adverse Pregnancy Outcomes in Early Spontaneous Abortion. [Abstract]2025 Jul;32(7):2233-2243. PMID: 40550988 -
Vet Microbiol
Immunological characteristics of the recombinant pseudorabies virus with chimeric PCV Cap protein in pigs. [Abstract]2025 Jun:305:110529. PMID: 40288026 -
Int J Immunopathol Pharmacol
Cucurbitacin B inhibits Th17 cell differentiation via the suppression of the JAK/STAT pathway and alleviates collagen-induced arthritis in mice. [Abstract]2025 Jan-Dec:39:3946320251348715. PMID: 40518910 -
Discov Oncol
PTTG1 promotes M2 macrophage polarization via the cGMP-PKG signaling pathway and facilitates EMT progression in human epithelial ovarian cancer cells. [Abstract]2025 May 12;16(1):730. PMID: 40353994 -
Biomol Biomed
Periplocin improves the sensitivity of oxaliplatin-resistant hepatocellular carcinoma cells by inhibiting M2 macrophage polarization. [Abstract]2025 Mar 7;25(4):857-868. PMID: 39207178 -
Cardiovasc Ther
A Positive Feedback Loop Between CXCL16 and the Inflammatory Factors IL-17A and TGF- β Promotes Large Artery Atherosclerosis by Activating the STAT3/NF- κ B Pathway. [Abstract]2025 Mar 24:2025:2973633. PMID: 40165931 -
Vet Microbiol
Porcine reproductive and respiratory syndrome virus infection activates ADAM17 to induce inflammatory responses. [Abstract]2024 May:292:110066. PMID: 38555788 -
J Pharmacol Sci
Wilforlide A ameliorates the progression of rheumatoid arthritis by inhibiting M1 macrophage polarization. [Abstract]2022 Jan;148(1):116-124. PMID: 34924115 -
FEBS Open Bio
Differential regulation of ZFAS1 splice variants by endoplasmic reticulum stress in hepatocyte cell lines. [Abstract]2026 Feb 6. PMID: 41649053 -
-
Gene
Pathogenicity analysis of three SCA14-associated missense mutations in PRKCG gene of Chinese patients with ataxia. [Abstract]2025 Jul 20:958:149483. PMID: 40221062 -
FEBS Open Bio
FXR activation reduces the formation of macrophage foam cells and atherosclerotic plaque, possibly by down regulating hepatic lipase in macrophages. [Abstract]2025 Feb;15(2):311-323. PMID: 39601316 -
Clin Breast Cancer
m6A Modification Mediates Exosomal LINC00657 to Trigger Breast Cancer Progression Via Inducing Macrophage M2 Polarization. [Abstract]2023 Jul;23(5):546-560. PMID: 37198028 -
-
Burns
Nucleotide-binding domain-like receptor protein 3 inflammasome contributes to vascular endothelial barrier dysfunction and shock after burn injury. [Abstract]2025 Jun 27;51(7):107589. PMID: 40651119 -
Hereditas
Integrated bioinformatic analysis identifies GADD45B as an immune-related prognostic biomarker in skin cutaneous melanoma. [Abstract]2025 May 11;162(1):74. PMID: 40350499 -
J Mol Histol
Hsa-miR-194-5p regulates TRAF6-mediated M1 macrophage apoptosis in recurrent spontaneous abortion. [Abstract]2025 May 26;56(3):166. PMID: 40418413 -
Prostaglandins Other Lipid Mediat
Omentin-1 attenuates lipopolysaccharide-induced inflammation and osteogenic differentiation in periodontal ligament stem cells and reduces M1 macrophages polarization through repressing endoplasmic reticulum stress. [Abstract]2024 Oct:174:106882. PMID: 39151819 -
BMC Med Genomics
Identification of potential diagnostic biomarkers of atherosclerosis based on bioinformatics strategy. [Abstract]2023 May 12;16(1):100. PMID: 37173673 -
J Nat Med
Non-carcinogenic/non-nephrotoxic aristolochic acid IVa exhibited anti-inflammatory activities in mice. [Abstract]2023 Mar;77(2):251-261. PMID: 36525161 -
Biochem Biophys Res Commun
Allograft inflammatory factor-1 in macrophages promotes renal tubular cell epithelial-mesenchymal transition via the NF-κB/IL-1β axis in diabetic kidney disease. [Abstract]2026 Jun 23:829:154192. PMID: 42349122 -
Biochem Biophys Res Commun
TPI1 promotes tumor progression and M2 macrophage polarization: Integrated pan-cancer and lung adenocarcinoma insights. [Abstract]2026 Jan 25:797:153099. PMID: 41447883 -
Biochem Biophys Res Commun
Glucose transports in the ileum: mechanism, regulation and physiological role of ileal glucose absorption. [Abstract]2025 Sep 19:785:152676. PMID: 41005286 -
Biochem Biophys Res Commun
2025 Sep 1:777:152330. PMID: 40652815 -
Biochem Biophys Res Commun
2025 Aug 15:775:152110. PMID: 40450990 -
Biochem Biophys Res Commun
Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy. [Abstract]2023 Jul 23:666:115-121. PMID: 37182286 -
Am J Reprod Immunol
NETs promote ROS production to induce human amniotic epithelial cell apoptosis via ERK1/2 signaling in spontaneous preterm birth. [Abstract]2023 Mar;89(3):e13656. PMID: 36409534 -
Biochem Biophys Res Commun
P-Tyr42 RhoA GTPase amplifies superoxide formation through p47phox, phosphorylated by ROCK. [Abstract]2020 Mar 19;523(4):972-978. PMID: 31973815 -
-
-
Pulm Circ
Didang decoction attenuates cancer-associated thrombosis by inhibiting PAD4-dependent NET formation in lung cancer. [Abstract]2024 Oct 9;14(4):e12454. PMID: 39386377 -
Onco Targets Ther
The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ. [Abstract]2018 Oct 18:11:7229-7243. PMID: 30425515 -
Ann Hematol
Identification and validation of a prognostic risk-scoring model in drug-resistant ALL and evaluation of immune micro-environment. [Abstract]2026 May 29. PMID: 42215742 -
Immunol Invest
PTBP1-TRAF6 Axis Aggravates Chronic Obstructive Pulmonary Disease by Promoting M1 Macrophage Polarization and Impairing Clearance of Neutrophil Extracellular Traps. [Abstract]2026 Jan 12:1-26. PMID: 41521889 -
Ann Hematol
MiR-525-5p modulates cell proliferation, cell cycle, and apoptosis in Burkitt's lymphoma by targeting MyD88 and regulating the NF-κB signaling pathway. [Abstract]2024 Dec;103(12):5817-5833. PMID: 39495280 -
Int J Gen Med
2024 Jan 10:17:59-74. PMID: 38221941 -
Immunol Invest
Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice. [Abstract]2022 Aug;51(6):1785-1803. PMID: 35332841 -
Int Arch Allergy Immunol
Increased Expressions and Roles of CC Chemokine Ligand 21 and CC Chemokine Ligand 25 in Chronic Rhinosinusitis with Nasal Polyps. [Abstract]2020;181(3):159-169. PMID: 31825941 -
Arch Oral Biol
Gingival mesenchymal stem cells attenuate pro-inflammatory macrophages stimulated with oxidized low-density lipoprotein and modulate lipid metabolism. [Abstract]2019 Feb:98:92-98. PMID: 30468993 -
Cytotechnology
Alcohol consumption affects macrophage polarization and promotes the malignant behavior of gastric cancer cells by regulating the miR-29c-3p/COL1A1 signaling pathway. [Abstract]2025 Dec;77(6):194. PMID: 41230538 -
Exp Ther Med
PDCD4 silencing alleviates KA‑induced neurotoxicity of HT22 cells by inhibiting endoplasmic reticulum stress via blocking the MAPK/NF‑κB signaling pathway. [Abstract]2023 Dec 6;27(2):55. PMID: 38234627 -
Exp Ther Med
MALT1 accelerates proatherogenic vascular smooth muscle cell growth, invasion and synthetic phenotype switching via nuclear factor‑κB signaling‑dependent way. [Abstract]2023 May 22;26(1):337. PMID: 37383381 -
Exp Ther Med
A20 affects macrophage polarization through the NLRP3 inflammasome signaling pathway and promotes breast cancer progression. [Abstract]2023 Feb 15;25(4):147. PMID: 36911385 -
Exp Ther Med
DUSP4 alleviates LPS-induced chondrocyte injury in knee osteoarthritis via the MAPK signaling pathway. [Abstract]2021 Dec;22(6):1401. PMID: 34650647 -
Braz J Microbiol
Mycobacterium tuberculosis reinforces M2 polarization of macrophages by activating glutamine metabolism. [Abstract]2026 May 18;57(1):146. PMID: 42149367 -
Oncol Lett
Lung squamous cell carcinoma downregulates haptoglobin expression to inhibit M2 macrophage ferroptosis via the hemoglobin-dependent CD163/HO-1 pathway. [Abstract]2026 Mar 30;31(5):203. PMID: 41987865 -
Asia Pac J Clin Oncol
The prognostic and immune significance of Rab11A in pan-cancer and its function and mechanism underlying estrogen receptor targeting in breast cancer. [Abstract]2025 Feb;21(1):12-30. PMID: 39395024 -
Oncol Lett
Tumor-associated macrophage-derived exosomes promote EGFR-TKI resistance in non-small cell lung cancer by regulating the AKT, ERK1/2 and STAT3 signaling pathways. [Abstract]2022 Aug 24;24(4):356. PMID: 36168315 -
-
Int J Genomics
Chaperonins in Hepatocellular Carcinoma: Unveiling Their Role in Tumor Proliferation and Immune Modulation Through Multiomics Analysis. [Abstract]2025 Nov 26:2025:6152675. PMID: 41312091 -
Anticancer Drugs
Thrombospondin-2 induces M2 macrophage polarization through fatty acid metabolism to drive lung adenocarcinoma proliferation. [Abstract]2025 Jul 1;36(6):459-467. PMID: 40053399 -
Anticancer Drugs
α-Asarone attenuates tumor-associated macrophages-induced gemcitabine resistance in pancreatic carcinoma via the transforming growth factor-beta 1/growth factor independent 1 axis. [Abstract]2025 Jun 13. PMID: 40511788 -
In Vitro Cell Dev Biol Anim
PKCβ expression contributes to M1 macrophage-induced impairment in the osteogenic differentiation of periodontal ligament stem cells. [Abstract]2025 Jun;61(6):635-643. PMID: 40526258 -
In Vitro Cell Dev Biol Anim
IL-27 attenuated macrophage injury and inflammation induced by Mycobacterium tuberculosis by activating autophagy. [Abstract]2025 Feb;61(2):245-256. PMID: 39455490 -
Int J Rheum Dis
MiR-223-3p and miR-22-3p inhibit monosodium urate-induced gouty inflammation by targeting NLRP3. [Abstract]2021 Apr;24(4):599-607. PMID: 33650318 -
Biochem Genet
FBXW7 Inhibited M2 Macrophage Polarization in Endometrial Cancer by Reducing CCL2 Secretion Through Ubiquitination of MYBL2 Subtitle: The Role of FBXW7 on M2 Macrophage Polarization in EC. [Abstract]2026 Jan 3. PMID: 41484508 -
Biochem Genet
Silencing THBS1 in M2 Macrophages Exerts an Inhibitory Effect on Tongue Squamous Cell Carcinoma by Suppressing TGF-β Pathway. [Abstract]2025 Jul 1. PMID: 40591142 -
J Interferon Cytokine Res
Lienal Polypeptide Decreases Immune Thrombocytopenia in a Mouse Model by Upregulating Cytokine Production and Increasing the Levels of CD4+, CD8+, and T Regulatory Cells. [Abstract]2025 Mar 21. PMID: 40113259 -
Eur J Histochem
Knockdown of miR-411-3p induces M2 macrophage polarization and promotes colorectal cancer progression by regulation of MMP7. [Abstract]2025 Apr 7;69(2). PMID: 40322788 -
Transl Androl Urol
Silencing SPP1 in M2 macrophages inhibits the progression of castration-resistant prostate cancer via the MMP9/TGFβ1 axis. [Abstract]2024 Jul 31;13(7):1239-1255. PMID: 39100821 -
Ann Dermatol
Exogenous Local Hyperthermia at 41℃ Is Effective to Eliminate Mouse Model of Sporotrichosis, Independent of Neutrophil Extracellular Traps Formation. [Abstract]2021 Feb;33(1):37-45. PMID: 33911810 -
Hum Mutat
Targeting LY6E Inhibits Neuroblastoma Progression and Suppresses M2 Macrophage Polarization. [Abstract]2026 Apr 15:2026:3003097. PMID: 41993132 -
Biol Pharm Bull
Ponicidin Induces Apoptosis of Murine Melanoma by Inhibiting the NF-κB Signaling Pathway. [Abstract]2023;46(6):803-810. PMID: 37258145 -
Acta Paediatr
MicroRNA profiling in Chinese children with Henoch-Schonlein purpura and association between selected microRNAs and inflammatory biomarkers. [Abstract]2021 Jul;110(7):2221-2229. PMID: 33533510 -
Iran J Pharm Res
KMT2D Induces M1 Macrophage Polarization to Repress Non-small Cell Lung Cancer Progression via Transcription Activation of ITGAL. [Abstract]2025 Mar 8;24(1):e159395. PMID: 40718439 -
Transpl Immunol
TLR3 stimulation rejuvenates aged mesenchymal stem cells and restores immunosuppressive function in graft-versus-host disease. [Abstract]2026 Feb:94:102346. PMID: 41520686 -
-
Crit Rev Eukaryot Gene Expr
2025;35(7):51-63. PMID: 41135077 -
Tohoku J Exp Med
MicroRNA-668-3p Mediates Macrophage M2 Polarization by Targeting NFKBIA to Affect Gastric Cancer Cell Proliferation and Migration. [Abstract]2025 Mar 27;265(3):173-182. PMID: 39505541 -
Tohoku J Exp Med
OxLDL-Stimulated Macrophages Transmit Exosomal MicroRNA-320b to Aggravate Viability, Invasion, and Phenotype Switching via Regulating PPARGC1A-Mediated MEK/ERK Pathway in Proatherogenic Vascular Smooth Muscle Cells. [Abstract]2024 Jan 10;262(1):13-22. PMID: 37793881 -
-
STAR Protoc
2026 Apr 24;7(2):104523. PMID: 42033729 -
-
-
Transfus Apher Sci
CFNAs of RBCs affect the release of inflammatory factors through the expression of CaMKIV in macrophages. [Abstract]2022 Dec;61(6):103494. PMID: 35773126 -
Biomed Pharmacother
Enhanced efficacy of methyl ferulate upon pentanoylation in ameliorating psoriasis via Nrf2/NF-κB pathway regulation and HDACs downregulation. [Abstract]2026 Jul:200:119638. PMID: 42269223 -
-
-
bioRxiv
ProNotch converts extracellular protease activity into programmable transcriptional outputs. [Abstract]2026 Jun 3:2026.06.01.728985. PMID: 42282718 -
-
bioRxiv
2026 May 29:2026.05.26.727520. PMID: 42244578 -
-
-
-
-
-
-
J Environ Sci (China)
Nanoplastics and triclosan co-exposure aggravates DSS-induced colitis in mice by interfering with Akkermansia muciniphila and tryptophan metabolism. [Abstract]2026 Mar:161:189-200. PMID: 41461466 -
-
-
-
-
-
-
-
bioRxiv
A human sensory neuron model for varicella-zoster virus latency and reactivation in vitro. [Abstract]2025 Dec 12:2025.12.12.693952. PMID: 41415445 -
-
-
-
bioRxiv
2025 Aug 14:2025.08.14.670414. PMID: 40832228 -
Environ Toxicol
2025 May 12. PMID: 40353638 -
-
-
-
-
bioRxiv
Optogenetic control of Protein Kinase C-epsilon activity reveals its intrinsic signaling properties with spatiotemporal resolution. [Abstract]2025 Jan 6:2025.01.06.631444. PMID: 39829776 -
-
-
-
-
Biomed Pharmacother
Cereblon mediates macrophage differentiation and microglial phagocytosis by regulating calpain protease activity. [Abstract]2024 Nov:180:117606. PMID: 39454366 -
Sci Total Environ
Microcystin-LR prenatal exposure induces coronary heart disease through macrophage polarization imbalance mediated by trophoblast-derived extracellular vesicles. [Abstract]2024 Oct 20:948:174979. PMID: 39053546 -
-
-
-
Heliyon
2024 May 23;10(11):e31818. PMID: 38845872 -
-
-
-
-
Heliyon
Oxidized low-density lipoprotein changes the inflammatory status and metabolomics profiles in human and mouse macrophages and microglia. [Abstract]2024 Mar 28;10(7):e28806. PMID: 38617955 -
-
Chemosphere
The effects of Spinosad on zebrafish larvae and THP-1 cells: Associated with immune cell damage and NF-kappa B signaling pathway activation. [Abstract]2023 Dec:343:140237. PMID: 37734501 -
-
-
Heliyon
A combination of all-trans retinoic acid derivative and COX-2 inhibitor has anticancer effects in human pharyngeal carcinoma cells. [Abstract]2023 Nov 17;9(11):e21664. PMID: 38074870 -
-
-
bioRxiv
2023 Sep 19:2023.09.18.558306. PMID: 37786722 -
-
-
-
-
Biomed Pharmacother
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment. [Abstract]2023 May:161:114560. PMID: 36940618 -
Environ Toxicol
Investigation on the immunotoxicity induced by Emamectin benzoate on THP-1 macrophages based on metabolomics analysis. [Abstract]2023 May;38(5):1053-1062. PMID: 36896474 -
Environ Toxicol
2023 Mar;38(3):500-510. PMID: 36269090 -
Sci Total Environ
Sequential exposures of single walled carbon nanotubes and heavy metal ions to macrophages induce different cytotoxicity. [Abstract]2023 Mar 15:864:161059. PMID: 36565863 -
-
-
-
-
-
-
-
-
-
Biomed Pharmacother
Dendrobium officinale polysaccharides attenuate uropathogenic Escherichia coli (UPEC)-induced pyroptosis in macrophage cells. [Abstract]2022 Jul;151:113098. PMID: 35594714 -
Oxid Med Cell Longev
A β 1-40 Oligomers Trigger Neutrophil Extracellular Trap Formation through TLR4- and NADPH Oxidase-Dependent Pathways in Age-Related Macular Degeneration. [Abstract]2022 Jun 18:2022:6489923. PMID: 35761872 -
Ann Transl Med
Oncostatin M promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the NF-κB pathway in THP-1 macrophages and promotes the progression of atherosclerosis. [Abstract]2022 Apr;10(8):456. PMID: 35571419 -
J Oncol
Identification of a Ferroptosis-Related Prognostic Gene PTGS2 Based on Risk Modeling and Immune Microenvironment of Early-Stage Cervical Cancer. [Abstract]2022 Apr 8:2022:3997562. PMID: 35432535 -
-
-
Elife
Genetically incorporated crosslinkers reveal NleE attenuates host autophagy dependent on PSMD10. [Abstract]2021 Jul 13;10:e69047. PMID: 34254583 -
Evid Based Complement Alternat Med
2021 Jul 16;2021:6622848. PMID: 34335832 -
-
Aging (Albany NY)
AKT3 deficiency in M2 macrophages impairs cutaneous wound healing by disrupting tissue remodeling. [Abstract]2020 Apr 14;12(8):6928-6946. PMID: 32291381 -
Solvent & Solubility
Ethanol : 100 mg/mL (162.12 mM; Need ultrasonic)
DMSO : 25 mg/mL (40.53 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.05 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.5 mg/mL (4.05 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Add each solvent one by one: 10% EtOH 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.05 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% EtOH 90% (20% SBE-β-CD in Saline)
Solubility: 2.5 mg/mL (4.05 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Add each solvent one by one: 10% EtOH 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (4.05 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
αT3-1 and LβT-2 cells are grown in monolayer cultured in DMEM in humidified incubator 5% CO2 at 37°C. Serum starvation is with 0.1% FCS in the same medium for 16 h. GnRH and PMA are then added for the length of time as indicated. In general, αT3-1 cells are transiently transfected by ExGen 500 or by jetPRIME, while LβT2 cells only by jetPRIME transfection reagent. For experiments with dominant-negative (DN) PKCs, αT3-1 cells (in 6 cm plates) are transfected with 1.5 μg of p38α-GFP with 3 μg of control vector, pCDNA3, or with 3 μg of the DN-PKCs constructs. For LβT2 cells, transfections are performed (in 10 cm plates) with 4 μg of p38α-GFP along with 9 μg of control vector, pCDNA3, or with 9 μg of the DN-PKCs constructs. Approximately 30 h after transfection, the cells are serum starved (0.1% FCS) for 16 h and later stimulated with GnRH or PMA, washed twice with ice-cold PBS, treated with the lysis buffer, followed by one freeze-thaw cycle. Cells are harvested; following centrifugation (15,000×g, 15 min, 4°C) supernatants are taken for immunoprecipitation experiments[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Rats[3]
All experiments qre performed with male Wistar rats (weighing 250-280 g). One hundred and thirty-five Wistar rats are randomly divided into seven groups. (1) Rats in the sham group (n=21) are given a lateral cerebral ventricle injection of 0.9% normal saline; (2) Rats in the IR group (n=21) are given a lateral cerebral ventricle injection of 0.9% normal saline 30 min before middle cerebral artery occlusion (MCAO); (3) Rats in the Carbenoxolone (CBX) group (n=21) are given a lateral cerebral ventricle injection of CBX (5 μg/mL×10 μL) 30 min before MCAO; (4) Rats in the Sch-6783 group (n=21) are given a lateral cerebral ventricle injection of DZX (2 mM×30 μL) 30 min prior to MCAO; (5) Rats in the 5-HD group (n=21) are given a lateral cerebral ventricle injection of 5-HD (100 mM×10 μL), and after 10 min, DZX is injected 15 min prior to MCAO; (6) The rats in the DZX + Ro group (n=15) are given a lateral cerebral ventricle injection of DZX, and after 10 min, Ro-31-8425 (400 μg/kg) is injected 15 min prior to MCAO; (7) The rats in the 5-HD+PMA group (n=15) are given an intraperitoneal injection of PMA (200 μg/kg) after the injection of 5-HD and DZX.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (287 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[2]. Zhang T, et al. MPTP-Induced Depletion in Basolateral Amygdala via Decrease of D2R Activation Suppresses GABAA Receptors Expression and LTD Induction Leading to Anxiety-Like Behaviors. Front Mol Neurosci. 2017 Aug 7;10:247. [Content Brief]
[3]. Schwende H, et al. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol. 1996;59(4):555-561. [Content Brief]
[4]. Mugami S, et al. Differential roles of PKC isoforms (PKCs) and Ca2+ in GnRH and phorbol 12-myristate 13-acetate (PMA) stimulation of p38MAPK phosphorylation in immortalized gonadotrope cells. Mol Cell Endocrinol. 2017 Jan 5;439:141-154. [Content Brief]
[5]. Starr T, et al. The phorbol 12-myristate-13-acetate differentiation protocol is critical to the interaction of THP-1 macrophages with Salmonella Typhimurium. PLoS One. 2018;13(3):e0193601. Published 2018 Mar 14. [Content Brief]
[6]. Hou S, et al. Mechanism of Mitochondrial Connexin43's Protection of the Neurovascular Unit under Acute Cerebral Ischemia-Reperfusion Injury. Int J Mol Sci. 2016 May 5;17(5). pii: E679. [Content Brief]
[7]. Heng-Ching Wen, et al. PMA inhibits endothelial cell migration through activating the PKC-δ/Syk/NF-κB-mediated up-regulation of Thy-1. Sci Rep. 2018 Nov 2;8(1):16247. [Content Brief]
[8]. Silván AM, et al. Inhibition by hydroxyachillin, sesquiterpene lactone from Tanacetum microphyllum, of PMA-induced mouse ear oedema. Inflamm Res. 1996 Jun;45(6):289-92. [Content Brief]
[9]. Kaur G, et al. Antiinflammatory evaluation of alcoholic extract of galls of Quercus infectoria. J Ethnopharmacol. 2004 Feb;90(2-3):285-92. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO / Ethanol | 1 mM | 1.6212 mL | 8.1060 mL | 16.2119 mL | 40.5298 mL |
| 5 mM | 0.3242 mL | 1.6212 mL | 3.2424 mL | 8.1060 mL | |
| 10 mM | 0.1621 mL | 0.8106 mL | 1.6212 mL | 4.0530 mL | |
| 15 mM | 0.1081 mL | 0.5404 mL | 1.0808 mL | 2.7020 mL | |
| 20 mM | 0.0811 mL | 0.4053 mL | 0.8106 mL | 2.0265 mL | |
| 25 mM | 0.0648 mL | 0.3242 mL | 0.6485 mL | 1.6212 mL | |
| 30 mM | 0.0540 mL | 0.2702 mL | 0.5404 mL | 1.3510 mL | |
| 40 mM | 0.0405 mL | 0.2026 mL | 0.4053 mL | 1.0132 mL | |
| Ethanol | 50 mM | 0.0324 mL | 0.1621 mL | 0.3242 mL | 0.8106 mL |
| 60 mM | 0.0270 mL | 0.1351 mL | 0.2702 mL | 0.6755 mL | |
| 80 mM | 0.0203 mL | 0.1013 mL | 0.2026 mL | 0.5066 mL | |
| 100 mM | 0.0162 mL | 0.0811 mL | 0.1621 mL | 0.4053 mL |